Query psy8879
Match_columns 694
No_of_seqs 572 out of 4553
Neff 7.4
Searched_HMMs 46136
Date Fri Aug 16 21:41:21 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy8879.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/8879hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG4194|consensus 100.0 2.4E-43 5.2E-48 378.6 9.7 408 97-508 151-612 (873)
2 KOG4194|consensus 100.0 8.4E-33 1.8E-37 297.7 8.1 312 54-376 44-380 (873)
3 KOG4237|consensus 100.0 3.3E-32 7.2E-37 282.5 -1.3 349 53-428 34-399 (498)
4 PLN00113 leucine-rich repeat r 100.0 5.9E-28 1.3E-32 295.3 20.9 278 94-376 92-371 (968)
5 PLN00113 leucine-rich repeat r 99.9 4.1E-27 8.8E-32 288.0 17.5 275 95-374 118-393 (968)
6 KOG0444|consensus 99.9 1.2E-26 2.5E-31 251.2 -3.3 288 79-380 42-358 (1255)
7 KOG0444|consensus 99.9 1.3E-24 2.9E-29 235.4 -0.1 273 95-378 103-379 (1255)
8 KOG0472|consensus 99.9 8.3E-25 1.8E-29 227.7 -3.6 171 96-276 138-308 (565)
9 KOG4237|consensus 99.9 4E-24 8.6E-29 222.6 -3.3 282 98-383 49-344 (498)
10 PRK15387 E3 ubiquitin-protein 99.8 1.6E-20 3.5E-25 218.6 15.4 268 64-381 198-465 (788)
11 KOG0472|consensus 99.8 2.3E-23 5E-28 217.0 -8.7 272 96-381 46-317 (565)
12 PRK15387 E3 ubiquitin-protein 99.8 6.5E-20 1.4E-24 213.5 15.8 241 96-381 202-442 (788)
13 PRK15370 E3 ubiquitin-protein 99.8 2.7E-19 5.8E-24 209.4 15.6 247 96-374 179-428 (754)
14 KOG0618|consensus 99.8 8E-21 1.7E-25 215.3 -2.9 269 95-371 241-510 (1081)
15 KOG0618|consensus 99.8 6.5E-20 1.4E-24 208.0 0.3 273 96-382 200-497 (1081)
16 PRK15370 E3 ubiquitin-protein 99.7 6.2E-18 1.3E-22 198.0 13.6 239 79-351 188-429 (754)
17 PLN03210 Resistant to P. syrin 99.7 1.7E-16 3.6E-21 196.8 22.2 264 96-379 590-888 (1153)
18 PLN03210 Resistant to P. syrin 99.7 2.2E-15 4.8E-20 186.8 20.7 259 94-372 610-904 (1153)
19 cd00116 LRR_RI Leucine-rich re 99.7 1.4E-17 3.1E-22 177.4 0.4 259 114-373 19-319 (319)
20 cd00116 LRR_RI Leucine-rich re 99.6 7.9E-17 1.7E-21 171.8 2.1 257 122-379 2-296 (319)
21 KOG0617|consensus 99.5 3.5E-16 7.6E-21 147.2 -2.3 158 168-330 33-190 (264)
22 KOG0617|consensus 99.5 1.1E-15 2.4E-20 143.8 -2.8 161 189-355 30-191 (264)
23 COG4886 Leucine-rich repeat (L 99.2 3.3E-11 7.1E-16 133.1 8.4 179 144-332 117-296 (394)
24 COG4886 Leucine-rich repeat (L 99.1 6E-11 1.3E-15 131.0 7.8 186 190-384 114-300 (394)
25 KOG0532|consensus 99.1 5E-12 1.1E-16 138.1 -1.7 199 147-355 54-252 (722)
26 KOG0532|consensus 99.1 3.4E-12 7.4E-17 139.4 -3.7 216 122-348 54-271 (722)
27 KOG3207|consensus 99.1 1E-11 2.2E-16 132.2 -1.0 160 143-304 121-286 (505)
28 PF14580 LRR_9: Leucine-rich r 99.1 9.3E-11 2E-15 114.3 5.4 140 103-248 5-148 (175)
29 PF14580 LRR_9: Leucine-rich r 99.1 6.9E-11 1.5E-15 115.2 4.3 108 168-279 19-127 (175)
30 KOG0531|consensus 99.1 3.7E-11 8.1E-16 133.7 1.8 265 96-377 50-321 (414)
31 KOG1259|consensus 99.0 7.3E-11 1.6E-15 120.1 2.2 135 237-378 281-416 (490)
32 KOG0531|consensus 99.0 6E-11 1.3E-15 132.1 1.3 244 95-354 72-322 (414)
33 KOG3207|consensus 99.0 1.9E-10 4.2E-15 122.6 3.7 208 168-375 121-340 (505)
34 KOG1909|consensus 99.0 8.1E-11 1.8E-15 122.5 -1.2 187 188-374 88-311 (382)
35 KOG1259|consensus 98.9 2.6E-10 5.7E-15 116.2 1.7 131 217-354 285-416 (490)
36 KOG1909|consensus 98.9 5.1E-10 1.1E-14 116.6 0.5 91 90-182 25-134 (382)
37 PF13855 LRR_8: Leucine rich r 98.8 4.4E-09 9.5E-14 84.4 2.9 57 291-347 3-59 (61)
38 PF13855 LRR_8: Leucine rich r 98.8 5.8E-09 1.3E-13 83.7 3.5 59 169-227 2-60 (61)
39 PLN03150 hypothetical protein; 98.6 5.7E-08 1.2E-12 113.6 7.1 107 193-300 419-526 (623)
40 PLN03150 hypothetical protein; 98.6 7.1E-08 1.5E-12 112.7 7.8 108 169-277 419-527 (623)
41 KOG4658|consensus 98.6 9.9E-08 2.1E-12 114.4 8.5 273 95-377 523-810 (889)
42 KOG1859|consensus 98.5 6.3E-09 1.4E-13 116.7 -5.2 199 168-377 84-295 (1096)
43 KOG1859|consensus 98.4 6E-09 1.3E-13 116.9 -8.2 180 111-302 102-292 (1096)
44 KOG4658|consensus 98.4 3.5E-07 7.5E-12 109.8 5.7 252 116-378 521-787 (889)
45 KOG2982|consensus 98.3 1.6E-07 3.6E-12 96.1 0.4 108 145-252 47-158 (418)
46 KOG2982|consensus 98.2 6E-07 1.3E-11 92.1 1.5 110 119-229 46-159 (418)
47 KOG4579|consensus 98.1 5.8E-07 1.3E-11 82.7 -0.9 88 266-355 54-141 (177)
48 PF13306 LRR_5: Leucine rich r 98.0 6.9E-06 1.5E-10 75.5 6.0 125 159-315 4-128 (129)
49 KOG1644|consensus 98.0 6.5E-06 1.4E-10 80.6 5.1 83 144-229 43-126 (233)
50 TIGR00864 PCC polycystin catio 98.0 8E-06 1.7E-10 104.5 6.6 69 343-423 1-71 (2740)
51 PF13306 LRR_5: Leucine rich r 98.0 1.4E-05 3E-10 73.5 6.1 77 145-225 14-90 (129)
52 COG5238 RNA1 Ran GTPase-activa 97.8 1.1E-05 2.3E-10 82.1 2.2 87 289-375 214-317 (388)
53 COG5238 RNA1 Ran GTPase-activa 97.8 2.6E-06 5.6E-11 86.5 -2.3 234 115-353 27-319 (388)
54 KOG2120|consensus 97.8 9.2E-07 2E-11 90.8 -5.6 176 169-347 186-373 (419)
55 KOG1644|consensus 97.7 3E-05 6.5E-10 76.0 4.7 103 146-252 22-125 (233)
56 KOG4579|consensus 97.7 6.3E-06 1.4E-10 76.0 -0.8 118 267-386 29-148 (177)
57 KOG2120|consensus 97.6 1.9E-06 4.2E-11 88.5 -5.3 223 145-371 138-373 (419)
58 PF12799 LRR_4: Leucine Rich r 97.6 7.2E-05 1.6E-09 55.9 3.3 38 338-376 2-39 (44)
59 PF12799 LRR_4: Leucine Rich r 97.5 0.00011 2.3E-09 55.0 3.7 37 169-206 2-38 (44)
60 PRK15386 type III secretion pr 97.2 0.0011 2.5E-08 72.7 9.4 51 96-153 53-104 (426)
61 PRK15386 type III secretion pr 97.2 0.0011 2.5E-08 72.7 9.1 134 116-276 50-188 (426)
62 KOG3665|consensus 97.2 0.0002 4.3E-09 84.4 3.3 182 96-279 61-264 (699)
63 cd05852 Ig5_Contactin-1 Fifth 97.2 0.00034 7.3E-09 58.2 3.4 38 463-500 31-69 (73)
64 cd05865 Ig1_NCAM-1 First immun 97.2 0.00068 1.5E-08 59.6 5.4 60 444-503 32-94 (96)
65 cd05745 Ig3_Peroxidasin Third 97.0 0.00083 1.8E-08 55.7 4.3 35 466-500 35-70 (74)
66 cd05866 Ig1_NCAM-2 First immun 97.0 0.001 2.3E-08 58.0 4.9 59 434-496 14-82 (92)
67 cd05723 Ig4_Neogenin Fourth im 96.9 0.0011 2.4E-08 54.5 4.5 52 445-501 16-68 (71)
68 cd05892 Ig_Myotilin_C C-termin 96.9 0.001 2.2E-08 55.7 4.2 53 445-499 15-70 (75)
69 KOG3665|consensus 96.9 0.00018 3.9E-09 84.8 -0.6 134 119-255 123-265 (699)
70 cd05746 Ig4_Peroxidasin Fourth 96.9 0.00061 1.3E-08 55.7 2.4 37 464-500 29-66 (69)
71 cd04969 Ig5_Contactin_like Fif 96.8 0.0012 2.5E-08 54.6 3.7 52 445-501 18-70 (73)
72 cd05725 Ig3_Robo Third immunog 96.8 0.0011 2.5E-08 54.0 3.5 50 445-500 15-65 (69)
73 cd05893 Ig_Palladin_C C-termin 96.8 0.0015 3.2E-08 54.7 3.8 51 445-499 15-70 (75)
74 KOG2123|consensus 96.7 0.00011 2.3E-09 75.3 -4.0 82 169-254 20-102 (388)
75 cd05876 Ig3_L1-CAM Third immun 96.7 0.002 4.4E-08 53.0 4.2 34 468-501 33-67 (71)
76 cd04977 Ig1_NCAM-1_like First 96.7 0.0035 7.5E-08 54.5 5.9 25 471-495 57-82 (92)
77 cd05853 Ig6_Contactin-4 Sixth 96.7 0.0013 2.8E-08 56.5 2.8 29 469-497 45-74 (85)
78 cd05727 Ig2_Contactin-2-like S 96.7 0.002 4.4E-08 56.6 4.1 28 469-496 58-86 (96)
79 cd05738 Ig2_RPTP_IIa_LAR_like 96.7 0.0014 3.1E-08 54.4 2.9 36 464-499 31-67 (74)
80 cd05732 Ig5_NCAM-1_like Fifth 96.6 0.0034 7.5E-08 54.5 5.5 31 471-501 62-93 (96)
81 cd05735 Ig8_DSCAM Eight immuno 96.6 0.0033 7.1E-08 54.2 5.3 34 471-504 47-81 (88)
82 cd05869 Ig5_NCAM-1 Fifth immun 96.6 0.0031 6.7E-08 55.3 5.1 32 471-502 63-95 (97)
83 cd05734 Ig7_DSCAM Seventh immu 96.6 0.0026 5.6E-08 53.4 4.3 36 463-498 36-72 (79)
84 cd05764 Ig_2 Subgroup of the i 96.6 0.0035 7.5E-08 51.8 5.0 53 444-500 17-70 (74)
85 cd04970 Ig6_Contactin_like Six 96.5 0.0032 6.9E-08 53.6 4.5 30 468-497 44-74 (85)
86 cd05744 Ig_Myotilin_C_like Imm 96.5 0.0031 6.6E-08 52.6 4.1 27 472-498 42-69 (75)
87 KOG2739|consensus 96.5 0.0017 3.6E-08 66.4 2.9 15 261-275 61-75 (260)
88 cd05726 Ig4_Robo Fhird immunog 96.5 0.0036 7.8E-08 54.0 4.7 38 462-499 38-76 (90)
89 cd05854 Ig6_Contactin-2 Sixth 96.5 0.0038 8.2E-08 53.5 4.7 33 469-501 45-78 (85)
90 KOG2123|consensus 96.5 0.00031 6.7E-09 72.0 -2.4 84 239-327 18-102 (388)
91 cd05857 Ig2_FGFR Second immuno 96.5 0.005 1.1E-07 52.2 5.2 55 445-500 26-81 (85)
92 cd05763 Ig_1 Subgroup of the i 96.4 0.0051 1.1E-07 51.0 4.9 31 470-500 39-70 (75)
93 KOG2739|consensus 96.4 0.002 4.3E-08 65.8 2.6 104 263-368 41-150 (260)
94 cd05870 Ig5_NCAM-2 Fifth immun 96.3 0.0083 1.8E-07 52.6 6.0 30 471-500 64-94 (98)
95 cd05724 Ig2_Robo Second immuno 96.3 0.0063 1.4E-07 51.6 5.1 38 465-502 45-83 (86)
96 cd05845 Ig2_L1-CAM_like Second 96.3 0.0059 1.3E-07 53.6 4.9 58 434-495 17-84 (95)
97 cd04971 Ig_TrKABC_d5 Fifth dom 96.3 0.0054 1.2E-07 52.1 4.2 32 470-501 45-77 (81)
98 cd04974 Ig3_FGFR Third immunog 96.2 0.01 2.2E-07 51.3 5.7 29 471-499 55-84 (90)
99 cd05737 Ig_Myomesin_like_C C-t 96.1 0.007 1.5E-07 52.4 4.5 30 472-501 59-89 (92)
100 cd05891 Ig_M-protein_C C-termi 96.1 0.0067 1.4E-07 52.7 4.2 55 445-502 33-90 (92)
101 cd05855 Ig_TrkB_d5 Fifth domai 96.1 0.0066 1.4E-07 51.4 4.0 57 445-501 15-75 (79)
102 cd05851 Ig3_Contactin-1 Third 96.1 0.008 1.7E-07 51.8 4.6 61 434-500 15-83 (88)
103 cd05895 Ig_Pro_neuregulin-1 Im 96.1 0.0066 1.4E-07 50.4 3.8 30 470-499 43-73 (76)
104 cd04978 Ig4_L1-NrCAM_like Four 96.1 0.008 1.7E-07 49.7 4.2 33 469-501 39-72 (76)
105 cd05740 Ig_CEACAM_D4 Fourth im 96.0 0.0075 1.6E-07 52.4 4.1 28 471-498 55-83 (91)
106 cd05858 Ig3_FGFR-2 Third immun 96.0 0.0098 2.1E-07 51.3 4.7 29 471-499 55-84 (90)
107 cd05731 Ig3_L1-CAM_like Third 96.0 0.007 1.5E-07 49.2 3.5 32 470-501 35-67 (71)
108 cd05867 Ig4_L1-CAM_like Fourth 95.9 0.0099 2.2E-07 49.4 4.2 31 470-500 40-71 (76)
109 cd05894 Ig_C5_MyBP-C C5 immuno 95.9 0.014 3E-07 50.1 5.0 31 471-501 52-83 (86)
110 cd04972 Ig_TrkABC_d4 Fourth do 95.8 0.015 3.3E-07 50.1 5.0 31 470-500 55-86 (90)
111 cd05742 Ig1_VEGFR_like First i 95.8 0.012 2.6E-07 49.9 4.3 29 471-499 49-78 (84)
112 cd05765 Ig_3 Subgroup of the i 95.8 0.013 2.8E-07 49.0 4.4 35 466-500 42-77 (81)
113 cd05736 Ig2_Follistatin_like S 95.8 0.012 2.6E-07 48.8 4.0 31 472-502 40-71 (76)
114 cd05747 Ig5_Titin_like M5, fif 95.7 0.014 3E-07 50.5 4.4 30 470-499 58-88 (92)
115 cd04973 Ig1_FGFR First immunog 95.7 0.012 2.7E-07 49.4 3.9 30 471-500 45-75 (79)
116 cd05862 Ig1_VEGFR First immuno 95.7 0.018 3.9E-07 49.4 5.0 29 471-499 50-79 (86)
117 cd05868 Ig4_NrCAM Fourth immun 95.7 0.011 2.4E-07 49.3 3.6 34 471-504 41-75 (76)
118 cd05760 Ig2_PTK7 Second immuno 95.6 0.025 5.3E-07 47.3 5.5 27 470-496 37-64 (77)
119 cd05882 Ig1_Necl-1 First (N-te 95.6 0.03 6.5E-07 49.1 6.2 31 470-502 61-92 (95)
120 cd04968 Ig3_Contactin_like Thi 95.6 0.02 4.4E-07 48.9 4.9 30 469-498 51-81 (88)
121 cd05748 Ig_Titin_like Immunogl 95.6 0.016 3.5E-07 47.8 4.1 54 445-501 16-71 (74)
122 KOG3513|consensus 95.6 0.013 2.9E-07 70.3 4.9 66 436-506 442-515 (1051)
123 cd05762 Ig8_MLCK Eighth immuno 95.5 0.021 4.7E-07 50.2 5.1 35 470-504 55-90 (98)
124 cd04976 Ig2_VEGFR Second immun 95.5 0.013 2.8E-07 48.3 3.3 33 470-502 34-67 (71)
125 cd05730 Ig3_NCAM-1_like Third 95.5 0.016 3.5E-07 50.3 4.0 33 471-503 58-91 (95)
126 cd04975 Ig4_SCFR_like Fourth i 95.4 0.019 4.1E-07 50.9 4.3 31 471-501 65-96 (101)
127 cd05864 Ig2_VEGFR-2 Second imm 95.4 0.012 2.5E-07 48.6 2.7 30 470-499 33-63 (70)
128 cd05750 Ig_Pro_neuregulin Immu 95.4 0.022 4.7E-07 46.8 4.3 31 470-500 42-73 (75)
129 cd05863 Ig2_VEGFR-3 Second imm 95.4 0.0075 1.6E-07 49.3 1.4 31 471-501 31-62 (67)
130 cd05856 Ig2_FGFRL1-like Second 95.3 0.021 4.4E-07 47.7 4.1 31 470-500 47-78 (82)
131 cd05850 Ig1_Contactin-2 First 95.2 0.027 5.7E-07 49.1 4.6 38 465-503 53-92 (94)
132 cd05873 Ig_Sema4D_like Immunog 95.2 0.026 5.5E-07 48.7 4.3 49 445-497 27-79 (87)
133 cd05849 Ig1_Contactin-1 First 95.2 0.029 6.2E-07 48.9 4.5 60 438-502 22-90 (93)
134 PF07679 I-set: Immunoglobulin 95.0 0.03 6.5E-07 47.7 4.3 55 445-501 32-87 (90)
135 cd05743 Ig_Perlecan_D2_like Im 95.0 0.024 5.2E-07 47.4 3.5 27 470-496 41-68 (78)
136 KOG1947|consensus 95.0 0.0082 1.8E-07 67.5 0.8 109 143-252 188-307 (482)
137 cd04979 Ig_Semaphorin_C Immuno 94.9 0.031 6.7E-07 47.9 4.1 51 445-496 27-77 (89)
138 cd05859 Ig4_PDGFR-alpha Fourth 94.9 0.03 6.4E-07 49.7 4.1 54 445-498 35-93 (101)
139 cd07693 Ig1_Robo First immunog 94.9 0.046 1E-06 47.2 5.2 20 478-497 72-91 (100)
140 cd05722 Ig1_Neogenin First imm 94.8 0.048 1E-06 47.3 5.0 52 445-499 31-89 (95)
141 cd05848 Ig1_Contactin-5 First 94.7 0.041 8.8E-07 48.0 4.4 57 437-497 21-86 (94)
142 KOG4341|consensus 94.7 0.0019 4.1E-08 69.8 -4.8 133 238-370 292-435 (483)
143 cd07702 Ig2_VEGFR-1 Second imm 94.6 0.03 6.4E-07 46.5 3.1 28 471-498 36-64 (72)
144 cd05861 Ig1_PDGFR-alphabeta Fr 94.5 0.067 1.5E-06 45.5 5.1 24 471-494 46-70 (84)
145 cd05874 Ig6_NrCAM Sixth immuno 94.5 0.049 1.1E-06 45.6 4.2 32 468-499 36-72 (77)
146 cd05774 Ig_CEACAM_D1 First imm 94.4 0.06 1.3E-06 48.2 4.6 41 458-498 57-98 (105)
147 PF00047 ig: Immunoglobulin do 94.3 0.026 5.7E-07 44.8 2.0 45 445-489 19-64 (64)
148 KOG4308|consensus 94.3 0.0023 4.9E-08 72.4 -5.7 182 170-351 89-304 (478)
149 cd05728 Ig4_Contactin-2-like F 94.3 0.062 1.4E-06 45.7 4.4 29 470-498 50-79 (85)
150 cd05773 Ig8_hNephrin_like Eigh 94.2 0.096 2.1E-06 47.0 5.6 34 471-504 69-104 (109)
151 cd05756 Ig1_IL1R_like First im 94.1 0.04 8.8E-07 48.1 3.0 31 470-500 59-90 (94)
152 cd05739 Ig3_RPTP_IIa_LAR_like 94.1 0.092 2E-06 42.9 4.9 27 471-499 38-65 (69)
153 cd07701 Ig1_Necl-3 First (N-te 93.9 0.11 2.5E-06 45.3 5.4 31 469-501 60-91 (95)
154 KOG1947|consensus 93.6 0.015 3.3E-07 65.3 -0.9 110 168-277 188-307 (482)
155 cd05733 Ig6_L1-CAM_like Sixth 93.6 0.069 1.5E-06 44.5 3.4 32 468-499 36-72 (77)
156 cd05757 Ig2_IL1R_like Second i 93.5 0.075 1.6E-06 46.3 3.5 25 469-493 50-75 (92)
157 cd05729 Ig2_FGFR_like Second i 93.3 0.17 3.7E-06 42.2 5.4 25 474-498 55-79 (85)
158 cd05758 Ig5_KIRREL3-like Fifth 93.2 0.12 2.6E-06 45.2 4.4 30 472-501 65-96 (98)
159 cd04967 Ig1_Contactin First Ig 93.1 0.098 2.1E-06 45.0 3.6 27 471-497 58-86 (91)
160 cd05871 Ig_Semaphorin_classIII 93.1 0.17 3.6E-06 44.0 5.0 33 463-495 46-78 (91)
161 cd05885 Ig2_Necl-4 Second immu 93.0 0.23 4.9E-06 42.1 5.5 38 469-506 41-79 (80)
162 PF13927 Ig_3: Immunoglobulin 93.0 0.13 2.9E-06 41.4 4.0 28 464-491 47-75 (75)
163 KOG4341|consensus 92.9 0.013 2.8E-07 63.6 -2.7 274 96-369 139-460 (483)
164 smart00408 IGc2 Immunoglobulin 92.9 0.14 3E-06 39.3 3.9 25 469-493 37-62 (63)
165 cd05875 Ig6_hNeurofascin_like 92.8 0.16 3.5E-06 42.4 4.4 32 468-499 36-72 (77)
166 cd05896 Ig1_IL1RAPL-1_like Fir 92.5 0.22 4.7E-06 44.3 4.9 36 464-499 64-99 (104)
167 cd05897 Ig2_IL1R2_like Second 92.2 0.16 3.4E-06 44.6 3.6 25 469-493 53-78 (95)
168 cd05872 Ig_Sema4B_like Immunog 92.1 0.14 3.1E-06 43.9 3.2 55 436-495 12-72 (85)
169 cd05898 Ig5_KIRREL3 Fifth immu 91.9 0.33 7.1E-06 42.9 5.4 32 471-502 64-97 (98)
170 cd05886 Ig1_Nectin-1_like Firs 91.8 0.11 2.4E-06 45.9 2.3 23 469-491 61-84 (99)
171 PHA02826 IL-1 receptor-like pr 91.8 0.29 6.4E-06 50.0 5.7 23 470-492 187-210 (227)
172 cd05717 Ig1_Necl-1-3_like Firs 91.7 0.22 4.8E-06 43.1 4.0 24 470-493 61-85 (95)
173 cd05714 Ig_CSPGs_LP Immunoglob 91.6 0.073 1.6E-06 47.2 0.9 36 469-504 66-102 (106)
174 smart00082 LRRCT Leucine rich 91.5 0.075 1.6E-06 40.5 0.8 31 387-417 5-36 (51)
175 PF00560 LRR_1: Leucine Rich R 91.3 0.077 1.7E-06 33.3 0.5 11 171-181 3-13 (22)
176 cd05754 Ig3_Perlecan_like Thir 91.1 0.082 1.8E-06 44.8 0.7 29 470-498 51-80 (85)
177 smart00369 LRR_TYP Leucine-ric 91.1 0.17 3.7E-06 32.9 2.0 22 361-382 2-23 (26)
178 smart00370 LRR Leucine-rich re 91.1 0.17 3.7E-06 32.9 2.0 22 361-382 2-23 (26)
179 cd05877 Ig_LP_like Immunoglobu 91.1 0.11 2.5E-06 45.9 1.6 36 470-505 67-103 (106)
180 cd05713 Ig_MOG_like Immunoglob 90.8 0.15 3.2E-06 44.6 2.1 26 471-496 65-91 (100)
181 cd05888 Ig1_Nectin-4_like Frst 90.8 0.17 3.8E-06 44.6 2.5 22 470-491 63-85 (100)
182 KOG4308|consensus 90.6 0.0084 1.8E-07 67.9 -7.7 182 145-327 89-304 (478)
183 cd05902 Ig_Neurocan Immunoglob 90.4 0.23 5E-06 44.8 3.0 46 459-504 54-106 (110)
184 cd05749 Ig2_Tyro3_like Second 90.3 0.31 6.8E-06 41.3 3.5 29 471-501 49-78 (81)
185 cd05879 Ig_P0 Immunoglobulin ( 90.2 0.13 2.8E-06 46.9 1.2 31 469-499 78-109 (116)
186 cd05753 Ig2_FcgammaR_like Seco 90.2 0.28 6.2E-06 41.6 3.2 25 471-495 48-73 (83)
187 cd05901 Ig_Versican Immunoglob 90.1 0.36 7.9E-06 44.0 4.0 36 469-504 77-113 (117)
188 cd05741 Ig_CEACAM_D1_like Firs 90.1 0.16 3.5E-06 43.4 1.7 33 461-493 47-80 (92)
189 PF00560 LRR_1: Leucine Rich R 89.9 0.17 3.8E-06 31.6 1.3 16 267-282 2-17 (22)
190 cd05718 Ig1_PVR_like First imm 89.5 0.3 6.5E-06 42.3 3.0 23 469-491 60-83 (98)
191 smart00370 LRR Leucine-rich re 89.4 0.3 6.4E-06 31.7 2.1 23 336-358 1-23 (26)
192 smart00369 LRR_TYP Leucine-ric 89.4 0.3 6.4E-06 31.7 2.1 23 336-358 1-23 (26)
193 cd05752 Ig1_FcgammaR_like Frst 88.9 0.48 1E-05 39.8 3.6 20 472-492 49-68 (78)
194 cd07690 Ig1_CD4 First immunogl 88.7 0.11 2.4E-06 45.5 -0.4 24 474-497 69-92 (94)
195 PF13504 LRR_7: Leucine rich r 88.6 0.27 5.9E-06 28.8 1.3 15 362-376 2-16 (17)
196 cd05900 Ig_Aggrecan Immunoglob 88.2 0.49 1.1E-05 42.8 3.4 33 470-502 73-106 (112)
197 PF13504 LRR_7: Leucine rich r 88.2 0.29 6.4E-06 28.7 1.3 16 338-353 2-17 (17)
198 cd05887 Ig1_Nectin-3_like Firs 88.1 0.27 5.8E-06 43.2 1.6 23 469-491 58-81 (96)
199 smart00409 IG Immunoglobulin. 88.0 1.5 3.2E-05 35.5 6.0 24 471-494 51-75 (86)
200 smart00410 IG_like Immunoglobu 88.0 1.5 3.2E-05 35.5 6.0 24 471-494 51-75 (86)
201 cd05880 Ig_EVA1 Immunoglobulin 87.5 0.29 6.4E-06 44.3 1.6 26 470-495 78-104 (115)
202 KOG0473|consensus 87.3 0.06 1.3E-06 54.3 -3.3 95 277-374 30-124 (326)
203 KOG4222|consensus 87.1 0.57 1.2E-05 56.7 4.0 66 440-507 159-224 (1281)
204 PHA02826 IL-1 receptor-like pr 86.8 0.29 6.2E-06 50.1 1.2 29 470-498 97-126 (227)
205 cd05881 Ig1_Necl-2 First (N-te 86.5 0.76 1.7E-05 40.3 3.5 18 474-491 66-83 (95)
206 cd05889 Ig1_DNAM-1_like First 86.4 0.36 7.8E-06 42.4 1.4 24 469-492 58-82 (96)
207 PHA02633 hypothetical protein; 86.3 0.59 1.3E-05 37.3 2.4 30 472-501 20-49 (63)
208 cd05878 Ig_Aggrecan_like Immun 85.7 0.44 9.6E-06 42.8 1.7 35 470-504 71-106 (110)
209 cd05715 Ig_P0-like Immunoglobu 85.2 0.49 1.1E-05 42.7 1.8 24 471-494 80-104 (116)
210 PHA02785 IL-beta-binding prote 85.1 1.4 3.1E-05 47.6 5.6 23 471-493 292-315 (326)
211 KOG3513|consensus 85.1 1 2.2E-05 54.8 4.7 67 435-510 256-331 (1051)
212 PHA03376 BARF1; Provisional 85.0 3.9 8.4E-05 40.3 7.8 30 474-506 91-120 (221)
213 cd05775 Ig_SLAM-CD84_like_N N- 83.5 0.61 1.3E-05 40.8 1.6 32 462-493 51-84 (97)
214 KOG0473|consensus 83.5 0.059 1.3E-06 54.4 -5.4 82 216-301 42-123 (326)
215 cd05771 IgC_Tapasin_R Tapasin- 83.1 0.49 1.1E-05 44.2 0.9 27 474-500 5-31 (139)
216 KOG4221|consensus 82.3 1.8 4E-05 52.9 5.3 43 445-491 269-312 (1381)
217 cd05846 Ig1_MRC-OX-2_like Firs 81.9 0.77 1.7E-05 40.0 1.5 22 469-490 59-81 (97)
218 KOG3864|consensus 81.5 0.29 6.3E-06 48.6 -1.4 34 192-225 151-185 (221)
219 PF13895 Ig_2: Immunoglobulin 81.2 5.1 0.00011 32.4 6.3 23 472-494 47-69 (80)
220 PF07354 Sp38: Zona-pellucida- 81.0 2.2 4.9E-05 43.9 4.7 52 443-498 13-65 (271)
221 PHA02785 IL-beta-binding prote 80.5 1.4 3.1E-05 47.5 3.4 33 464-496 170-203 (326)
222 cd04983 IgV_TCR_alpha_like Imm 77.6 1.5 3.2E-05 38.8 2.0 21 472-492 71-92 (109)
223 cd00099 IgV Immunoglobulin var 77.0 1.6 3.4E-05 38.1 2.0 19 474-492 71-89 (105)
224 cd05751 Ig1_LILRB1_like First 76.8 1.5 3.3E-05 37.7 1.8 19 474-492 57-75 (91)
225 cd07694 Ig2_CD4 Second immunog 76.3 3 6.4E-05 36.0 3.3 38 445-490 33-71 (88)
226 KOG3864|consensus 76.3 0.91 2E-05 45.2 0.3 81 169-249 102-185 (221)
227 cd05759 Ig2_KIRREL3-like Secon 76.2 6.6 0.00014 32.7 5.5 25 474-498 50-74 (82)
228 KOG4242|consensus 72.2 21 0.00046 40.0 9.4 84 145-229 216-312 (553)
229 PF07686 V-set: Immunoglobulin 70.8 2.3 5.1E-05 37.1 1.6 21 472-492 80-101 (114)
230 smart00406 IGv Immunoglobulin 69.2 1.6 3.5E-05 35.7 0.1 19 471-489 62-81 (81)
231 cd00096 Ig Immunoglobulin doma 67.0 5.5 0.00012 30.0 2.8 20 474-493 47-66 (74)
232 cd04984 IgV_L_lambda Immunoglo 66.9 2.8 6.1E-05 36.4 1.2 20 472-491 64-84 (98)
233 cd04980 IgV_L_kappa Immunoglob 66.4 2.3 5E-05 37.5 0.6 28 472-499 72-103 (106)
234 cd05860 Ig4_SCFR Fourth immuno 64.7 10 0.00022 33.7 4.3 29 474-502 69-97 (101)
235 PF02439 Adeno_E3_CR2: Adenovi 64.6 13 0.00029 26.7 3.9 16 593-610 21-36 (38)
236 PF13516 LRR_6: Leucine Rich r 63.9 3.7 8.1E-05 25.9 1.0 19 216-234 2-20 (24)
237 PF12273 RCR: Chitin synthesis 63.5 9.2 0.0002 35.5 4.0 38 580-618 6-43 (130)
238 PHA02987 Ig domain OX-2-like p 63.1 6.6 0.00014 38.7 3.0 41 471-513 85-128 (189)
239 cd05899 IgV_TCR_beta Immunoglo 62.4 3.9 8.5E-05 36.3 1.3 21 471-491 72-93 (110)
240 cd05884 Ig2_Necl-3 Second immu 61.6 22 0.00048 30.0 5.7 27 481-507 57-83 (83)
241 cd05712 Ig_Siglec_N Immunoglob 60.7 6.2 0.00013 35.7 2.3 20 472-491 81-101 (119)
242 cd04982 IgV_TCR_gamma Immunogl 60.6 11 0.00023 33.7 3.8 20 472-491 78-98 (116)
243 smart00364 LRR_BAC Leucine-ric 58.9 6.4 0.00014 25.9 1.4 17 362-378 3-19 (26)
244 cd05761 Ig2_Necl-1-4_like Seco 58.6 24 0.00052 29.5 5.4 34 473-506 47-81 (82)
245 smart00365 LRR_SD22 Leucine-ri 56.9 8.7 0.00019 25.3 1.8 15 361-375 2-16 (26)
246 PF15050 SCIMP: SCIMP protein 56.9 19 0.0004 32.7 4.4 30 581-611 16-45 (133)
247 KOG3763|consensus 56.6 5.3 0.00011 45.4 1.2 66 286-351 215-284 (585)
248 cd00098 IgC Immunoglobulin Con 53.3 22 0.00048 30.1 4.4 16 480-495 72-87 (95)
249 cd05720 Ig_CD8_alpha Immunoglo 52.3 5.5 0.00012 35.2 0.5 19 472-490 70-89 (104)
250 cd07706 IgV_TCR_delta Immunogl 51.6 6.7 0.00014 35.2 0.9 20 472-491 73-93 (116)
251 PF12273 RCR: Chitin synthesis 51.0 11 0.00025 34.8 2.4 11 581-591 4-14 (130)
252 KOG3763|consensus 50.9 7.2 0.00016 44.4 1.2 64 263-327 216-284 (585)
253 PTZ00370 STEVOR; Provisional 50.7 13 0.00028 38.9 2.9 23 577-599 259-281 (296)
254 PF02009 Rifin_STEVOR: Rifin/s 50.0 22 0.00048 37.8 4.6 8 567-574 250-257 (299)
255 KOG4242|consensus 49.2 60 0.0013 36.6 7.8 101 290-390 355-469 (553)
256 cd05767 IgC_MHC_II_alpha Class 49.1 91 0.002 27.1 7.6 47 445-493 34-84 (94)
257 cd05716 Ig_pIgR Immunoglobulin 48.5 6.6 0.00014 33.9 0.3 23 472-494 65-88 (98)
258 cd07705 Ig2_Necl-1 Second immu 47.8 63 0.0014 27.2 6.3 27 480-506 56-82 (83)
259 PF13150 DUF3989: Protein of u 45.5 60 0.0013 27.9 5.7 53 574-630 30-84 (85)
260 cd05711 Ig_FcalphaRI Immunoglo 45.1 25 0.00054 30.4 3.5 18 473-490 58-75 (94)
261 KOG4221|consensus 44.4 34 0.00073 42.6 5.4 34 462-495 184-218 (1381)
262 PF07010 Endomucin: Endomucin; 43.0 53 0.0011 33.2 5.6 33 595-639 208-240 (259)
263 TIGR01478 STEVOR variant surfa 40.0 35 0.00076 35.8 4.0 23 577-599 263-285 (295)
264 KOG3884|consensus 39.2 40 0.00086 36.1 4.3 26 575-600 297-322 (437)
265 PF04639 Baculo_E56: Baculovir 38.5 32 0.0007 35.9 3.5 11 534-544 231-241 (305)
266 cd07700 IgV_CD8_beta Immunoglo 38.0 12 0.00027 33.0 0.4 19 472-490 73-92 (107)
267 cd05766 IgC_MHC_II_beta Class 38.0 1.3E+02 0.0028 26.0 6.9 58 436-495 15-85 (94)
268 PTZ00370 STEVOR; Provisional 38.0 13 0.00029 38.9 0.6 30 578-609 256-286 (296)
269 cd07698 IgC_MHC_I_alpha3 Class 37.1 78 0.0017 27.1 5.3 30 466-495 52-85 (93)
270 PF07654 C1-set: Immunoglobuli 36.5 1.3E+02 0.0027 25.0 6.4 47 445-493 27-77 (83)
271 PF01102 Glycophorin_A: Glycop 36.1 40 0.00086 31.0 3.4 10 593-602 84-93 (122)
272 smart00407 IGc1 Immunoglobulin 35.4 1.1E+02 0.0023 25.0 5.6 14 480-493 58-71 (75)
273 cd04981 IgV_H Immunoglobulin ( 35.3 28 0.00061 31.4 2.3 20 472-491 77-97 (117)
274 cd05770 IgC_beta2m Class I maj 35.3 1.6E+02 0.0034 25.6 6.9 47 445-494 34-84 (93)
275 PF06143 Baculo_11_kDa: Baculo 34.3 41 0.00089 28.8 2.9 17 567-583 29-45 (84)
276 smart00368 LRR_RI Leucine rich 34.2 32 0.00068 22.7 1.8 14 361-374 2-15 (28)
277 cd07703 Ig2_Nectin-2_like Seco 33.8 74 0.0016 27.8 4.6 31 471-501 59-90 (95)
278 PF05961 Chordopox_A13L: Chord 32.3 56 0.0012 26.6 3.2 19 577-595 2-20 (68)
279 PF11120 DUF2636: Protein of u 32.2 18 0.00038 29.1 0.4 24 581-607 11-34 (62)
280 PHA03289 envelope glycoprotein 31.1 4E+02 0.0086 28.7 10.0 60 548-610 234-300 (352)
281 PF13260 DUF4051: Protein of u 30.6 39 0.00084 25.5 1.9 24 585-608 10-33 (54)
282 PF15102 TMEM154: TMEM154 prot 29.8 14 0.0003 34.9 -0.7 11 593-603 75-85 (146)
283 PF14654 Epiglycanin_C: Mucin, 29.6 1.2E+02 0.0026 26.6 4.9 34 572-607 18-51 (106)
284 PF06679 DUF1180: Protein of u 28.8 1.1E+02 0.0024 29.6 5.2 64 547-612 60-127 (163)
285 PF01102 Glycophorin_A: Glycop 26.0 1E+02 0.0022 28.4 4.2 27 590-618 78-104 (122)
286 cd05883 Ig2_Necl-2 Second immu 25.8 1.3E+02 0.0028 25.6 4.6 24 471-494 44-68 (82)
287 TIGR00864 PCC polycystin catio 25.6 42 0.0009 45.6 2.3 32 149-181 1-32 (2740)
288 COG2871 NqrF Na+-transporting 25.6 77 0.0017 33.4 3.7 55 577-648 8-62 (410)
289 PF05568 ASFV_J13L: African sw 25.4 81 0.0018 29.6 3.5 42 575-621 32-76 (189)
290 PF04277 OAD_gamma: Oxaloaceta 24.7 1.3E+02 0.0029 24.9 4.5 31 573-604 6-36 (79)
291 PF15048 OSTbeta: Organic solu 23.6 88 0.0019 28.7 3.3 34 570-610 33-67 (125)
292 smart00013 LRRNT Leucine rich 23.5 54 0.0012 22.5 1.5 26 56-88 2-27 (33)
293 PF05393 Hum_adeno_E3A: Human 23.3 72 0.0016 27.4 2.5 8 620-627 74-81 (94)
294 COG3190 FliO Flagellar biogene 23.1 1.8E+02 0.0038 27.4 5.2 28 573-602 23-50 (137)
295 PF05790 C2-set: Immunoglobuli 23.0 39 0.00085 28.6 0.9 30 474-505 47-76 (80)
296 PF13120 DUF3974: Domain of un 22.2 61 0.0013 28.1 1.9 40 573-612 5-44 (126)
297 PRK13415 flagella biosynthesis 22.1 1.5E+02 0.0033 30.0 5.0 14 590-603 79-92 (219)
298 PHA03281 envelope glycoprotein 22.1 2.8E+02 0.0061 31.8 7.5 19 472-490 477-495 (642)
299 PHA03049 IMV membrane protein; 22.0 1.1E+02 0.0024 24.8 3.2 20 577-596 2-21 (68)
300 cd05719 Ig2_PVR_like Second im 21.6 1.5E+02 0.0034 25.7 4.5 30 471-500 59-89 (95)
301 PF01462 LRRNT: Leucine rich r 20.8 42 0.00091 22.3 0.5 17 56-77 2-18 (28)
302 KOG1480|consensus 20.6 55 0.0012 38.9 1.7 29 470-498 182-211 (909)
303 PF03597 CcoS: Cytochrome oxid 20.5 1.4E+02 0.003 22.4 3.3 7 597-603 21-27 (45)
304 cd07697 IgC_TCR_gamma T cell r 20.0 2.5E+02 0.0054 24.5 5.4 16 476-491 67-83 (96)
No 1
>KOG4194|consensus
Probab=100.00 E-value=2.4e-43 Score=378.60 Aligned_cols=408 Identities=24% Similarity=0.325 Sum_probs=324.9
Q ss_pred eeEEEcCCCCCCCCCc-cccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEc
Q psy8879 97 VSLLDCTLSNVTVLPG-KFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDL 175 (694)
Q Consensus 97 L~~Ldls~n~l~~lp~-~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~L 175 (694)
|+.||+|.|.|.++|. .|.+-.++++|+|++|.|+.+..+.|.++. +|..|.|+.|+++.+|...|+++ ++|+.|+|
T Consensus 151 lrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~ln-sL~tlkLsrNrittLp~r~Fk~L-~~L~~LdL 228 (873)
T KOG4194|consen 151 LRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLN-SLLTLKLSRNRITTLPQRSFKRL-PKLESLDL 228 (873)
T ss_pred hhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccc-hheeeecccCcccccCHHHhhhc-chhhhhhc
Confidence 5666777777766654 355667899999999999999999998877 59999999999999999999999 99999999
Q ss_pred cCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCC
Q psy8879 176 SHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGP 255 (694)
Q Consensus 176 s~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 255 (694)
..|+|..+....|.++++|+.|.|..|.|..+..++|..+.++++|+|..|++......++.+++.|+.|++++|.+..
T Consensus 229 nrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~r- 307 (873)
T KOG4194|consen 229 NRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQR- 307 (873)
T ss_pred cccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhe-
Confidence 9999988877889999999999999999999999999999999999999999998888999999999999999999985
Q ss_pred CCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccc---cc
Q psy8879 256 LGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSG---AS 332 (694)
Q Consensus 256 i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~---~~ 332 (694)
+.++.++-.++|++|+|+.|+|++++++.|..+..|++|+|++|.|+.+...+|.++++|+.|||++|.|+.... ..
T Consensus 308 ih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~ 387 (873)
T KOG4194|consen 308 IHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVA 387 (873)
T ss_pred eecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhh
Confidence 778999999999999999999999999999999999999999999999999999999999999999999987644 46
Q ss_pred hhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCccccc----------CCCC-CCccccccccccccc
Q psy8879 333 LAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIYV----------GFNT-MDLELIYSGVWRHST 401 (694)
Q Consensus 333 f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~----------~~Np-CdC~l~~~~~wl~~~ 401 (694)
|.++++|+.|+|.+|+|+.++..+|..+++|++|||.+|.|..|.+..|. +.+- |||.+.||..|+...
T Consensus 388 f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qWl~~~ 467 (873)
T KOG4194|consen 388 FNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQWLYRR 467 (873)
T ss_pred hccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHHHHhc
Confidence 88999999999999999999999999999999999999999999999887 2222 999999999999643
Q ss_pred ccCCccCccccCCcccceeeEEEEE-----------------eecCccccceeeeeceeE---------EEEeccCcccc
Q psy8879 402 LLIPVMLSLCTRSSVVTRYRYCVVL-----------------IEGSNILDQSALVLGCSE---------ILALVPTLTSQ 455 (694)
Q Consensus 402 ~~~~~~~~~C~~~~~~~~~~~~~v~-----------------~~~~~~~~~~~~~l~c~~---------i~~l~~~~~~~ 455 (694)
.........|++|+.-......-+. .+......+.-.-+.|.+ +.|...+. ++
T Consensus 468 ~lq~sv~a~CayPe~Lad~~i~svd~~~lvC~DspkpqI~~qPe~~~al~g~nirftC~a~sssasplsi~WR~dne-vq 546 (873)
T KOG4194|consen 468 KLQSSVIAKCAYPEPLADQSIVSVDTANLVCDDSPKPQIVTQPETVSALIGENIRFTCNAYSSSASPLSIEWRKDNE-VQ 546 (873)
T ss_pred ccccceeeeccCCcccccceeEeechhhceecCCCCcceecCchHhhhhhccceEEEEEeccCCCCCceeEeeeccc-cC
Confidence 3222233344443222111111000 001111222335566766 55666555 44
Q ss_pred ccceeEeeeeEEec------------ccEE-EEEEEecCCCcceeEEEEEeeeccceeEEeeccCC
Q psy8879 456 PLSYVTSLRANVTG------------LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKNTNCS 508 (694)
Q Consensus 456 ~~~~i~~~~~n~~~------------~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~~~~ 508 (694)
+...+.+.-.-.+. .+.| ..||+..|+|.|.|+|+|..++.=+-.++-++|..
T Consensus 547 ~rv~ved~a~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~FGStysqk~KltV~~~ 612 (873)
T KOG4194|consen 547 PRVDVEDFATFLSQNRNGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTVNQA 612 (873)
T ss_pred cccchhcchhhhhhhccCccchhhhhhheeeeeeeecccCceEEEEEecccCcchhheeEEEeecc
Confidence 11111111111111 1233 88999999999999999987776555555555544
No 2
>KOG4194|consensus
Probab=99.97 E-value=8.4e-33 Score=297.65 Aligned_cols=312 Identities=30% Similarity=0.475 Sum_probs=205.4
Q ss_pred CCCCCCCCCCCCCCCCCcEEEccCCCchhhh-hhhcCCCCCCCCeeEEEcCCCCCCCCC-ccccCCCCccEEEccCCCCC
Q psy8879 54 WSCPSIKNDLCACDLPHTLRCTANKSDLYAI-SESLRGLEPDERVSLLDCTLSNVTVLP-GKFLEGVTLHGLVISSGELK 131 (694)
Q Consensus 54 ~~Cp~~~~~~C~C~~~~~v~C~~~~~~l~~i-~~~L~~l~~~~~L~~Ldls~n~l~~lp-~~~~~~~~L~~L~Ls~n~i~ 131 (694)
..||. .|.|.. ..+.|... .+..+ ...|.+.-|. ..+.||+++|.+..+. ..|.++++|+++++..|.++
T Consensus 44 ~~cpa----~c~c~~-~lldcs~~--~lea~~~~~l~g~lp~-~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt 115 (873)
T KOG4194|consen 44 SECPA----TCPCNT-RLLDCSDR--ELEAIDKSRLKGFLPS-QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT 115 (873)
T ss_pred ccCCC----cCCCCc-eeeecCcc--ccccccccccCCcCcc-ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh
Confidence 57887 788863 34667553 34433 3345666555 5566777777776553 23445555555555555555
Q ss_pred CC-----------------------CcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccc
Q psy8879 132 NI-----------------------SDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSF 188 (694)
Q Consensus 132 ~i-----------------------~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f 188 (694)
.| ....+..++. |+.|||+.|.|+.++...|..- .++++|+|++|.|+.+..+.|
T Consensus 116 ~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~a-lrslDLSrN~is~i~~~sfp~~-~ni~~L~La~N~It~l~~~~F 193 (873)
T KOG4194|consen 116 RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPA-LRSLDLSRNLISEIPKPSFPAK-VNIKKLNLASNRITTLETGHF 193 (873)
T ss_pred hcccccccccceeEEeeeccccccccHHHHHhHhh-hhhhhhhhchhhcccCCCCCCC-CCceEEeeccccccccccccc
Confidence 54 4444433333 6666666666666666556555 566666666666666666666
Q ss_pred cCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccc
Q psy8879 189 KGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLK 268 (694)
Q Consensus 189 ~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~ 268 (694)
.++.+|..|.|+.|+++.+++..|.++++|+.|+|..|+|...--..|.++++|+.|.|..|.+.. +..+.|..+.+++
T Consensus 194 ~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k-L~DG~Fy~l~kme 272 (873)
T KOG4194|consen 194 DSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK-LDDGAFYGLEKME 272 (873)
T ss_pred cccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc-ccCcceeeecccc
Confidence 666666666666666666666666666666666666666664444556666666666666666654 4466677777777
Q ss_pred eeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeecCCCC
Q psy8879 269 VLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNF 348 (694)
Q Consensus 269 ~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~ 348 (694)
+|+|+.|+++.+..+++.+++.|+.|+|++|.|..+..+.++-.++|+.|+|++|+|+.+++++|..+..|++|+|++|.
T Consensus 273 ~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 273 HLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred eeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCCcChhhhCCCCCCCEEEccCCCCCCC
Q psy8879 349 LRALTQDLITPLKSLQELRLDDNDISME 376 (694)
Q Consensus 349 L~~l~~~~~~~l~~L~~L~Ls~N~L~~l 376 (694)
+..+....|..+++|++|||++|.|+..
T Consensus 353 i~~l~e~af~~lssL~~LdLr~N~ls~~ 380 (873)
T KOG4194|consen 353 IDHLAEGAFVGLSSLHKLDLRSNELSWC 380 (873)
T ss_pred hHHHHhhHHHHhhhhhhhcCcCCeEEEE
Confidence 7777777777777777777777777643
No 3
>KOG4237|consensus
Probab=99.97 E-value=3.3e-32 Score=282.52 Aligned_cols=349 Identities=24% Similarity=0.316 Sum_probs=273.9
Q ss_pred CCCCCCCCCCCCCCCC--CCcEEEccCCCchhhhhhhcCCCCCCCCeeEEEcCCCCCCCCCcc-ccCCCCccEEEccCCC
Q psy8879 53 PWSCPSIKNDLCACDL--PHTLRCTANKSDLYAISESLRGLEPDERVSLLDCTLSNVTVLPGK-FLEGVTLHGLVISSGE 129 (694)
Q Consensus 53 ~~~Cp~~~~~~C~C~~--~~~v~C~~~~~~l~~i~~~L~~l~~~~~L~~Ldls~n~l~~lp~~-~~~~~~L~~L~Ls~n~ 129 (694)
...||. .|.|+. ...|.|.+ ..+..+|..|+. ....+++..|+|+.+|+. |..+.+|+.|+|++|.
T Consensus 34 ~~~CP~----pC~Cs~~~g~~VdCr~--~GL~eVP~~LP~-----~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~ 102 (498)
T KOG4237|consen 34 ASACPA----PCTCSDVEGGIVDCRG--KGLTEVPANLPP-----ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNN 102 (498)
T ss_pred cccCCC----CcccCCCCCceEEccC--CCcccCcccCCC-----cceEEEeccCCcccCChhhccchhhhceecccccc
Confidence 346888 899974 35677765 457788877753 677889999999999764 6667889999999999
Q ss_pred CCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCc
Q psy8879 130 LKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQ 209 (694)
Q Consensus 130 i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~ 209 (694)
|+.|.+++|.|+..-++.+.+++|+|+++|.++|.++ ..|+.|.+.-|++.-+..+.|..+++|..|.+.+|.+..+..
T Consensus 103 Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL-~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~ 181 (498)
T KOG4237|consen 103 ISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL-SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICK 181 (498)
T ss_pred hhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH-HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhcc
Confidence 9999999999987644455555589999999999999 899999999999999988999999999999999999998888
Q ss_pred cccCCCCCCcEEeccCCccc------------chhhhhhccCcccccccCCCCcCCCCCCCCCCCCc-cccc-eeeccCC
Q psy8879 210 DCLAPLVTLRVLRLQGNRLT------------VSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRL-SSLK-VLSIAHN 275 (694)
Q Consensus 210 ~~f~~L~~L~~L~Ls~N~l~------------~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l-~~L~-~L~Ls~N 275 (694)
..|..+..++.+.+..|.+- ...+..+++..-..-..+.+.++.. +++..|... ..+. .+....+
T Consensus 182 ~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q-~~a~kf~c~~esl~s~~~~~d~ 260 (498)
T KOG4237|consen 182 GTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQ-EDARKFLCSLESLPSRLSSEDF 260 (498)
T ss_pred ccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcc-cchhhhhhhHHhHHHhhccccC
Confidence 88999999999999888732 1223344444444444455555442 334433322 1121 1222333
Q ss_pred cccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeecCCCCCCCcChh
Q psy8879 276 QFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQD 355 (694)
Q Consensus 276 ~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~ 355 (694)
.....|...|.++++|++|+|++|+|+.+.+.+|.+...++.|.|..|+|..+....|.++..|++|+|.+|+|+.+.+.
T Consensus 261 ~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~ 340 (498)
T KOG4237|consen 261 PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG 340 (498)
T ss_pred cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc
Confidence 44455666899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCEEEccCCCCCCCCcccccCCCCCCcccccccccccccccCCccCccccCCcccceeeEEEEEee
Q psy8879 356 LITPLKSLQELRLDDNDISMEPECIYVGFNTMDLELIYSGVWRHSTLLIPVMLSLCTRSSVVTRYRYCVVLIE 428 (694)
Q Consensus 356 ~~~~l~~L~~L~Ls~N~L~~l~~~~f~~~NpCdC~l~~~~~wl~~~~~~~~~~~~C~~~~~~~~~~~~~v~~~ 428 (694)
.|..+.+|..|+|-.|+|. |||.+.|+.+|++... ...+..|+.|.......+..|.+.
T Consensus 341 aF~~~~~l~~l~l~~Np~~------------CnC~l~wl~~Wlr~~~--~~~~~~Cq~p~~~~~~~~~dv~~~ 399 (498)
T KOG4237|consen 341 AFQTLFSLSTLNLLSNPFN------------CNCRLAWLGEWLRKKS--VVGNPRCQSPGFVRQIPISDVAFG 399 (498)
T ss_pred cccccceeeeeehccCccc------------CccchHHHHHHHhhCC--CCCCCCCCCCchhccccchhcccc
Confidence 9999999999999999999 9999999999998655 334667887665555444444433
No 4
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.95 E-value=5.9e-28 Score=295.33 Aligned_cols=278 Identities=26% Similarity=0.313 Sum_probs=237.2
Q ss_pred CCCeeEEEcCCCCCC-CCCcccc-CCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCcc
Q psy8879 94 DERVSLLDCTLSNVT-VLPGKFL-EGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLD 171 (694)
Q Consensus 94 ~~~L~~Ldls~n~l~-~lp~~~~-~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~ 171 (694)
.+.|+.|++++|++. .+|..+. .+.+|++|++++|.+....+. +.+.+|++|+|++|.+....+..+..+ ++|+
T Consensus 92 l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~~~~~l-~~L~ 167 (968)
T PLN00113 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSF-SSLK 167 (968)
T ss_pred CCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCChHHhcC-CCCC
Confidence 348999999999996 6887766 788999999999988754332 234569999999999986666678888 8999
Q ss_pred EEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCc
Q psy8879 172 RLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNL 251 (694)
Q Consensus 172 ~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~ 251 (694)
+|+|++|.+.+..+..|.++++|++|+|++|++.+..|..+..+++|++|++++|++.+..|..+.++++|++|++++|.
T Consensus 168 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 247 (968)
T PLN00113 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247 (968)
T ss_pred EEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCce
Confidence 99999999887777888999999999999999988888888999999999999999988888899999999999999999
Q ss_pred CCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCcccccccc
Q psy8879 252 LAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGA 331 (694)
Q Consensus 252 l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~ 331 (694)
+.+.+ |..+.++++|+.|++++|.+.+..+..+.++++|++|++++|.+....+..+..+++|+.|++++|.+.+..+.
T Consensus 248 l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~ 326 (968)
T PLN00113 248 LTGPI-PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326 (968)
T ss_pred ecccc-ChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCCh
Confidence 88755 77788899999999999998877777788889999999999998877777888889999999999999888888
Q ss_pred chhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCC
Q psy8879 332 SLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISME 376 (694)
Q Consensus 332 ~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l 376 (694)
.+..+++|+.|+|++|.+.+..+..+..+++|+.|++++|++++.
T Consensus 327 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~ 371 (968)
T PLN00113 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371 (968)
T ss_pred hHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEee
Confidence 888889999999999998877777788888899999998888754
No 5
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.94 E-value=4.1e-27 Score=287.95 Aligned_cols=275 Identities=26% Similarity=0.277 Sum_probs=157.6
Q ss_pred CCeeEEEcCCCCCC-CCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEE
Q psy8879 95 ERVSLLDCTLSNVT-VLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRL 173 (694)
Q Consensus 95 ~~L~~Ldls~n~l~-~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L 173 (694)
++|++|++++|++. .+|. ..+++|++|++++|.+....+..|..+. +|++|+|++|.+....+..+.++ ++|++|
T Consensus 118 ~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L 193 (968)
T PLN00113 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFS-SLKVLDLGGNVLVGKIPNSLTNL-TSLEFL 193 (968)
T ss_pred CCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCC-CCCEEECccCcccccCChhhhhC-cCCCee
Confidence 46777777777774 3333 2355666777766666644444454433 46666666666655444456666 666666
Q ss_pred EccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCC
Q psy8879 174 DLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLA 253 (694)
Q Consensus 174 ~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~ 253 (694)
+|++|.+.+..+..++++++|++|+|++|++.+..|..|..+++|++|++++|.+.+..|..+.++++|++|++++|.+.
T Consensus 194 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 273 (968)
T PLN00113 194 TLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273 (968)
T ss_pred eccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeee
Confidence 66666666555556666666666666666666555555666666666666666666556666666666666666666665
Q ss_pred CCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccch
Q psy8879 254 GPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASL 333 (694)
Q Consensus 254 ~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f 333 (694)
+.+ |..+..+++|+.|++++|.+.+..+..+.++++|+.|++++|.++...+..+..+++|+.|++++|++.+..|..+
T Consensus 274 ~~~-p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l 352 (968)
T PLN00113 274 GPI-PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352 (968)
T ss_pred ccC-chhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHH
Confidence 533 4445555566666666665555555555555555555555555555444455555555555555555555445455
Q ss_pred hcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCC
Q psy8879 334 AHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDIS 374 (694)
Q Consensus 334 ~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~ 374 (694)
..+++|+.|+|++|++.+..+..+..+++|+.|++++|++.
T Consensus 353 ~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~ 393 (968)
T PLN00113 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393 (968)
T ss_pred hCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEec
Confidence 55555555555555554433333333444444444444433
No 6
>KOG0444|consensus
Probab=99.91 E-value=1.2e-26 Score=251.24 Aligned_cols=288 Identities=28% Similarity=0.406 Sum_probs=152.6
Q ss_pred CchhhhhhhcCCCCCCCCeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCC--CCCcchhcCCCCCccEEEccCCCCC
Q psy8879 79 SDLYAISESLRGLEPDERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELK--NISDGAFIGLSSPLQALGLPNNLLS 156 (694)
Q Consensus 79 ~~l~~i~~~L~~l~~~~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~--~i~~~~F~~l~~~L~~L~Ls~N~L~ 156 (694)
+.+..+|+.|..+. +|+.|.+++|++..+-..+..++.|+.+++.+|+++ .|+++.|. +..|..||||+|++.
T Consensus 42 t~L~~vPeEL~~lq---kLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~--l~dLt~lDLShNqL~ 116 (1255)
T KOG0444|consen 42 TKLEQVPEELSRLQ---KLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFR--LKDLTILDLSHNQLR 116 (1255)
T ss_pred hhhhhChHHHHHHh---hhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcc--cccceeeecchhhhh
Confidence 44556666665544 556666666666555555555555666666555554 34444442 223556666666666
Q ss_pred CCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccch-----
Q psy8879 157 VVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVS----- 231 (694)
Q Consensus 157 ~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~----- 231 (694)
+.|.. +... +++-.|+||+|+|..|+...|-++..|-.|||++|++..++|. +..+..|++|.|++|.+.-.
T Consensus 117 EvP~~-LE~A-Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ-~RRL~~LqtL~Ls~NPL~hfQLrQL 193 (1255)
T KOG0444|consen 117 EVPTN-LEYA-KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQ-IRRLSMLQTLKLSNNPLNHFQLRQL 193 (1255)
T ss_pred hcchh-hhhh-cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHH-HHHHhhhhhhhcCCChhhHHHHhcC
Confidence 55553 3333 5555566666666666555555555555666666665555554 44555555555555555433
Q ss_pred --------------------hhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCccc
Q psy8879 232 --------------------VVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKL 291 (694)
Q Consensus 232 --------------------~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L 291 (694)
+|.++..+.+|..+|++.|.+.. -|+.+-++++|+.|+||+|+|+++.. ......+|
T Consensus 194 PsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~--vPecly~l~~LrrLNLS~N~iteL~~-~~~~W~~l 270 (1255)
T KOG0444|consen 194 PSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI--VPECLYKLRNLRRLNLSGNKITELNM-TEGEWENL 270 (1255)
T ss_pred ccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc--chHHHhhhhhhheeccCcCceeeeec-cHHHHhhh
Confidence 34444444455555555555542 14444455555555555555554432 12233445
Q ss_pred ceecccCCccccccchhhhcccccccccCCCCccc--cccccchhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEcc
Q psy8879 292 TSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIV--AVSGASLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLD 369 (694)
Q Consensus 292 ~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~--~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls 369 (694)
++|+|+.|+++.+|. ++..++.|+.|.+.+|+++ |+ |..++.+.+|+.+..++|.+.-.| +.+..+..|+.|.|+
T Consensus 271 EtLNlSrNQLt~LP~-avcKL~kL~kLy~n~NkL~FeGi-PSGIGKL~~Levf~aanN~LElVP-EglcRC~kL~kL~L~ 347 (1255)
T KOG0444|consen 271 ETLNLSRNQLTVLPD-AVCKLTKLTKLYANNNKLTFEGI-PSGIGKLIQLEVFHAANNKLELVP-EGLCRCVKLQKLKLD 347 (1255)
T ss_pred hhhccccchhccchH-HHhhhHHHHHHHhccCcccccCC-ccchhhhhhhHHHHhhccccccCc-hhhhhhHHHHHhccc
Confidence 555555555554443 4445555555555555542 33 333455555555555555554443 235556666666666
Q ss_pred CCCCCCCCccc
Q psy8879 370 DNDISMEPECI 380 (694)
Q Consensus 370 ~N~L~~l~~~~ 380 (694)
.|++..+|..+
T Consensus 348 ~NrLiTLPeaI 358 (1255)
T KOG0444|consen 348 HNRLITLPEAI 358 (1255)
T ss_pred ccceeechhhh
Confidence 66666666543
No 7
>KOG0444|consensus
Probab=99.89 E-value=1.3e-24 Score=235.40 Aligned_cols=273 Identities=27% Similarity=0.368 Sum_probs=211.7
Q ss_pred CCeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEE
Q psy8879 95 ERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLD 174 (694)
Q Consensus 95 ~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~ 174 (694)
+.|+.||+|+|+++..|..+-.-.++-.|+||+|+|..|+...|..+.. |-.||||+|++..+||. ..++ ..|++|+
T Consensus 103 ~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtD-LLfLDLS~NrLe~LPPQ-~RRL-~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTD-LLFLDLSNNRLEMLPPQ-IRRL-SMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHh-HhhhccccchhhhcCHH-HHHH-hhhhhhh
Confidence 3666777777777777766666666667777777777777666666654 66777777777777764 5556 6677777
Q ss_pred ccCCCCCCCCcccccCCCCccEEEecCCCCC--CCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcC
Q psy8879 175 LSHNQLYKLENTSFKGLSSLNFLDLSYNKLM--TLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLL 252 (694)
Q Consensus 175 Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~--~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l 252 (694)
|++|.+....-..+..+++|+.|.+++.+-+ .+ |.++..+.+|..++++.|.+. ..|+.+.++.+|+.|+|++|.+
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~-Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNI-PTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcC-CCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 7777665444344445566666677665522 33 445778889999999999998 7899999999999999999999
Q ss_pred CCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccc--cccchhhhcccccccccCCCCccccccc
Q psy8879 253 AGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQID--VLEDHSFRALSTLSHLDLAHNRIVAVSG 330 (694)
Q Consensus 253 ~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~--~i~~~~f~~l~~L~~L~Ls~N~L~~i~~ 330 (694)
++. ........+|++|+||.|+++.+| .++..+++|+.|.+.+|+++ ++|. .++.+.+|+.+..++|.+.-+ |
T Consensus 258 teL--~~~~~~W~~lEtLNlSrNQLt~LP-~avcKL~kL~kLy~n~NkL~FeGiPS-GIGKL~~Levf~aanN~LElV-P 332 (1255)
T KOG0444|consen 258 TEL--NMTEGEWENLETLNLSRNQLTVLP-DAVCKLTKLTKLYANNNKLTFEGIPS-GIGKLIQLEVFHAANNKLELV-P 332 (1255)
T ss_pred eee--eccHHHHhhhhhhccccchhccch-HHHhhhHHHHHHHhccCcccccCCcc-chhhhhhhHHHHhhccccccC-c
Confidence 863 445666789999999999999886 57889999999999999876 5554 678899999999999988766 7
Q ss_pred cchhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCc
Q psy8879 331 ASLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPE 378 (694)
Q Consensus 331 ~~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~ 378 (694)
+.+..|.+|+.|.|+.|++-.+|. .+.-++.|++||++.|+=-..|+
T Consensus 333 EglcRC~kL~kL~L~~NrLiTLPe-aIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 333 EGLCRCVKLQKLKLDHNRLITLPE-AIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hhhhhhHHHHHhcccccceeechh-hhhhcCCcceeeccCCcCccCCC
Confidence 789999999999999999999875 47778999999999997655555
No 8
>KOG0472|consensus
Probab=99.88 E-value=8.3e-25 Score=227.73 Aligned_cols=171 Identities=31% Similarity=0.421 Sum_probs=111.9
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEc
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDL 175 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~L 175 (694)
.++.+|-.+|++.++|+++..+.++..|++.+|+++.++++... ++.|++||...|.++.+|+. ++.+ .+|+.|+|
T Consensus 138 ~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~--m~~L~~ld~~~N~L~tlP~~-lg~l-~~L~~LyL 213 (565)
T KOG0472|consen 138 DLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIA--MKRLKHLDCNSNLLETLPPE-LGGL-ESLELLYL 213 (565)
T ss_pred hhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHH--HHHHHhcccchhhhhcCChh-hcch-hhhHHHHh
Confidence 55666777777777777777777777777777777777665443 34477777777777777764 5566 67777777
Q ss_pred cCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCC
Q psy8879 176 SHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGP 255 (694)
Q Consensus 176 s~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 255 (694)
..|+|..++ .|.++..|++|.++.|+|..++.+....+++|.+|+|++|+++ ..|+.+.-+.+|++||+++|.+++
T Consensus 214 ~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~- 289 (565)
T KOG0472|consen 214 RRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS- 289 (565)
T ss_pred hhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-
Confidence 777776666 4666666667777666666666666666666667777777666 456666666666666666666664
Q ss_pred CCCCCCCCccccceeeccCCc
Q psy8879 256 LGPSTVPRLSSLKVLSIAHNQ 276 (694)
Q Consensus 256 i~p~~~~~l~~L~~L~Ls~N~ 276 (694)
+ |..++++ .|+.|-+.+|.
T Consensus 290 L-p~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 290 L-PYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred C-Ccccccc-eeeehhhcCCc
Confidence 2 4445555 45555454444
No 9
>KOG4237|consensus
Probab=99.87 E-value=4e-24 Score=222.62 Aligned_cols=282 Identities=24% Similarity=0.351 Sum_probs=231.7
Q ss_pred eEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEccC
Q psy8879 98 SLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDLSH 177 (694)
Q Consensus 98 ~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~ 177 (694)
..+||++.+++++|..+.. .-..+.|..|.|+.|++++|..+.+ |++|||++|.|+.|.+.+|.++ ++|..|-+-+
T Consensus 49 ~~VdCr~~GL~eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~-LRrLdLS~N~Is~I~p~AF~GL-~~l~~Lvlyg 124 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHR-LRRLDLSKNNISFIAPDAFKGL-ASLLSLVLYG 124 (498)
T ss_pred ceEEccCCCcccCcccCCC--cceEEEeccCCcccCChhhccchhh-hceecccccchhhcChHhhhhh-HhhhHHHhhc
Confidence 3589999999999998764 5678899999999999999988765 9999999999999999999999 7777766555
Q ss_pred -CCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCC
Q psy8879 178 -NQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPL 256 (694)
Q Consensus 178 -N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i 256 (694)
|+|+.++.+.|++|..|+-|.+.-|++.-+..++|..+++|..|.+.+|.+..+....|..+..++.+.+..|.+....
T Consensus 125 ~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 125 NNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred CCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence 9999999999999999999999999999999999999999999999999998666668999999999999998843211
Q ss_pred -----------CCCCCCCccccceeeccCCcccccccccccCC-ccc-ceecccCCccccccchhhhcccccccccCCCC
Q psy8879 257 -----------GPSTVPRLSSLKVLSIAHNQFSSVRRGALAGL-DKL-TSLSCHHNQIDVLEDHSFRALSTLSHLDLAHN 323 (694)
Q Consensus 257 -----------~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L-~~L-~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N 323 (694)
.+..++......-..+.++++..+.+..|... ..+ ..+....+....-|...|+.+++|+.|+|++|
T Consensus 205 nL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN 284 (498)
T KOG4237|consen 205 NLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNN 284 (498)
T ss_pred ccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCC
Confidence 12223333333344455555655655544322 111 22333444555667788999999999999999
Q ss_pred ccccccccchhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCcccccC
Q psy8879 324 RIVAVSGASLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIYVG 383 (694)
Q Consensus 324 ~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~ 383 (694)
+|+++.+.+|.+...++.|.|..|+|..+...+|.++..|+.|+|.+|+|+.+.+..|+.
T Consensus 285 ~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~ 344 (498)
T KOG4237|consen 285 KITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQT 344 (498)
T ss_pred ccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccc
Confidence 999999999999999999999999999999999999999999999999999777776654
No 10
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.84 E-value=1.6e-20 Score=218.62 Aligned_cols=268 Identities=25% Similarity=0.253 Sum_probs=201.7
Q ss_pred CCCCCCCcEEEccCCCchhhhhhhcCCCCCCCCeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCC
Q psy8879 64 CACDLPHTLRCTANKSDLYAISESLRGLEPDERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSS 143 (694)
Q Consensus 64 C~C~~~~~v~C~~~~~~l~~i~~~L~~l~~~~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~ 143 (694)
|.+.....+.|... .+..+|..+. ..++.|++++|+++.+|.. .++|++|++++|+|+.++. .+.
T Consensus 198 Cl~~~~~~LdLs~~--~LtsLP~~l~-----~~L~~L~L~~N~Lt~LP~l---p~~Lk~LdLs~N~LtsLP~-----lp~ 262 (788)
T PRK15387 198 CLNNGNAVLNVGES--GLTTLPDCLP-----AHITTLVIPDNNLTSLPAL---PPELRTLEVSGNQLTSLPV-----LPP 262 (788)
T ss_pred HhcCCCcEEEcCCC--CCCcCCcchh-----cCCCEEEccCCcCCCCCCC---CCCCcEEEecCCccCcccC-----ccc
Confidence 44444455666543 3445565443 2688899999999988863 4678999999999988864 245
Q ss_pred CccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEec
Q psy8879 144 PLQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRL 223 (694)
Q Consensus 144 ~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~L 223 (694)
+|+.|++++|.++.+|.. +++|+.|++++|+++.++. .+++|+.|++++|++++++.. ..+|+.|++
T Consensus 263 sL~~L~Ls~N~L~~Lp~l-----p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~l----p~~L~~L~L 329 (788)
T PRK15387 263 GLLELSIFSNPLTHLPAL-----PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPAL----PSELCKLWA 329 (788)
T ss_pred ccceeeccCCchhhhhhc-----hhhcCEEECcCCccccccc----cccccceeECCCCccccCCCC----ccccccccc
Confidence 689999999998887752 2678889999999988764 346899999999999887541 246888899
Q ss_pred cCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCcccc
Q psy8879 224 QGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDV 303 (694)
Q Consensus 224 s~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~ 303 (694)
++|++++ +|.. ..+|+.|+|++|++.+ + |.. .++|+.|++++|.++.++.. ..+|+.|++++|+|+.
T Consensus 330 s~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-L-P~l---p~~L~~L~Ls~N~L~~LP~l----~~~L~~LdLs~N~Lt~ 396 (788)
T PRK15387 330 YNNQLTS-LPTL---PSGLQELSVSDNQLAS-L-PTL---PSELYKLWAYNNRLTSLPAL----PSGLKELIVSGNRLTS 396 (788)
T ss_pred ccCcccc-cccc---ccccceEecCCCccCC-C-CCC---CcccceehhhccccccCccc----ccccceEEecCCcccC
Confidence 9998875 3431 2478999999999986 4 432 24788889999999887642 3578999999999998
Q ss_pred ccchhhhcccccccccCCCCccccccccchhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCcccc
Q psy8879 304 LEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIY 381 (694)
Q Consensus 304 i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 381 (694)
++.. .++|+.|++++|++++++. . ..+|+.|+|++|+|+.+|.. +..+++|+.|+|++|+|++.....+
T Consensus 397 LP~l----~s~L~~LdLS~N~LssIP~-l---~~~L~~L~Ls~NqLt~LP~s-l~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 397 LPVL----PSELKELMVSGNRLTSLPM-L---PSGLLSLSVYRNQLTRLPES-LIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCCc----ccCCCEEEccCCcCCCCCc-c---hhhhhhhhhccCcccccChH-HhhccCCCeEECCCCCCCchHHHHH
Confidence 7752 3679999999999998753 2 35788899999999988765 6778999999999999986655443
No 11
>KOG0472|consensus
Probab=99.83 E-value=2.3e-23 Score=217.02 Aligned_cols=272 Identities=28% Similarity=0.397 Sum_probs=229.2
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEc
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDL 175 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~L 175 (694)
.+..+++++|.+..+.+++..+..+..|++.+|++..+++. .+-...++.|+.++|++..+|.. ...+ .+|+.++.
T Consensus 46 ~l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~~lp~a--ig~l~~l~~l~vs~n~ls~lp~~-i~s~-~~l~~l~~ 121 (565)
T KOG0472|consen 46 DLQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLSQLPAA--IGELEALKSLNVSHNKLSELPEQ-IGSL-ISLVKLDC 121 (565)
T ss_pred chhhhhhccCchhhccHhhhcccceeEEEeccchhhhCCHH--HHHHHHHHHhhcccchHhhccHH-Hhhh-hhhhhhhc
Confidence 57778899999999888888888999999999999888765 23233488899999999999885 4555 78999999
Q ss_pred cCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCC
Q psy8879 176 SHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGP 255 (694)
Q Consensus 176 s~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 255 (694)
++|.+..+++ .++.+..|+.|+..+|+++..+++ +..+.+|..|++.+|+++...|.... ++.|+.||...|.+..
T Consensus 122 s~n~~~el~~-~i~~~~~l~dl~~~~N~i~slp~~-~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~t- 197 (565)
T KOG0472|consen 122 SSNELKELPD-SIGRLLDLEDLDATNNQISSLPED-MVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLET- 197 (565)
T ss_pred cccceeecCc-hHHHHhhhhhhhccccccccCchH-HHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhc-
Confidence 9999988875 567788899999999999888766 66678889999999999866666555 8899999999998874
Q ss_pred CCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhc
Q psy8879 256 LGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAH 335 (694)
Q Consensus 256 i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~ 335 (694)
+ |..++.+.+|+-|+|..|++..+| .|.++..|++|+++.|+|..++....+++++|..|||.+|++.+. |..+..
T Consensus 198 l-P~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~-Pde~cl 273 (565)
T KOG0472|consen 198 L-PPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEV-PDEICL 273 (565)
T ss_pred C-ChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccC-chHHHH
Confidence 5 667888999999999999999887 588999999999999999999988888999999999999999988 455677
Q ss_pred ccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCcccc
Q psy8879 336 LSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIY 381 (694)
Q Consensus 336 l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 381 (694)
+.+|+.||+++|.|+++|+. ++++ +|+.|.+.||++..+-.++.
T Consensus 274 LrsL~rLDlSNN~is~Lp~s-Lgnl-hL~~L~leGNPlrTiRr~ii 317 (565)
T KOG0472|consen 274 LRSLERLDLSNNDISSLPYS-LGNL-HLKFLALEGNPLRTIRREII 317 (565)
T ss_pred hhhhhhhcccCCccccCCcc-cccc-eeeehhhcCCchHHHHHHHH
Confidence 88999999999999999876 7778 89999999999987776664
No 12
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.82 E-value=6.5e-20 Score=213.54 Aligned_cols=241 Identities=27% Similarity=0.284 Sum_probs=198.3
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEc
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDL 175 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~L 175 (694)
.-..|||+.++++.+|..+.. +|+.|++.+|+++.++. .+++|++|++++|+|+.+|.. +++|+.|+|
T Consensus 202 ~~~~LdLs~~~LtsLP~~l~~--~L~~L~L~~N~Lt~LP~-----lp~~Lk~LdLs~N~LtsLP~l-----p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGESGLTTLPDCLPA--HITTLVIPDNNLTSLPA-----LPPELRTLEVSGNQLTSLPVL-----PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCCCCCcCCcchhc--CCCEEEccCCcCCCCCC-----CCCCCcEEEecCCccCcccCc-----ccccceeec
Confidence 456799999999999998764 79999999999999874 246799999999999999852 278999999
Q ss_pred cCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCC
Q psy8879 176 SHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGP 255 (694)
Q Consensus 176 s~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 255 (694)
++|.++.++. ...+|+.|++++|+++.++. ..++|+.|++++|++++. |.. ..+|+.|++++|.+.+
T Consensus 270 s~N~L~~Lp~----lp~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~- 336 (788)
T PRK15387 270 FSNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS- 336 (788)
T ss_pred cCCchhhhhh----chhhcCEEECcCCccccccc----cccccceeECCCCccccC-CCC---cccccccccccCcccc-
Confidence 9999988774 23579999999999998864 247899999999999863 432 2468899999999985
Q ss_pred CCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhc
Q psy8879 256 LGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAH 335 (694)
Q Consensus 256 i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~ 335 (694)
+ |. + ..+|+.|+|++|+|+.+++. .++|+.|++++|.|+.++.. ..+|+.|++++|+|++++..
T Consensus 337 L-P~-l--p~~Lq~LdLS~N~Ls~LP~l----p~~L~~L~Ls~N~L~~LP~l----~~~L~~LdLs~N~Lt~LP~l---- 400 (788)
T PRK15387 337 L-PT-L--PSGLQELSVSDNQLASLPTL----PSELYKLWAYNNRLTSLPAL----PSGLKELIVSGNRLTSLPVL---- 400 (788)
T ss_pred c-cc-c--ccccceEecCCCccCCCCCC----CcccceehhhccccccCccc----ccccceEEecCCcccCCCCc----
Confidence 4 33 1 25899999999999988652 35789999999999988752 35799999999999987542
Q ss_pred ccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCcccc
Q psy8879 336 LSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIY 381 (694)
Q Consensus 336 l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f 381 (694)
.++|+.|++++|+++++|.. ..+|+.|++++|+|+.+|..+.
T Consensus 401 ~s~L~~LdLS~N~LssIP~l----~~~L~~L~Ls~NqLt~LP~sl~ 442 (788)
T PRK15387 401 PSELKELMVSGNRLTSLPML----PSGLLSLSVYRNQLTRLPESLI 442 (788)
T ss_pred ccCCCEEEccCCcCCCCCcc----hhhhhhhhhccCcccccChHHh
Confidence 36899999999999998752 3578899999999999988654
No 13
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.80 E-value=2.7e-19 Score=209.42 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=199.2
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEc
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDL 175 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~L 175 (694)
+...|++++++++.+|..+. ..|+.|++++|+|+.++...+ .+|++|++++|.|+.+|.. +. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~----~nL~~L~Ls~N~LtsLP~~-l~---~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLPENLQ----GNIKTLYANSNQLTSIPAT-LP---DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCChhhc----cCCCEEECCCCccccCChh-hh---ccccEEEC
Confidence 56789999999999998764 479999999999999987544 4699999999999999874 22 67999999
Q ss_pred cCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCC
Q psy8879 176 SHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGP 255 (694)
Q Consensus 176 s~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~ 255 (694)
++|++..++.. +. .+|+.|++++|+++.++.. +. ++|+.|++++|+++. +|..+. ++|+.|++++|.+..
T Consensus 249 s~N~L~~LP~~-l~--s~L~~L~Ls~N~L~~LP~~-l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRITELPER-LP--SALQSLDLFHNKISCLPEN-LP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccCcCChh-Hh--CCCCEEECcCCccCccccc-cC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence 99999988754 32 5799999999999987553 32 589999999999985 444332 479999999999985
Q ss_pred CCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhc
Q psy8879 256 LGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAH 335 (694)
Q Consensus 256 i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~ 335 (694)
+ |..+ .++|+.|++++|.++.++.. + .++|+.|++++|+|+.++.. + .++|+.|+|++|+++.+++. +.
T Consensus 319 L-P~~l--~~sL~~L~Ls~N~Lt~LP~~-l--~~sL~~L~Ls~N~L~~LP~~-l--p~~L~~LdLs~N~Lt~LP~~-l~- 387 (754)
T PRK15370 319 L-PETL--PPGLKTLEAGENALTSLPAS-L--PPELQVLDVSKNQITVLPET-L--PPTITTLDVSRNALTNLPEN-LP- 387 (754)
T ss_pred C-Cccc--cccceeccccCCccccCChh-h--cCcccEEECCCCCCCcCChh-h--cCCcCEEECCCCcCCCCCHh-HH-
Confidence 4 4333 26899999999999987643 3 26899999999999987753 3 36899999999999988654 33
Q ss_pred ccccCeeecCCCCCCCcChh---hhCCCCCCCEEEccCCCCC
Q psy8879 336 LSNLTTLDLSHNFLRALTQD---LITPLKSLQELRLDDNDIS 374 (694)
Q Consensus 336 l~~L~~L~Ls~N~L~~l~~~---~~~~l~~L~~L~Ls~N~L~ 374 (694)
..|+.|++++|++..+|.. .+..++++..|++.+|+|+
T Consensus 388 -~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 388 -AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 3699999999999988753 3445688999999999987
No 14
>KOG0618|consensus
Probab=99.78 E-value=8e-21 Score=215.33 Aligned_cols=269 Identities=28% Similarity=0.321 Sum_probs=138.4
Q ss_pred CCeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEE
Q psy8879 95 ERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLD 174 (694)
Q Consensus 95 ~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~ 174 (694)
..++++|+++|++..+|+.+..+.+|+.+...+|.+..++...|.. .+|+.|.+..|.++.+|+. ..++ +.|++|+
T Consensus 241 ~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~--~~L~~l~~~~nel~yip~~-le~~-~sL~tLd 316 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLPEWIGACANLEALNANHNRLVALPLRISRI--TSLVSLSAAYNELEYIPPF-LEGL-KSLRTLD 316 (1081)
T ss_pred ccceeeecchhhhhcchHHHHhcccceEecccchhHHhhHHHHhhh--hhHHHHHhhhhhhhhCCCc-cccc-ceeeeee
Confidence 3555555555555555555555555555555555555554443321 2355555555555555552 3334 5555555
Q ss_pred ccCCCCCCCCcccccCCCC-ccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCC
Q psy8879 175 LSHNQLYKLENTSFKGLSS-LNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLA 253 (694)
Q Consensus 175 Ls~N~L~~i~~~~f~~L~~-L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~ 253 (694)
|..|+|...++..|.-+.. |+.|+.+.|.+...+...=..++.|+.|++.+|.++...-..+.+..+|+.|+|++|++.
T Consensus 317 L~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 317 LQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred ehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 5555555555544433333 455555555555444322223344555555555555555555555555555555555554
Q ss_pred CCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccch
Q psy8879 254 GPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASL 333 (694)
Q Consensus 254 ~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f 333 (694)
. ++...+.+++.|++|+||+|+++.++ ....++..|++|...+|+|..+| .+..++.|+.+|++.|+|+.+.-...
T Consensus 397 ~-fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~ 472 (1081)
T KOG0618|consen 397 S-FPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEA 472 (1081)
T ss_pred c-CCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHhhcCCceeech--hhhhcCcceEEecccchhhhhhhhhh
Confidence 3 33444555555555555555555554 34455555555555555555555 34555555555555555554432222
Q ss_pred hcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCC
Q psy8879 334 AHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDN 371 (694)
Q Consensus 334 ~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N 371 (694)
...++|++|||++|.-..+....|..++++...+++-|
T Consensus 473 ~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 473 LPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred CCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 22255555555555544444444444455555544444
No 15
>KOG0618|consensus
Probab=99.76 E-value=6.5e-20 Score=208.05 Aligned_cols=273 Identities=27% Similarity=0.339 Sum_probs=200.7
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEc
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDL 175 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~L 175 (694)
.++.+.|..|++..+- ...++|+.|+.++|.+..+.. ...+.+|++++++.|+++.+| .....+ .+|+.|+.
T Consensus 200 ~l~~l~c~rn~ls~l~---~~g~~l~~L~a~~n~l~~~~~---~p~p~nl~~~dis~n~l~~lp-~wi~~~-~nle~l~~ 271 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELE---ISGPSLTALYADHNPLTTLDV---HPVPLNLQYLDISHNNLSNLP-EWIGAC-ANLEALNA 271 (1081)
T ss_pred chhhhhhhhcccceEE---ecCcchheeeeccCcceeecc---ccccccceeeecchhhhhcch-HHHHhc-ccceEecc
Confidence 5666777777766552 234567777777777774433 233456777777777777777 556666 77777777
Q ss_pred cCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhh-------------------
Q psy8879 176 SHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAAL------------------- 236 (694)
Q Consensus 176 s~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~------------------- 236 (694)
.+|.+..++. .+....+|+.|....|.++.+++. ..++..|++|+|..|++....+..|
T Consensus 272 n~N~l~~lp~-ri~~~~~L~~l~~~~nel~yip~~-le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~ 349 (1081)
T KOG0618|consen 272 NHNRLVALPL-RISRITSLVSLSAAYNELEYIPPF-LEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLST 349 (1081)
T ss_pred cchhHHhhHH-HHhhhhhHHHHHhhhhhhhhCCCc-ccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccc
Confidence 7777766653 334456666666666666666553 4456666666666666653221111
Q ss_pred ------ccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhh
Q psy8879 237 ------QGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFR 310 (694)
Q Consensus 237 ------~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~ 310 (694)
...+.|+.|++.+|.+++.+ ...+.+.++|+.|+|++|++..++...+.+++.|++|+|++|+++.++ ....
T Consensus 350 lp~~~e~~~~~Lq~LylanN~Ltd~c-~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva 427 (1081)
T KOG0618|consen 350 LPSYEENNHAALQELYLANNHLTDSC-FPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLP-DTVA 427 (1081)
T ss_pred cccccchhhHHHHHHHHhcCcccccc-hhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhh-HHHH
Confidence 12346888999999998765 445778899999999999999999999999999999999999999998 5788
Q ss_pred cccccccccCCCCccccccccchhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCccccc
Q psy8879 311 ALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIYV 382 (694)
Q Consensus 311 ~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~ 382 (694)
.++.|+.|...+|+|...+ .+..++.|+.+|++.|+|+.+.-..-.+-++|++||++||....++.+.|.
T Consensus 428 ~~~~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~ 497 (1081)
T KOG0618|consen 428 NLGRLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLK 497 (1081)
T ss_pred hhhhhHHHhhcCCceeech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhH
Confidence 8999999999999999986 678899999999999999876543333448999999999997666655544
No 16
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.75 E-value=6.2e-18 Score=198.01 Aligned_cols=239 Identities=23% Similarity=0.351 Sum_probs=189.8
Q ss_pred CchhhhhhhcCCCCCCCCeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCC
Q psy8879 79 SDLYAISESLRGLEPDERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVV 158 (694)
Q Consensus 79 ~~l~~i~~~L~~l~~~~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~l 158 (694)
..+..+|..+. ..++.|++++|+++.+|..+. .+|++|++++|.++.++.. ++.+|+.|+|++|.+..+
T Consensus 188 ~~LtsLP~~Ip-----~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~----l~~~L~~L~Ls~N~L~~L 256 (754)
T PRK15370 188 LGLTTIPACIP-----EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPAT----LPDTIQEMELSINRITEL 256 (754)
T ss_pred CCcCcCCcccc-----cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChh----hhccccEEECcCCccCcC
Confidence 34555555432 379999999999999998775 4899999999999988753 234699999999999999
Q ss_pred CccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhcc
Q psy8879 159 PTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQG 238 (694)
Q Consensus 159 p~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~ 238 (694)
|.. +. ++|++|++++|+|+.++.. +. ++|+.|++++|+++.++.. +. ++|+.|++++|+++. +|..+.
T Consensus 257 P~~-l~---s~L~~L~Ls~N~L~~LP~~-l~--~sL~~L~Ls~N~Lt~LP~~-lp--~sL~~L~Ls~N~Lt~-LP~~l~- 324 (754)
T PRK15370 257 PER-LP---SALQSLDLFHNKISCLPEN-LP--EELRYLSVYDNSIRTLPAH-LP--SGITHLNVQSNSLTA-LPETLP- 324 (754)
T ss_pred Chh-Hh---CCCCEEECcCCccCccccc-cC--CCCcEEECCCCccccCccc-ch--hhHHHHHhcCCcccc-CCcccc-
Confidence 874 32 6799999999999987653 32 5899999999999988653 22 479999999999985 444332
Q ss_pred CcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccc
Q psy8879 239 LRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHL 318 (694)
Q Consensus 239 L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L 318 (694)
++|+.|++++|.+++ + |..+. ++|+.|++++|+++.++.. + .++|++|++++|+++.+++... ..|+.|
T Consensus 325 -~sL~~L~Ls~N~Lt~-L-P~~l~--~sL~~L~Ls~N~L~~LP~~-l--p~~L~~LdLs~N~Lt~LP~~l~---~sL~~L 393 (754)
T PRK15370 325 -PGLKTLEAGENALTS-L-PASLP--PELQVLDVSKNQITVLPET-L--PPTITTLDVSRNALTNLPENLP---AALQIM 393 (754)
T ss_pred -ccceeccccCCcccc-C-Chhhc--CcccEEECCCCCCCcCChh-h--cCCcCEEECCCCcCCCCCHhHH---HHHHHH
Confidence 689999999999986 5 44443 6999999999999987643 3 3689999999999999887532 479999
Q ss_pred cCCCCcccccccc---chhcccccCeeecCCCCCCC
Q psy8879 319 DLAHNRIVAVSGA---SLAHLSNLTTLDLSHNFLRA 351 (694)
Q Consensus 319 ~Ls~N~L~~i~~~---~f~~l~~L~~L~Ls~N~L~~ 351 (694)
++++|++..++.. .+..++.+..|+|.+|.+..
T Consensus 394 dLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 394 QASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred hhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 9999999987432 23445889999999999874
No 17
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.72 E-value=1.7e-16 Score=196.78 Aligned_cols=264 Identities=23% Similarity=0.279 Sum_probs=158.4
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCC-CCCCCCccccccCCCCccEEE
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNN-LLSVVPTSALAPLAPNLDRLD 174 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N-~L~~lp~~~~~~l~~~L~~L~ 174 (694)
.|+.|++.++.+..+|..+ ...+|++|+++++.+..++.+ + ..+.+|+.|+|+++ .++.+|. +..+ ++|++|+
T Consensus 590 ~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~-~~l~~Lk~L~Ls~~~~l~~ip~--ls~l-~~Le~L~ 663 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-V-HSLTGLRNIDLRGSKNLKEIPD--LSMA-TNLETLK 663 (1153)
T ss_pred ccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-c-ccCCCCCEEECCCCCCcCcCCc--cccC-CcccEEE
Confidence 5777777777777777766 456777777777777776554 2 22345777777765 3566654 5556 7777777
Q ss_pred ccCCC-CCCCCcccccCCCCccEEEecCCC-CCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcC
Q psy8879 175 LSHNQ-LYKLENTSFKGLSSLNFLDLSYNK-LMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLL 252 (694)
Q Consensus 175 Ls~N~-L~~i~~~~f~~L~~L~~L~Ls~N~-l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l 252 (694)
|++|. +..+ +..+.++++|+.|++++|. +..++.. + ++++|+.|++++|......|.. ..+|++|++++|.+
T Consensus 664 L~~c~~L~~l-p~si~~L~~L~~L~L~~c~~L~~Lp~~-i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i 737 (1153)
T PLN03210 664 LSDCSSLVEL-PSSIQYLNKLEDLDMSRCENLEILPTG-I-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAI 737 (1153)
T ss_pred ecCCCCcccc-chhhhccCCCCEEeCCCCCCcCccCCc-C-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcc
Confidence 77764 3333 3466777777777777753 4454433 2 5667777777776544333332 24566666666665
Q ss_pred CCCCCCCCC------------------------------CCccccceeeccCCcccccccccccCCcccceecccCC-cc
Q psy8879 253 AGPLGPSTV------------------------------PRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHN-QI 301 (694)
Q Consensus 253 ~~~i~p~~~------------------------------~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N-~L 301 (694)
.. + |..+ ...++|+.|+|++|......|..+.++++|+.|++++| .+
T Consensus 738 ~~-l-P~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L 815 (1153)
T PLN03210 738 EE-F-PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL 815 (1153)
T ss_pred cc-c-cccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc
Confidence 43 2 2111 11245666666666443333445666677777777665 35
Q ss_pred ccccchhhhcccccccccCCCCccccccccchhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccC-CCCCCCCcc
Q psy8879 302 DVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDD-NDISMEPEC 379 (694)
Q Consensus 302 ~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~-N~L~~l~~~ 379 (694)
..++... .+++|+.|++++|......|. ...+|+.|+|++|.++.+|. .+..+++|+.|++++ |+++.+|..
T Consensus 816 ~~LP~~~--~L~sL~~L~Ls~c~~L~~~p~---~~~nL~~L~Ls~n~i~~iP~-si~~l~~L~~L~L~~C~~L~~l~~~ 888 (1153)
T PLN03210 816 ETLPTGI--NLESLESLDLSGCSRLRTFPD---ISTNISDLNLSRTGIEEVPW-WIEKFSNLSFLDMNGCNNLQRVSLN 888 (1153)
T ss_pred CeeCCCC--CccccCEEECCCCCccccccc---cccccCEeECCCCCCccChH-HHhcCCCCCEEECCCCCCcCccCcc
Confidence 5554432 466677777766543222222 12567777777777777654 366677777777776 556666654
No 18
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.66 E-value=2.2e-15 Score=186.84 Aligned_cols=259 Identities=25% Similarity=0.285 Sum_probs=195.3
Q ss_pred CCCeeEEEcCCCCCCCCCccccCCCCccEEEccCC-CCCCCCcchhcCCCCCccEEEccCCC-CCCCCccccccCCCCcc
Q psy8879 94 DERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSG-ELKNISDGAFIGLSSPLQALGLPNNL-LSVVPTSALAPLAPNLD 171 (694)
Q Consensus 94 ~~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n-~i~~i~~~~F~~l~~~L~~L~Ls~N~-L~~lp~~~~~~l~~~L~ 171 (694)
.++|..|+++++.+..++..+..+++|+.|+++++ .++.++. +.. .++|+.|+|++|. +..+|. .+..+ ++|+
T Consensus 610 ~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~-l~~Le~L~L~~c~~L~~lp~-si~~L-~~L~ 684 (1153)
T PLN03210 610 PENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSM-ATNLETLKLSDCSSLVELPS-SIQYL-NKLE 684 (1153)
T ss_pred ccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--ccc-CCcccEEEecCCCCccccch-hhhcc-CCCC
Confidence 35899999999999999999999999999999875 4666654 333 4569999999874 666765 57888 8999
Q ss_pred EEEccCC-CCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhh---------------
Q psy8879 172 RLDLSHN-QLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAA--------------- 235 (694)
Q Consensus 172 ~L~Ls~N-~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~--------------- 235 (694)
.|++++| .++.++.. + ++++|+.|++++|......|. ...+|++|++++|.+.. +|..
T Consensus 685 ~L~L~~c~~L~~Lp~~-i-~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~ 758 (1153)
T PLN03210 685 DLDMSRCENLEILPTG-I-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIEE-FPSNLRLENLDELILCEMK 758 (1153)
T ss_pred EEeCCCCCCcCccCCc-C-CCCCCCEEeCCCCCCcccccc---ccCCcCeeecCCCcccc-ccccccccccccccccccc
Confidence 9999986 56666643 2 678888888888764333332 23467777777777653 2221
Q ss_pred ---------------hccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCC-cccccccccccCCcccceecccCC
Q psy8879 236 ---------------LQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHN-QFSSVRRGALAGLDKLTSLSCHHN 299 (694)
Q Consensus 236 ---------------~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N-~L~~i~~~~~~~L~~L~~L~Ls~N 299 (694)
+...++|+.|++++|...+.+ |..+.++++|+.|++++| .+..++.. . ++++|+.|++++|
T Consensus 759 ~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~l-P~si~~L~~L~~L~Ls~C~~L~~LP~~-~-~L~sL~~L~Ls~c 835 (1153)
T PLN03210 759 SEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVEL-PSSIQNLHKLEHLEIENCINLETLPTG-I-NLESLESLDLSGC 835 (1153)
T ss_pred hhhccccccccchhhhhccccchheeCCCCCCcccc-ChhhhCCCCCCEEECCCCCCcCeeCCC-C-CccccCEEECCCC
Confidence 112357888888888766656 777999999999999987 46666543 3 7899999999997
Q ss_pred c-cccccchhhhcccccccccCCCCccccccccchhcccccCeeecCC-CCCCCcChhhhCCCCCCCEEEccCCC
Q psy8879 300 Q-IDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSH-NFLRALTQDLITPLKSLQELRLDDND 372 (694)
Q Consensus 300 ~-L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~-N~L~~l~~~~~~~l~~L~~L~Ls~N~ 372 (694)
. +..++. ..++|+.|+|++|.++.+ |.++..+++|+.|+|++ |++..++.. +..+++|+.+++++|.
T Consensus 836 ~~L~~~p~----~~~nL~~L~Ls~n~i~~i-P~si~~l~~L~~L~L~~C~~L~~l~~~-~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 836 SRLRTFPD----ISTNISDLNLSRTGIEEV-PWWIEKFSNLSFLDMNGCNNLQRVSLN-ISKLKHLETVDFSDCG 904 (1153)
T ss_pred Cccccccc----cccccCEeECCCCCCccC-hHHHhcCCCCCEEECCCCCCcCccCcc-cccccCCCeeecCCCc
Confidence 4 444432 236899999999999987 56788999999999998 677877654 5678899999998874
No 19
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.65 E-value=1.4e-17 Score=177.44 Aligned_cols=259 Identities=24% Similarity=0.242 Sum_probs=146.9
Q ss_pred ccCCCCccEEEccCCCCCCCCcchh---cCCCCCccEEEccCCCCCCCC------ccccccCCCCccEEEccCCCCCCCC
Q psy8879 114 FLEGVTLHGLVISSGELKNISDGAF---IGLSSPLQALGLPNNLLSVVP------TSALAPLAPNLDRLDLSHNQLYKLE 184 (694)
Q Consensus 114 ~~~~~~L~~L~Ls~n~i~~i~~~~F---~~l~~~L~~L~Ls~N~L~~lp------~~~~~~l~~~L~~L~Ls~N~L~~i~ 184 (694)
+.....|+.|+++++.++......+ ....++|++|+++++.+...+ ...+..+ ++|++|++++|.+....
T Consensus 19 ~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~-~~L~~L~l~~~~~~~~~ 97 (319)
T cd00116 19 LPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG-CGLQELDLSDNALGPDG 97 (319)
T ss_pred HHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc-CceeEEEccCCCCChhH
Confidence 3444556667776666643221111 112233677777766655311 1234455 67777777777776544
Q ss_pred cccccCCCC---ccEEEecCCCCCCCC----ccccCCC-CCCcEEeccCCcccch----hhhhhccCcccccccCCCCcC
Q psy8879 185 NTSFKGLSS---LNFLDLSYNKLMTLS----QDCLAPL-VTLRVLRLQGNRLTVS----VVAALQGLRSVTDLDLSHNLL 252 (694)
Q Consensus 185 ~~~f~~L~~---L~~L~Ls~N~l~~i~----~~~f~~L-~~L~~L~Ls~N~l~~~----~~~~~~~L~~L~~L~Ls~N~l 252 (694)
+..+..+.+ |++|++++|++.+.. ...+..+ ++|++|++++|.+++. ....+..+.+|++|++++|.+
T Consensus 98 ~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l 177 (319)
T cd00116 98 CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI 177 (319)
T ss_pred HHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCC
Confidence 444444443 777777777766321 1234455 6777777777777632 233455566777777777776
Q ss_pred CCCCC---CCCCCCccccceeeccCCccccccc----ccccCCcccceecccCCccccccchhhhc-----ccccccccC
Q psy8879 253 AGPLG---PSTVPRLSSLKVLSIAHNQFSSVRR----GALAGLDKLTSLSCHHNQIDVLEDHSFRA-----LSTLSHLDL 320 (694)
Q Consensus 253 ~~~i~---p~~~~~l~~L~~L~Ls~N~L~~i~~----~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~-----l~~L~~L~L 320 (694)
.+... +..+..+++|+.|++++|.+++... ..+..+++|++|++++|.++......+.. .+.|+.|++
T Consensus 178 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l 257 (319)
T cd00116 178 GDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257 (319)
T ss_pred chHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEc
Confidence 63110 1123334577777777777664322 23455667777777777776432222221 257777777
Q ss_pred CCCccccccc----cchhcccccCeeecCCCCCCCcCh----hhhCCC-CCCCEEEccCCCC
Q psy8879 321 AHNRIVAVSG----ASLAHLSNLTTLDLSHNFLRALTQ----DLITPL-KSLQELRLDDNDI 373 (694)
Q Consensus 321 s~N~L~~i~~----~~f~~l~~L~~L~Ls~N~L~~l~~----~~~~~l-~~L~~L~Ls~N~L 373 (694)
++|.++.... ..+..+++|+.+++++|.+..-+. ..+... +.|+.+++.+|+|
T Consensus 258 ~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 258 SCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 7777763221 234455677777888777775432 233333 5677777777764
No 20
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.62 E-value=7.9e-17 Score=171.76 Aligned_cols=257 Identities=27% Similarity=0.273 Sum_probs=185.1
Q ss_pred EEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCC----ccccccCCCCccEEEccCCCCCCC------CcccccCC
Q psy8879 122 GLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVP----TSALAPLAPNLDRLDLSHNQLYKL------ENTSFKGL 191 (694)
Q Consensus 122 ~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp----~~~~~~l~~~L~~L~Ls~N~L~~i------~~~~f~~L 191 (694)
.|+|+.+.++.-....+.....+|+.|+++++.++... ...+... +.|++|+++++.+... .+..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~-~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQ-PSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhC-CCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 46666676663332222233345999999999985421 1234455 7799999999988631 12456778
Q ss_pred CCccEEEecCCCCCCCCccccCCCCC---CcEEeccCCcccc----hhhhhhccC-cccccccCCCCcCCCCCC---CCC
Q psy8879 192 SSLNFLDLSYNKLMTLSQDCLAPLVT---LRVLRLQGNRLTV----SVVAALQGL-RSVTDLDLSHNLLAGPLG---PST 260 (694)
Q Consensus 192 ~~L~~L~Ls~N~l~~i~~~~f~~L~~---L~~L~Ls~N~l~~----~~~~~~~~L-~~L~~L~Ls~N~l~~~i~---p~~ 260 (694)
++|++|++++|.+....+..+..+.+ |++|++++|++.+ .+...+..+ ++|+.|++++|.+.+... ...
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 99999999999998666655555555 9999999999874 233456667 899999999999884210 234
Q ss_pred CCCccccceeeccCCcccccc----cccccCCcccceecccCCccccccc----hhhhcccccccccCCCCccccccccc
Q psy8879 261 VPRLSSLKVLSIAHNQFSSVR----RGALAGLDKLTSLSCHHNQIDVLED----HSFRALSTLSHLDLAHNRIVAVSGAS 332 (694)
Q Consensus 261 ~~~l~~L~~L~Ls~N~L~~i~----~~~~~~L~~L~~L~Ls~N~L~~i~~----~~f~~l~~L~~L~Ls~N~L~~i~~~~ 332 (694)
+..+++|++|++++|.+++.. ...+..+++|++|++++|.++.... ..+..+++|++|++++|.+++.....
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~ 240 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence 556778999999999998421 2234556799999999999875443 34556788999999999998754444
Q ss_pred hhc-----ccccCeeecCCCCCCCcC----hhhhCCCCCCCEEEccCCCCCCCCcc
Q psy8879 333 LAH-----LSNLTTLDLSHNFLRALT----QDLITPLKSLQELRLDDNDISMEPEC 379 (694)
Q Consensus 333 f~~-----l~~L~~L~Ls~N~L~~l~----~~~~~~l~~L~~L~Ls~N~L~~l~~~ 379 (694)
+.. .+.|+.|++++|.++... ...+..+++|+.+++++|+++..+..
T Consensus 241 l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~ 296 (319)
T cd00116 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296 (319)
T ss_pred HHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHH
Confidence 332 379999999999997322 23456678999999999999865543
No 21
>KOG0617|consensus
Probab=99.54 E-value=3.5e-16 Score=147.18 Aligned_cols=158 Identities=27% Similarity=0.396 Sum_probs=97.8
Q ss_pred CCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccC
Q psy8879 168 PNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDL 247 (694)
Q Consensus 168 ~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~L 247 (694)
.+++.|.||+|+++.++| .+..+.+|+.|++++|+|+.++.. ++.+++|+.|++.-|++. ..|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~~vpp-nia~l~nlevln~~nnqie~lp~~-issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTVVPP-NIAELKNLEVLNLSNNQIEELPTS-ISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCceeecCC-cHHHhhhhhhhhcccchhhhcChh-hhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 566666777777766665 356666777777777777766544 666777777777777665 56666777777777777
Q ss_pred CCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCcccc
Q psy8879 248 SHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVA 327 (694)
Q Consensus 248 s~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~ 327 (694)
.+|++.+..-|..|..+..|+.|+|++|.+.-+++ ..+++++|+.|.+.+|.+-.++. .++.++.|++|.+.+|+++-
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~-dvg~lt~lqil~lrdndll~lpk-eig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPP-DVGKLTNLQILSLRDNDLLSLPK-EIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCCh-hhhhhcceeEEeeccCchhhCcH-HHHHHHHHHHHhcccceeee
Confidence 77766655445556566666666666666655543 35556666666666665555543 34455555555555555554
Q ss_pred ccc
Q psy8879 328 VSG 330 (694)
Q Consensus 328 i~~ 330 (694)
++|
T Consensus 188 lpp 190 (264)
T KOG0617|consen 188 LPP 190 (264)
T ss_pred cCh
Confidence 443
No 22
>KOG0617|consensus
Probab=99.50 E-value=1.1e-15 Score=143.78 Aligned_cols=161 Identities=24% Similarity=0.373 Sum_probs=138.3
Q ss_pred cCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccc
Q psy8879 189 KGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLK 268 (694)
Q Consensus 189 ~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~ 268 (694)
-++.+.+.|.|++|+++.++|+ +..+.+|+.|++.+|+++ ..|..++.+++|+.|+++.|++. +.|..|+.+|.|+
T Consensus 30 f~~s~ITrLtLSHNKl~~vppn-ia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~--~lprgfgs~p~le 105 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLTVVPPN-IAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN--ILPRGFGSFPALE 105 (264)
T ss_pred cchhhhhhhhcccCceeecCCc-HHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh--cCccccCCCchhh
Confidence 3567788899999999999887 788999999999999998 67888999999999999999997 3488999999999
Q ss_pred eeeccCCcccc-cccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeecCCC
Q psy8879 269 VLSIAHNQFSS-VRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHN 347 (694)
Q Consensus 269 ~L~Ls~N~L~~-i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N 347 (694)
.|||..|++.+ ..|+.|..+..|+.|+|++|.+..+++ ..+.+++|+.|.+.+|.+-.+ |..++.+..|+.|++.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~-dvg~lt~lqil~lrdndll~l-pkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPP-DVGKLTNLQILSLRDNDLLSL-PKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcccCCh-hhhhhcceeEEeeccCchhhC-cHHHHHHHHHHHHhcccc
Confidence 99999998875 457778888899999999999888877 467888899999988888887 556788888888888888
Q ss_pred CCCCcChh
Q psy8879 348 FLRALTQD 355 (694)
Q Consensus 348 ~L~~l~~~ 355 (694)
+++-+||+
T Consensus 184 rl~vlppe 191 (264)
T KOG0617|consen 184 RLTVLPPE 191 (264)
T ss_pred eeeecChh
Confidence 88888876
No 23
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.19 E-value=3.3e-11 Score=133.10 Aligned_cols=179 Identities=30% Similarity=0.455 Sum_probs=113.6
Q ss_pred CccEEEccCCCCCCCCccccccCCC-CccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEe
Q psy8879 144 PLQALGLPNNLLSVVPTSALAPLAP-NLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLR 222 (694)
Q Consensus 144 ~L~~L~Ls~N~L~~lp~~~~~~l~~-~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~ 222 (694)
.++.|++.+|.++.+++.. .... +|+.|++++|.+..++ ..++.+++|+.|++++|++..+++. ....++|+.|+
T Consensus 117 ~l~~L~l~~n~i~~i~~~~--~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~l~~l~~~-~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNITDIPPLI--GLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFNDLSDLPKL-LSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccccCcccc--ccchhhcccccccccchhhhh-hhhhccccccccccCCchhhhhhhh-hhhhhhhhhee
Confidence 4677777777777766632 2212 6777777777776664 2356667777777777777766553 22556677777
Q ss_pred ccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccc
Q psy8879 223 LQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQID 302 (694)
Q Consensus 223 Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~ 302 (694)
+++|++.. +|........|++|.+++|.+... +..+..+.++..+.+.+|++..+ +..+.++++++.|++++|.++
T Consensus 193 ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~~~--~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 193 LSGNKISD-LPPEIELLSALEELDLSNNSIIEL--LSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred ccCCcccc-CchhhhhhhhhhhhhhcCCcceec--chhhhhcccccccccCCceeeec-cchhccccccceecccccccc
Confidence 77777763 344334445577777777743321 44566666777777777776654 234566667777777777777
Q ss_pred cccchhhhcccccccccCCCCccccccccc
Q psy8879 303 VLEDHSFRALSTLSHLDLAHNRIVAVSGAS 332 (694)
Q Consensus 303 ~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~ 332 (694)
.++. +..+.+|+.|++++|.+..+.+..
T Consensus 269 ~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 269 SISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred cccc--ccccCccCEEeccCccccccchhh
Confidence 7765 666777777777777776665543
No 24
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.14 E-value=6e-11 Score=130.99 Aligned_cols=186 Identities=32% Similarity=0.452 Sum_probs=115.8
Q ss_pred CCCCccEEEecCCCCCCCCccccCCC-CCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccc
Q psy8879 190 GLSSLNFLDLSYNKLMTLSQDCLAPL-VTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLK 268 (694)
Q Consensus 190 ~L~~L~~L~Ls~N~l~~i~~~~f~~L-~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~ 268 (694)
.++.++.|++.+|.++.+++. ...+ ++|+.|++++|++. .++..+..+++|+.|++++|++.. + +......++|+
T Consensus 114 ~~~~l~~L~l~~n~i~~i~~~-~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~-l-~~~~~~~~~L~ 189 (394)
T COG4886 114 ELTNLTSLDLDNNNITDIPPL-IGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-L-PKLLSNLSNLN 189 (394)
T ss_pred cccceeEEecCCcccccCccc-cccchhhcccccccccchh-hhhhhhhccccccccccCCchhhh-h-hhhhhhhhhhh
Confidence 334555555555555555443 2223 25666666666655 233455566666666666666664 2 33333566777
Q ss_pred eeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeecCCCC
Q psy8879 269 VLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNF 348 (694)
Q Consensus 269 ~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~ 348 (694)
.|++++|++..++.. ......|++|.+++|.+...+. .+..+.++..|.+.+|++..+ +..+..+++++.|++++|.
T Consensus 190 ~L~ls~N~i~~l~~~-~~~~~~L~~l~~~~N~~~~~~~-~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 190 NLDLSGNKISDLPPE-IELLSALEELDLSNNSIIELLS-SLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred heeccCCccccCchh-hhhhhhhhhhhhcCCcceecch-hhhhcccccccccCCceeeec-cchhccccccceecccccc
Confidence 777777777776543 2234457777777775333332 466677777777777777664 4456677778888888888
Q ss_pred CCCcChhhhCCCCCCCEEEccCCCCCCCCcccccCC
Q psy8879 349 LRALTQDLITPLKSLQELRLDDNDISMEPECIYVGF 384 (694)
Q Consensus 349 L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~~ 384 (694)
++.++. +..+.+++.|++++|.+..+++......
T Consensus 267 i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~ 300 (394)
T COG4886 267 ISSISS--LGSLTNLRELDLSGNSLSNALPLIALLL 300 (394)
T ss_pred cccccc--ccccCccCEEeccCccccccchhhhccc
Confidence 887776 6677788888888888777666555443
No 25
>KOG0532|consensus
Probab=99.13 E-value=5e-12 Score=138.06 Aligned_cols=199 Identities=26% Similarity=0.321 Sum_probs=121.4
Q ss_pred EEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCC
Q psy8879 147 ALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGN 226 (694)
Q Consensus 147 ~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N 226 (694)
+|.|++-+++.+|..++..-...-...||+.|++..++. .+..+..|+.+.|..|.+..++. .+.++..|.+|+|+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~-~~~~f~~Le~liLy~n~~r~ip~-~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPE-EACAFVSLESLILYHNCIRTIPE-AICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccccCch-HHHHHHHHHHHHHHhccceecch-hhhhhhHHHHhhhccc
Confidence 456777777777766554222445567777777777663 44555667777777777766643 3666667777777777
Q ss_pred cccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccc
Q psy8879 227 RLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLED 306 (694)
Q Consensus 227 ~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~ 306 (694)
++. ..|..+..++ |+.|-+++|+++. + |..++.++.|..||.+.|++..+++. +.++.+|+.|.+..|++..+++
T Consensus 132 qlS-~lp~~lC~lp-Lkvli~sNNkl~~-l-p~~ig~~~tl~~ld~s~nei~slpsq-l~~l~slr~l~vrRn~l~~lp~ 206 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-LKVLIVSNNKLTS-L-PEEIGLLPTLAHLDVSKNEIQSLPSQ-LGYLTSLRDLNVRRNHLEDLPE 206 (722)
T ss_pred hhh-cCChhhhcCc-ceeEEEecCcccc-C-CcccccchhHHHhhhhhhhhhhchHH-hhhHHHHHHHHHhhhhhhhCCH
Confidence 766 3444444443 6666666666663 3 55555666666666666666666543 5566666666666666666655
Q ss_pred hhhhcccccccccCCCCccccccccchhcccccCeeecCCCCCCCcChh
Q psy8879 307 HSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQD 355 (694)
Q Consensus 307 ~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~ 355 (694)
.. ..++ |..||+|.|+++.+ |..|.+|..|++|.|.+|.+.+-|..
T Consensus 207 El-~~Lp-Li~lDfScNkis~i-Pv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 207 EL-CSLP-LIRLDFSCNKISYL-PVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred HH-hCCc-eeeeecccCceeec-chhhhhhhhheeeeeccCCCCCChHH
Confidence 32 2332 56666666666665 34456666666666666666655543
No 26
>KOG0532|consensus
Probab=99.11 E-value=3.4e-12 Score=139.36 Aligned_cols=216 Identities=28% Similarity=0.351 Sum_probs=175.2
Q ss_pred EEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecC
Q psy8879 122 GLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSY 201 (694)
Q Consensus 122 ~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~ 201 (694)
.|.|++-.++..+..++..-+..-...+|+.|++..+|.. +..+ ..|+.+.|..|.+..++ ..+.++..|++|+|+.
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~~-~~~f-~~Le~liLy~n~~r~ip-~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPEE-ACAF-VSLESLILYHNCIRTIP-EAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccccCchH-HHHH-HHHHHHHHHhccceecc-hhhhhhhHHHHhhhcc
Confidence 3566777777777666664344477889999999999985 5555 78999999999998887 5789999999999999
Q ss_pred CCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccc
Q psy8879 202 NKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVR 281 (694)
Q Consensus 202 N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~ 281 (694)
|+++.++.+ +..++ |+.|.+++|+++ .+|..++.+..|..|+.+.|.+.. + |..+..+.+|+.|.+..|++..++
T Consensus 131 NqlS~lp~~-lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-l-psql~~l~slr~l~vrRn~l~~lp 205 (722)
T KOG0532|consen 131 NQLSHLPDG-LCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-L-PSQLGYLTSLRDLNVRRNHLEDLP 205 (722)
T ss_pred chhhcCChh-hhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhh-c-hHHhhhHHHHHHHHHhhhhhhhCC
Confidence 999999776 44444 999999999998 678888888999999999999985 4 777889999999999999999998
Q ss_pred cccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccch--hcccccCeeecCCCC
Q psy8879 282 RGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASL--AHLSNLTTLDLSHNF 348 (694)
Q Consensus 282 ~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f--~~l~~L~~L~Ls~N~ 348 (694)
++ +.. -.|..||++.|++..+|. .|..+..|++|.|.+|.+..-+...- +...-.++|+..-++
T Consensus 206 ~E-l~~-LpLi~lDfScNkis~iPv-~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 206 EE-LCS-LPLIRLDFSCNKISYLPV-DFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred HH-HhC-CceeeeecccCceeecch-hhhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchhcc
Confidence 76 443 458999999999999986 69999999999999999987643321 122334667766664
No 27
>KOG3207|consensus
Probab=99.10 E-value=1e-11 Score=132.24 Aligned_cols=160 Identities=24% Similarity=0.243 Sum_probs=99.6
Q ss_pred CCccEEEccCCCCCCCCc-cccccCCCCccEEEccCCCCCCCCc--ccccCCCCccEEEecCCCCCCCCc-cccCCCCCC
Q psy8879 143 SPLQALGLPNNLLSVVPT-SALAPLAPNLDRLDLSHNQLYKLEN--TSFKGLSSLNFLDLSYNKLMTLSQ-DCLAPLVTL 218 (694)
Q Consensus 143 ~~L~~L~Ls~N~L~~lp~-~~~~~l~~~L~~L~Ls~N~L~~i~~--~~f~~L~~L~~L~Ls~N~l~~i~~-~~f~~L~~L 218 (694)
..|+.+.|.+......+. .....+ ++++.|||++|-+....+ .....+++|+.|+|+.|++..... ..-..+++|
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~-~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~l 199 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKIL-PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHL 199 (505)
T ss_pred HhhhheeecCccccccchhhhhhhC-CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhh
Confidence 458888888887776553 234455 888888888887766433 223567888888888888654322 222356778
Q ss_pred cEEeccCCcccchh-hhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccc-cccCCcccceecc
Q psy8879 219 RVLRLQGNRLTVSV-VAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRG-ALAGLDKLTSLSC 296 (694)
Q Consensus 219 ~~L~Ls~N~l~~~~-~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~-~~~~L~~L~~L~L 296 (694)
+.|.|+.|.++... ...+..+|+|+.|+|..|.... +.......+..|++|||++|++-..+.. ....++.|+.|++
T Consensus 200 K~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~-~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 200 KQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIIL-IKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred heEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccc-eecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 88888888877432 2334566778888887774221 1122333455677777777776655421 2345566666666
Q ss_pred cCCccccc
Q psy8879 297 HHNQIDVL 304 (694)
Q Consensus 297 s~N~L~~i 304 (694)
+.+.|..+
T Consensus 279 s~tgi~si 286 (505)
T KOG3207|consen 279 SSTGIASI 286 (505)
T ss_pred cccCcchh
Confidence 66666544
No 28
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.09 E-value=9.3e-11 Score=114.30 Aligned_cols=140 Identities=29% Similarity=0.381 Sum_probs=46.9
Q ss_pred CCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCC
Q psy8879 103 TLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYK 182 (694)
Q Consensus 103 s~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~ 182 (694)
+.+.|...+. +.+...+++|+|.+|.|+.|.. +...+.+|+.|+|++|.|+.++. +..+ ++|++|++++|.|+.
T Consensus 5 t~~~i~~~~~-~~n~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~l~~--l~~L-~~L~~L~L~~N~I~~ 78 (175)
T PF14580_consen 5 TANMIEQIAQ-YNNPVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITKLEG--LPGL-PRLKTLDLSNNRISS 78 (175)
T ss_dssp --------------------------------S----TT-TT--EEE-TTS--S--TT-------TT--EEE--SS---S
T ss_pred cccccccccc-cccccccccccccccccccccc--hhhhhcCCCEEECCCCCCccccC--ccCh-hhhhhcccCCCCCCc
Confidence 3344444433 3344467788888888887753 22233458888888888887764 6667 788888888888887
Q ss_pred CCcccccCCCCccEEEecCCCCCCCCc-cccCCCCCCcEEeccCCcccchh---hhhhccCcccccccCC
Q psy8879 183 LENTSFKGLSSLNFLDLSYNKLMTLSQ-DCLAPLVTLRVLRLQGNRLTVSV---VAALQGLRSVTDLDLS 248 (694)
Q Consensus 183 i~~~~f~~L~~L~~L~Ls~N~l~~i~~-~~f~~L~~L~~L~Ls~N~l~~~~---~~~~~~L~~L~~L~Ls 248 (694)
+.......+++|++|++++|+|..+.. ..+..+++|++|++.+|.+.... ...+..+|+|+.||-.
T Consensus 79 i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 79 ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp -CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 764333457788888888888776543 45667788888888888776421 1234566777776653
No 29
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.08 E-value=6.9e-11 Score=115.21 Aligned_cols=108 Identities=31% Similarity=0.402 Sum_probs=28.0
Q ss_pred CCccEEEccCCCCCCCCccccc-CCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCccccccc
Q psy8879 168 PNLDRLDLSHNQLYKLENTSFK-GLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLD 246 (694)
Q Consensus 168 ~~L~~L~Ls~N~L~~i~~~~f~-~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~ 246 (694)
.++++|+|++|.|+.+.. ++ .+.+|+.|+|++|.|+.+.. +..+++|++|++++|+|+...+.....+++|++|+
T Consensus 19 ~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -----------------S----TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccccccc--hhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 455666666666655542 33 34556666666666665532 55566666666666666543222223455666666
Q ss_pred CCCCcCCCCCCCCCCCCccccceeeccCCcccc
Q psy8879 247 LSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSS 279 (694)
Q Consensus 247 Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~ 279 (694)
+++|++.+.-.-..+..+++|+.|+|.+|.++.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 666665542112234445556666666665543
No 30
>KOG0531|consensus
Probab=99.07 E-value=3.7e-11 Score=133.73 Aligned_cols=265 Identities=29% Similarity=0.312 Sum_probs=183.0
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEEc
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLDL 175 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~L 175 (694)
.++.++...+.+.........+..++.+.+..|.|..+... . +...+|+.|++.+|.|..+... +..+ ++|++|+|
T Consensus 50 ~~~~~~~~~~~~~~~~~~~~~l~~l~~l~l~~n~i~~~~~~-l-~~~~~l~~l~l~~n~i~~i~~~-l~~~-~~L~~L~l 125 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDLVESLTSLKELNLRQNLIAKILNH-L-SKLKSLEALDLYDNKIEKIENL-LSSL-VNLQVLDL 125 (414)
T ss_pred hhhhhcchhccccchhhhHHHhHhHHhhccchhhhhhhhcc-c-ccccceeeeeccccchhhcccc-hhhh-hcchheec
Confidence 44445555444432221113445677777777877763221 1 2234588888888888887762 4556 88899999
Q ss_pred cCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhh-hhhccCcccccccCCCCcCCC
Q psy8879 176 SHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVV-AALQGLRSVTDLDLSHNLLAG 254 (694)
Q Consensus 176 s~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~-~~~~~L~~L~~L~Ls~N~l~~ 254 (694)
++|.|+.+.. +..++.|+.|++++|.|+.+.. +..++.|+.+++++|++....+ . ...+.+++.+++.+|.+..
T Consensus 126 s~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~~~--~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 126 SFNKITKLEG--LSTLTLLKELNLSGNLISDISG--LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred cccccccccc--hhhccchhhheeccCcchhccC--CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 9998888864 6677778899999998888754 5568888999999998885544 2 5677888889999988864
Q ss_pred CCCCCCCCCccccceeeccCCcccccccccccCCcc--cceecccCCccccccchhhhcccccccccCCCCccccccccc
Q psy8879 255 PLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDK--LTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGAS 332 (694)
Q Consensus 255 ~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~--L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~ 332 (694)
...+..+..+..+++..|.++.+.. +..+.. |+.+++++|.+..++ ..+..+..+..|++.+|++..+..
T Consensus 201 ---i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~~~-- 272 (414)
T KOG0531|consen 201 ---IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNLEG-- 272 (414)
T ss_pred ---ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccccc--
Confidence 3445555666667888888887643 233333 888999999888774 246677888899999998877643
Q ss_pred hhcccccCeeecCCCCCCCc---Ch-hhhCCCCCCCEEEccCCCCCCCC
Q psy8879 333 LAHLSNLTTLDLSHNFLRAL---TQ-DLITPLKSLQELRLDDNDISMEP 377 (694)
Q Consensus 333 f~~l~~L~~L~Ls~N~L~~l---~~-~~~~~l~~L~~L~Ls~N~L~~l~ 377 (694)
+.....+..+.+..|.+... .. ......+++..+.+.+|++....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 273 LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred ccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence 44556777788888877632 11 22455778888888888877543
No 31
>KOG1259|consensus
Probab=99.03 E-value=7.3e-11 Score=120.14 Aligned_cols=135 Identities=30% Similarity=0.408 Sum_probs=99.2
Q ss_pred ccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccc
Q psy8879 237 QGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLS 316 (694)
Q Consensus 237 ~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~ 316 (694)
..+..|+++||++|.++. + .+...-+|.++.|++++|.+..+. .+..+++|+.|||++|.++.+.. .-..+.+.+
T Consensus 281 dTWq~LtelDLS~N~I~~-i-DESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls~~~G-wh~KLGNIK 355 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLITQ-I-DESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLAECVG-WHLKLGNIK 355 (490)
T ss_pred chHhhhhhccccccchhh-h-hhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhHhhhh-hHhhhcCEe
Confidence 344567788888888874 3 555666788888888888888774 36677888888888888877654 233466778
Q ss_pred cccCCCCccccccccchhcccccCeeecCCCCCCCcCh-hhhCCCCCCCEEEccCCCCCCCCc
Q psy8879 317 HLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQ-DLITPLKSLQELRLDDNDISMEPE 378 (694)
Q Consensus 317 ~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~-~~~~~l~~L~~L~Ls~N~L~~l~~ 378 (694)
.|.|++|.|..+. .+..+-+|..||+++|+|..+.. ..++++|-|+.+.|.+|++..+++
T Consensus 356 tL~La~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 356 TLKLAQNKIETLS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred eeehhhhhHhhhh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 8888888877663 35667788888888888877653 456778888888888888887765
No 32
>KOG0531|consensus
Probab=99.03 E-value=6e-11 Score=132.08 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=188.8
Q ss_pred CCeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCCCCCCCccccccCCCCccEEE
Q psy8879 95 ERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNLLSVVPTSALAPLAPNLDRLD 174 (694)
Q Consensus 95 ~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~ 174 (694)
..++.+++..|.+..+-..+..+.+|+.|++.+|.|..+... ...+.+|++|++++|.|+.+.. +..+ +.|+.|+
T Consensus 72 ~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~--l~~~~~L~~L~ls~N~I~~i~~--l~~l-~~L~~L~ 146 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL--LSSLVNLQVLDLSFNKITKLEG--LSTL-TLLKELN 146 (414)
T ss_pred HhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc--hhhhhcchheeccccccccccc--hhhc-cchhhhe
Confidence 356667788888888666678889999999999999998762 2334569999999999999887 6677 7899999
Q ss_pred ccCCCCCCCCcccccCCCCccEEEecCCCCCCCCc-cccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCC
Q psy8879 175 LSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQ-DCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLA 253 (694)
Q Consensus 175 Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~-~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~ 253 (694)
+++|.|+.+.. +..++.|+.+++++|++..+.+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.+.
T Consensus 147 l~~N~i~~~~~--~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDISG--LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhccC--CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccce
Confidence 99999998864 6668999999999999998877 3 4678899999999999874 334444556666788889887
Q ss_pred CCCCCCCCCCccc--cceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccc---
Q psy8879 254 GPLGPSTVPRLSS--LKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAV--- 328 (694)
Q Consensus 254 ~~i~p~~~~~l~~--L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i--- 328 (694)
. + ..+..+.. |+.+++++|.+..++ ..+..+..+..|++.+|++..+.. +...+.+..+.+..|.+...
T Consensus 222 ~-~--~~l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 295 (414)
T KOG0531|consen 222 K-L--EGLNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKLALSEAI 295 (414)
T ss_pred e-c--cCcccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccccc--ccccchHHHhccCcchhcchhhh
Confidence 4 2 22333444 899999999998874 346778899999999999887764 45567788888888887632
Q ss_pred ccc-chhcccccCeeecCCCCCCCcCh
Q psy8879 329 SGA-SLAHLSNLTTLDLSHNFLRALTQ 354 (694)
Q Consensus 329 ~~~-~f~~l~~L~~L~Ls~N~L~~l~~ 354 (694)
... .....+.+..+.+..|.+....+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 296 SQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hccccccccccccccccccCccccccc
Confidence 111 14566888999999998876543
No 33
>KOG3207|consensus
Probab=99.00 E-value=1.9e-10 Score=122.60 Aligned_cols=208 Identities=21% Similarity=0.229 Sum_probs=102.1
Q ss_pred CCccEEEccCCCCCCCCc-ccccCCCCccEEEecCCCCCCCCc--cccCCCCCCcEEeccCCcccchhhhh-hccCcccc
Q psy8879 168 PNLDRLDLSHNQLYKLEN-TSFKGLSSLNFLDLSYNKLMTLSQ--DCLAPLVTLRVLRLQGNRLTVSVVAA-LQGLRSVT 243 (694)
Q Consensus 168 ~~L~~L~Ls~N~L~~i~~-~~f~~L~~L~~L~Ls~N~l~~i~~--~~f~~L~~L~~L~Ls~N~l~~~~~~~-~~~L~~L~ 243 (694)
++|+.+.|.+........ .....+++++.|||++|-+..+.+ .....+|+|+.|+++.|++....... -..++.|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 566666666665544332 234456666677777666654433 23455666666666666654221111 11344556
Q ss_pred cccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccc-hhhhcccccccccCCC
Q psy8879 244 DLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLED-HSFRALSTLSHLDLAH 322 (694)
Q Consensus 244 ~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~-~~f~~l~~L~~L~Ls~ 322 (694)
.|.+++|.++..--......+|+|+.|+|..|..-.+.......+..|++|+|++|++-..+. ...+.++.|+.|+++.
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 666666655421001112334566666666664222222333444556666666665544331 2234455566666666
Q ss_pred Cccccccccc------hhcccccCeeecCCCCCCCcCh-hhhCCCCCCCEEEccCCCCCC
Q psy8879 323 NRIVAVSGAS------LAHLSNLTTLDLSHNFLRALTQ-DLITPLKSLQELRLDDNDISM 375 (694)
Q Consensus 323 N~L~~i~~~~------f~~l~~L~~L~Ls~N~L~~l~~-~~~~~l~~L~~L~Ls~N~L~~ 375 (694)
+.+.++..-. ...+++|++|+++.|++...+. ..+..+++|+.|.+..|.++.
T Consensus 281 tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 281 TGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 6555442111 1234556666666665544332 112234455555555555543
No 34
>KOG1909|consensus
Probab=98.95 E-value=8.1e-11 Score=122.50 Aligned_cols=187 Identities=17% Similarity=0.160 Sum_probs=121.4
Q ss_pred ccCCCCccEEEecCCCCCCCCcc----ccCCCCCCcEEeccCCcccchhh-------------hhhccCcccccccCCCC
Q psy8879 188 FKGLSSLNFLDLSYNKLMTLSQD----CLAPLVTLRVLRLQGNRLTVSVV-------------AALQGLRSVTDLDLSHN 250 (694)
Q Consensus 188 f~~L~~L~~L~Ls~N~l~~i~~~----~f~~L~~L~~L~Ls~N~l~~~~~-------------~~~~~L~~L~~L~Ls~N 250 (694)
+.+.++|++|+||+|.+..-.+. .++.+..|++|+|.+|.+...-. .....-+.|+++...+|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 34456677777777766533222 24455677777777776642111 12233467777777777
Q ss_pred cCCCCC---CCCCCCCccccceeeccCCcccc----cccccccCCcccceecccCCcccccc----chhhhccccccccc
Q psy8879 251 LLAGPL---GPSTVPRLSSLKVLSIAHNQFSS----VRRGALAGLDKLTSLSCHHNQIDVLE----DHSFRALSTLSHLD 319 (694)
Q Consensus 251 ~l~~~i---~p~~~~~l~~L~~L~Ls~N~L~~----i~~~~~~~L~~L~~L~Ls~N~L~~i~----~~~f~~l~~L~~L~ 319 (694)
++...- ....|...+.|+++.+..|.|.. .....|..+++|+.|||.+|-++... ..+++.+++|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 775310 02235556778888888887653 22345677888888888888876433 34566778888999
Q ss_pred CCCCccccccccchh-----cccccCeeecCCCCCCCcC----hhhhCCCCCCCEEEccCCCCC
Q psy8879 320 LAHNRIVAVSGASLA-----HLSNLTTLDLSHNFLRALT----QDLITPLKSLQELRLDDNDIS 374 (694)
Q Consensus 320 Ls~N~L~~i~~~~f~-----~l~~L~~L~Ls~N~L~~l~----~~~~~~l~~L~~L~Ls~N~L~ 374 (694)
+++|.+..-...+|. ..++|+.|.|.+|.|+.-. .......+.|..|+|++|.+.
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 998888776554442 3588999999999886422 223445788999999999984
No 35
>KOG1259|consensus
Probab=98.93 E-value=2.6e-10 Score=116.15 Aligned_cols=131 Identities=27% Similarity=0.370 Sum_probs=70.4
Q ss_pred CCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecc
Q psy8879 217 TLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSC 296 (694)
Q Consensus 217 ~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~L 296 (694)
.|++|+|++|.|+ .+..+..-++.++.|++++|.+.. -..+..+++|+.|||++|.++.+. ++-..+-++++|.|
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~---v~nLa~L~~L~~LDLS~N~Ls~~~-Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT---VQNLAELPQLQLLDLSGNLLAECV-GWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceee---ehhhhhcccceEeecccchhHhhh-hhHhhhcCEeeeeh
Confidence 3444444444444 233333344455555555555542 122444555555666655555542 23344556666666
Q ss_pred cCCccccccchhhhcccccccccCCCCccccccc-cchhcccccCeeecCCCCCCCcCh
Q psy8879 297 HHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSG-ASLAHLSNLTTLDLSHNFLRALTQ 354 (694)
Q Consensus 297 s~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~-~~f~~l~~L~~L~Ls~N~L~~l~~ 354 (694)
++|.|..+. .+..+-+|..||+++|+|..+.. ..++++|-|+.+.|.+|.+..++.
T Consensus 360 a~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIETLS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHhhhh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 666665443 24455566666666666655432 345666777777777777766654
No 36
>KOG1909|consensus
Probab=98.85 E-value=5.1e-10 Score=116.61 Aligned_cols=91 Identities=22% Similarity=0.250 Sum_probs=49.2
Q ss_pred CCCCCCCeeEEEcCCCCCCC-----CCccccCCCCccEEEccCCCCCC----CCc------chhcCCCCCccEEEccCCC
Q psy8879 90 GLEPDERVSLLDCTLSNVTV-----LPGKFLEGVTLHGLVISSGELKN----ISD------GAFIGLSSPLQALGLPNNL 154 (694)
Q Consensus 90 ~l~~~~~L~~Ldls~n~l~~-----lp~~~~~~~~L~~L~Ls~n~i~~----i~~------~~F~~l~~~L~~L~Ls~N~ 154 (694)
.+.+...++.+++++|.+.. +...+.+.++|+..++++--... +++ .++.+.+ .|++|+||+|.
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~-~L~~ldLSDNA 103 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCP-KLQKLDLSDNA 103 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCC-ceeEeeccccc
Confidence 34456688999999999853 44555666678777776532222 111 1222223 36666666666
Q ss_pred CCCCCcc----ccccCCCCccEEEccCCCCCC
Q psy8879 155 LSVVPTS----ALAPLAPNLDRLDLSHNQLYK 182 (694)
Q Consensus 155 L~~lp~~----~~~~l~~~L~~L~Ls~N~L~~ 182 (694)
|+.-... .++.+ ..|++|.|.+|.+..
T Consensus 104 ~G~~g~~~l~~ll~s~-~~L~eL~L~N~Glg~ 134 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSC-TDLEELYLNNCGLGP 134 (382)
T ss_pred cCccchHHHHHHHHhc-cCHHHHhhhcCCCCh
Confidence 5532111 12233 556666666665543
No 37
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.76 E-value=4.4e-09 Score=84.38 Aligned_cols=57 Identities=35% Similarity=0.561 Sum_probs=23.2
Q ss_pred cceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeecCCC
Q psy8879 291 LTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHN 347 (694)
Q Consensus 291 L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N 347 (694)
|++|++++|+++.+++..|.++++|+.|++++|+++.+++..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333444444444444334444444444444444444443334444444444444443
No 38
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.75 E-value=5.8e-09 Score=83.68 Aligned_cols=59 Identities=42% Similarity=0.623 Sum_probs=29.1
Q ss_pred CccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCc
Q psy8879 169 NLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNR 227 (694)
Q Consensus 169 ~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~ 227 (694)
+|++|++++|+|+.+++..|.++++|++|++++|.++.+++++|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444555444444444444445555555555555544444444555555555554443
No 39
>PLN03150 hypothetical protein; Provisional
Probab=98.60 E-value=5.7e-08 Score=113.56 Aligned_cols=107 Identities=26% Similarity=0.374 Sum_probs=89.1
Q ss_pred CccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeec
Q psy8879 193 SLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSI 272 (694)
Q Consensus 193 ~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~L 272 (694)
.++.|+|++|.+.+..|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+ |..+..+++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~i-P~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI-PESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCC-chHHhcCCCCCEEEC
Confidence 3778899999988888888888899999999999998888888889999999999999998866 777888899999999
Q ss_pred cCCcccccccccccCC-cccceecccCCc
Q psy8879 273 AHNQFSSVRRGALAGL-DKLTSLSCHHNQ 300 (694)
Q Consensus 273 s~N~L~~i~~~~~~~L-~~L~~L~Ls~N~ 300 (694)
++|.+++..|..+.++ .++..+++.+|.
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCc
Confidence 9999887766666553 456777888775
No 40
>PLN03150 hypothetical protein; Provisional
Probab=98.59 E-value=7.1e-08 Score=112.74 Aligned_cols=108 Identities=25% Similarity=0.287 Sum_probs=94.8
Q ss_pred CccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCC
Q psy8879 169 NLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLS 248 (694)
Q Consensus 169 ~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls 248 (694)
.++.|+|++|.+.+..+..+..+++|+.|+|++|++.+..|..+..+++|+.|+|++|++.+.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999998888889999999999999999998888889999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCCCCCC-ccccceeeccCCcc
Q psy8879 249 HNLLAGPLGPSTVPR-LSSLKVLSIAHNQF 277 (694)
Q Consensus 249 ~N~l~~~i~p~~~~~-l~~L~~L~Ls~N~L 277 (694)
+|.+.|.+ |..+.. ..++..+++.+|..
T Consensus 499 ~N~l~g~i-P~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 499 GNSLSGRV-PAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred CCcccccC-ChHHhhccccCceEEecCCcc
Confidence 99999877 555554 34667888888854
No 41
>KOG4658|consensus
Probab=98.58 E-value=9.9e-08 Score=114.43 Aligned_cols=273 Identities=23% Similarity=0.267 Sum_probs=165.8
Q ss_pred CCeeEEEcCCCCCCCCCccccCCCCccEEEccCCC--CCCCCcchhcCCCCCccEEEccCC-CCCCCCccccccCCCCcc
Q psy8879 95 ERVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGE--LKNISDGAFIGLSSPLQALGLPNN-LLSVVPTSALAPLAPNLD 171 (694)
Q Consensus 95 ~~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~--i~~i~~~~F~~l~~~L~~L~Ls~N-~L~~lp~~~~~~l~~~L~ 171 (694)
...+...+-+|.+..++.... .+.|++|-+..|. +..++...|..+.. |++|||++| .+..+|. .++.+ -+|+
T Consensus 523 ~~~rr~s~~~~~~~~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~-LrVLDLs~~~~l~~LP~-~I~~L-i~Lr 598 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPL-LRVLDLSGNSSLSKLPS-SIGEL-VHLR 598 (889)
T ss_pred hheeEEEEeccchhhccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcc-eEEEECCCCCccCcCCh-HHhhh-hhhh
Confidence 466777777778777765543 3478889888886 77787777776654 999999987 5677776 47778 8999
Q ss_pred EEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcc--cchhhhhhccCcccccccCCC
Q psy8879 172 RLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRL--TVSVVAALQGLRSVTDLDLSH 249 (694)
Q Consensus 172 ~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l--~~~~~~~~~~L~~L~~L~Ls~ 249 (694)
+|+|++..+..+| ..++++.+|.+|++..+.-....++....+++|++|.+..... ....-..+..+.+|+.+....
T Consensus 599 yL~L~~t~I~~LP-~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 599 YLDLSDTGISHLP-SGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccCCCccccc-hHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence 9999999998877 4688899999999998876555577677789999998876542 222333445555555555533
Q ss_pred CcCCCCCCCCCCCCccccc----eeeccCCcccccccccccCCcccceecccCCccccccchhhhc------cccccccc
Q psy8879 250 NLLAGPLGPSTVPRLSSLK----VLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRA------LSTLSHLD 319 (694)
Q Consensus 250 N~l~~~i~p~~~~~l~~L~----~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~------l~~L~~L~ 319 (694)
.... + ...+..+..|. .+.+.++..... ...+..+.+|+.|.+.++.+..+....+.. ++++..+.
T Consensus 678 ~s~~--~-~e~l~~~~~L~~~~~~l~~~~~~~~~~-~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~ 753 (889)
T KOG4658|consen 678 SSVL--L-LEDLLGMTRLRSLLQSLSIEGCSKRTL-ISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVS 753 (889)
T ss_pred chhH--h-HhhhhhhHHHHHHhHhhhhccccccee-ecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHH
Confidence 3220 0 11122223332 222222222222 234667778888888877775443222111 22333333
Q ss_pred CCCCccccccccchhcccccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCC
Q psy8879 320 LAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISMEP 377 (694)
Q Consensus 320 Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~ 377 (694)
..++..-.. +.+....++|+.|.+......+.+......+..++.+-+..+.+.+.+
T Consensus 754 ~~~~~~~r~-l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~ 810 (889)
T KOG4658|consen 754 ILNCHMLRD-LTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLR 810 (889)
T ss_pred hhccccccc-cchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccce
Confidence 333322111 122233478888888877665544444444555555556666665543
No 42
>KOG1859|consensus
Probab=98.47 E-value=6.3e-09 Score=116.71 Aligned_cols=199 Identities=25% Similarity=0.295 Sum_probs=131.9
Q ss_pred CCccEEEccCCCCCCCC-cccccCCCCccEEEecCCCCCCCCccccCCC-CCCcEEeccCCcccchhhhhh-------c-
Q psy8879 168 PNLDRLDLSHNQLYKLE-NTSFKGLSSLNFLDLSYNKLMTLSQDCLAPL-VTLRVLRLQGNRLTVSVVAAL-------Q- 237 (694)
Q Consensus 168 ~~L~~L~Ls~N~L~~i~-~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L-~~L~~L~Ls~N~l~~~~~~~~-------~- 237 (694)
++++.|.+-.-.-.+-. |-.+..+.+|+.|.|.++.+.... + +..+ ..|+.|.-.+ .+. ...+.| .
T Consensus 84 qkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~~~-G-L~~lr~qLe~LIC~~-Sl~-Al~~v~ascggd~~n 159 (1096)
T KOG1859|consen 84 QKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLSTAK-G-LQELRHQLEKLICHN-SLD-ALRHVFASCGGDISN 159 (1096)
T ss_pred hhheeeeecccCCCCCCCCceeccccceeeEEecCcchhhhh-h-hHHHHHhhhhhhhhc-cHH-HHHHHHHHhcccccc
Confidence 45555555433221111 334556778999999988876521 1 1111 2455554332 221 111111 1
Q ss_pred --cCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhccccc
Q psy8879 238 --GLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTL 315 (694)
Q Consensus 238 --~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L 315 (694)
.+..|...++++|.+.- + ...+.-++.|+.|+|++|+++++. .+..+++|++|||+.|.+..++.-...++. |
T Consensus 160 s~~Wn~L~~a~fsyN~L~~-m-D~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L 234 (1096)
T KOG1859|consen 160 SPVWNKLATASFSYNRLVL-M-DESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-L 234 (1096)
T ss_pred chhhhhHhhhhcchhhHHh-H-HHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-h
Confidence 12467788888888873 2 566777888999999999998885 678889999999999999888875555665 9
Q ss_pred ccccCCCCccccccccchhcccccCeeecCCCCCCCcCh-hhhCCCCCCCEEEccCCCCCCCC
Q psy8879 316 SHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQ-DLITPLKSLQELRLDDNDISMEP 377 (694)
Q Consensus 316 ~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~-~~~~~l~~L~~L~Ls~N~L~~l~ 377 (694)
..|.|++|.++.+- .+.++.+|+.||+++|-|.+-.. ..+..+..|+.|+|.||++-.-|
T Consensus 235 ~~L~lrnN~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 235 QLLNLRNNALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred eeeeecccHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999999888763 35688899999999998865432 22455678889999999887443
No 43
>KOG1859|consensus
Probab=98.37 E-value=6e-09 Score=116.88 Aligned_cols=180 Identities=24% Similarity=0.211 Sum_probs=98.9
Q ss_pred CccccCCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCC----------CCCCCCccccccCCCCccEEEccCCCC
Q psy8879 111 PGKFLEGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNN----------LLSVVPTSALAPLAPNLDRLDLSHNQL 180 (694)
Q Consensus 111 p~~~~~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N----------~L~~lp~~~~~~l~~~L~~L~Ls~N~L 180 (694)
|-.++.+..|+.|.+.++++.... -+.++-..|+.|.-.+. ...++... +.. -.|...+.++|.+
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~--GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns-~~W--n~L~~a~fsyN~L 176 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAK--GLQELRHQLEKLICHNSLDALRHVFASCGGDISNS-PVW--NKLATASFSYNRL 176 (1096)
T ss_pred CceeccccceeeEEecCcchhhhh--hhHHHHHhhhhhhhhccHHHHHHHHHHhccccccc-hhh--hhHhhhhcchhhH
Confidence 666777888899999888887632 12333334555544331 01111111 111 2456666666666
Q ss_pred CCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCC
Q psy8879 181 YKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPST 260 (694)
Q Consensus 181 ~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~ 260 (694)
..++ .++.-++.|+.|+|++|+++... .+..+++|++|+|+.|.+....--...++. |+.|.+++|.++. -..
T Consensus 177 ~~mD-~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~t---L~g 249 (1096)
T KOG1859|consen 177 VLMD-ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTT---LRG 249 (1096)
T ss_pred HhHH-HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHh---hhh
Confidence 5554 34555666666666666666554 356666666666666666532222222332 6666666666653 234
Q ss_pred CCCccccceeeccCCcccccccc-cccCCcccceecccCCccc
Q psy8879 261 VPRLSSLKVLSIAHNQFSSVRRG-ALAGLDKLTSLSCHHNQID 302 (694)
Q Consensus 261 ~~~l~~L~~L~Ls~N~L~~i~~~-~~~~L~~L~~L~Ls~N~L~ 302 (694)
+.++.+|+.||+++|-|.+...- .+..+..|+.|+|.+|.+-
T Consensus 250 ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 250 IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 55566666666666665543211 2334456666666666654
No 44
>KOG4658|consensus
Probab=98.37 E-value=3.5e-07 Score=109.82 Aligned_cols=252 Identities=25% Similarity=0.256 Sum_probs=156.2
Q ss_pred CCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccCCC--CCCCCccccccCCCCccEEEccCC-CCCCCCcccccCCC
Q psy8879 116 EGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPNNL--LSVVPTSALAPLAPNLDRLDLSHN-QLYKLENTSFKGLS 192 (694)
Q Consensus 116 ~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~N~--L~~lp~~~~~~l~~~L~~L~Ls~N-~L~~i~~~~f~~L~ 192 (694)
.....+...+-+|.+..+... ...+ .|++|-+..|. +..++...|..+ +.|+.|||++| .+..+| ..++++-
T Consensus 521 ~~~~~rr~s~~~~~~~~~~~~--~~~~-~L~tLll~~n~~~l~~is~~ff~~m-~~LrVLDLs~~~~l~~LP-~~I~~Li 595 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIEHIAGS--SENP-KLRTLLLQRNSDWLLEISGEFFRSL-PLLRVLDLSGNSSLSKLP-SSIGELV 595 (889)
T ss_pred chhheeEEEEeccchhhccCC--CCCC-ccceEEEeecchhhhhcCHHHHhhC-cceEEEECCCCCccCcCC-hHHhhhh
Confidence 335677777777777776554 2222 48888888886 788888888888 89999999987 344454 6788888
Q ss_pred CccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCC-CCCCCCCCCccccceee
Q psy8879 193 SLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAG-PLGPSTVPRLSSLKVLS 271 (694)
Q Consensus 193 ~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~-~i~p~~~~~l~~L~~L~ 271 (694)
+|++|++++..+..+|.+ +.++.+|.+|++..+......+.....+.+|++|.+....... ...-..+.++.+|+.+.
T Consensus 596 ~LryL~L~~t~I~~LP~~-l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls 674 (889)
T KOG4658|consen 596 HLRYLDLSDTGISHLPSG-LGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLS 674 (889)
T ss_pred hhhcccccCCCccccchH-HHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhe
Confidence 999999999988877655 8888899999998887665667777778889988887665221 11122234444555444
Q ss_pred ccCCcccccccccccCCcccc----eecccCCccccccchhhhcccccccccCCCCccccccccchhc------ccccCe
Q psy8879 272 IAHNQFSSVRRGALAGLDKLT----SLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAH------LSNLTT 341 (694)
Q Consensus 272 Ls~N~L~~i~~~~~~~L~~L~----~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~------l~~L~~ 341 (694)
...... .+. ..+..+..|. .+.+.++..... ...+..+.+|+.|.+.++.+.++....+.. ++++..
T Consensus 675 ~~~~s~-~~~-e~l~~~~~L~~~~~~l~~~~~~~~~~-~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~ 751 (889)
T KOG4658|consen 675 ITISSV-LLL-EDLLGMTRLRSLLQSLSIEGCSKRTL-ISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSK 751 (889)
T ss_pred eecchh-HhH-hhhhhhHHHHHHhHhhhhccccccee-ecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHH
Confidence 433322 111 1223333333 233323222222 235677889999999999987654433221 222333
Q ss_pred eecCCCC-CCCcChhhhCCCCCCCEEEccCCCCCCCCc
Q psy8879 342 LDLSHNF-LRALTQDLITPLKSLQELRLDDNDISMEPE 378 (694)
Q Consensus 342 L~Ls~N~-L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~ 378 (694)
+...+.. ...+.. ....++|+.|.+...+....+.
T Consensus 752 ~~~~~~~~~r~l~~--~~f~~~L~~l~l~~~~~~e~~i 787 (889)
T KOG4658|consen 752 VSILNCHMLRDLTW--LLFAPHLTSLSLVSCRLLEDII 787 (889)
T ss_pred HHhhccccccccch--hhccCcccEEEEecccccccCC
Confidence 3222222 222222 2236799999999877654443
No 45
>KOG2982|consensus
Probab=98.29 E-value=1.6e-07 Score=96.11 Aligned_cols=108 Identities=29% Similarity=0.380 Sum_probs=70.9
Q ss_pred ccEEEccCCCCCCCCc-cccccCCCCccEEEccCCCCCCCCc--ccccCCCCccEEEecCCCCCCCCccccCCCCCCcEE
Q psy8879 145 LQALGLPNNLLSVVPT-SALAPLAPNLDRLDLSHNQLYKLEN--TSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVL 221 (694)
Q Consensus 145 L~~L~Ls~N~L~~lp~-~~~~~l~~~L~~L~Ls~N~L~~i~~--~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L 221 (694)
++.|.+.+..|..... ..|+...+.++.+||.+|.|+.... ..+.++|.|+.|+|+.|++.......-..+.+|+.|
T Consensus 47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l 126 (418)
T KOG2982|consen 47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL 126 (418)
T ss_pred hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence 5566666766654432 2333334788888999888876432 235678888889998888765433211355688888
Q ss_pred eccCCcccchh-hhhhccCcccccccCCCCcC
Q psy8879 222 RLQGNRLTVSV-VAALQGLRSVTDLDLSHNLL 252 (694)
Q Consensus 222 ~Ls~N~l~~~~-~~~~~~L~~L~~L~Ls~N~l 252 (694)
.|.+..+.... ...+..+|.+++|+++.|.+
T Consensus 127 VLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 127 VLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred EEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 88887775433 33456677788888887744
No 46
>KOG2982|consensus
Probab=98.16 E-value=6e-07 Score=92.07 Aligned_cols=110 Identities=27% Similarity=0.262 Sum_probs=80.9
Q ss_pred CccEEEccCCCCCCCCc-chhcCCCCCccEEEccCCCCCCCC--ccccccCCCCccEEEccCCCCCCCCcccccCCCCcc
Q psy8879 119 TLHGLVISSGELKNISD-GAFIGLSSPLQALGLPNNLLSVVP--TSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLN 195 (694)
Q Consensus 119 ~L~~L~Ls~n~i~~i~~-~~F~~l~~~L~~L~Ls~N~L~~lp--~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~ 195 (694)
.+.-|.+.++.|..+.. ..|......++.|||.+|.|+.-. ...+.++ |.|+.|+|+.|++.......-..+.+|+
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~l-P~l~~LNls~N~L~s~I~~lp~p~~nl~ 124 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQL-PALTTLNLSCNSLSSDIKSLPLPLKNLR 124 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcC-ccceEeeccCCcCCCccccCcccccceE
Confidence 45567777888877654 345555667999999999998632 2346678 9999999999998765533224667999
Q ss_pred EEEecCCCCCCCCc-cccCCCCCCcEEeccCCccc
Q psy8879 196 FLDLSYNKLMTLSQ-DCLAPLVTLRVLRLQGNRLT 229 (694)
Q Consensus 196 ~L~Ls~N~l~~i~~-~~f~~L~~L~~L~Ls~N~l~ 229 (694)
.|.|.+..+..... ..+..+|++++|.++.|.+.
T Consensus 125 ~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r 159 (418)
T KOG2982|consen 125 VLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR 159 (418)
T ss_pred EEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh
Confidence 99999987764333 34677899999999988544
No 47
>KOG4579|consensus
Probab=98.06 E-value=5.8e-07 Score=82.69 Aligned_cols=88 Identities=24% Similarity=0.315 Sum_probs=42.8
Q ss_pred ccceeeccCCcccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeecC
Q psy8879 266 SLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLS 345 (694)
Q Consensus 266 ~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls 345 (694)
.|+..+|++|.+.++++..-...+.++.|+|++|.|+.+|.. +..++.|+.|+++.|.+...+ ..+..+.+|..|+..
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl~~N~l~~~p-~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNLRFNPLNAEP-RVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhcccccCccccch-HHHHHHHhHHHhcCC
Confidence 344445555555555444333334455555555555555443 555555555555555554442 222234555555555
Q ss_pred CCCCCCcChh
Q psy8879 346 HNFLRALTQD 355 (694)
Q Consensus 346 ~N~L~~l~~~ 355 (694)
+|.+..++.+
T Consensus 132 ~na~~eid~d 141 (177)
T KOG4579|consen 132 ENARAEIDVD 141 (177)
T ss_pred CCccccCcHH
Confidence 5555555444
No 48
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.05 E-value=6.9e-06 Score=75.46 Aligned_cols=125 Identities=17% Similarity=0.377 Sum_probs=44.9
Q ss_pred CccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchhhhhhcc
Q psy8879 159 PTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSVVAALQG 238 (694)
Q Consensus 159 p~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~~~~~~~ 238 (694)
+..+|.+. ++|+.+.+.. .+..+....|.++++|+.+.+.++ +..+...+|..+++|+.+.+.+ .+..
T Consensus 4 ~~~~F~~~-~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~-------- 71 (129)
T PF13306_consen 4 GNNAFYNC-SNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKS-------- 71 (129)
T ss_dssp -TTTTTT--TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-E--------
T ss_pred CHHHHhCC-CCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccc--------
Confidence 33444444 4555555542 344455455555555555555443 4444444455544455554432 2221
Q ss_pred CcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccchhhhccccc
Q psy8879 239 LRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTL 315 (694)
Q Consensus 239 L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L 315 (694)
++...|..+++|+.+++..+ +..+....|.+. +|+.+.+.. .+..++..+|.++++|
T Consensus 72 -----------------i~~~~F~~~~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 72 -----------------IGDNAFSNCTNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp -----------------E-TTTTTT-TTECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred -----------------cccccccccccccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 22334444555555555443 444555555554 555555543 4444555555555444
No 49
>KOG1644|consensus
Probab=98.01 E-value=6.5e-06 Score=80.56 Aligned_cols=83 Identities=30% Similarity=0.379 Sum_probs=43.3
Q ss_pred CccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCc-cccCCCCCCcEEe
Q psy8879 144 PLQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQ-DCLAPLVTLRVLR 222 (694)
Q Consensus 144 ~L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~-~~f~~L~~L~~L~ 222 (694)
+...+||++|.+..++. |.++ +.|.+|.|++|+|+.|.+..-.-+++|+.|.|.+|+|..+.. +.+..+|+|++|.
T Consensus 43 ~~d~iDLtdNdl~~l~~--lp~l-~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Lt 119 (233)
T KOG1644|consen 43 QFDAIDLTDNDLRKLDN--LPHL-PRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLT 119 (233)
T ss_pred ccceecccccchhhccc--CCCc-cccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceee
Confidence 35555555555555443 4444 555556665555555555433344555555555555443321 2244555555555
Q ss_pred ccCCccc
Q psy8879 223 LQGNRLT 229 (694)
Q Consensus 223 Ls~N~l~ 229 (694)
+-+|..+
T Consensus 120 ll~Npv~ 126 (233)
T KOG1644|consen 120 LLGNPVE 126 (233)
T ss_pred ecCCchh
Confidence 5555544
No 50
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=97.98 E-value=8e-06 Score=104.46 Aligned_cols=69 Identities=19% Similarity=0.279 Sum_probs=57.3
Q ss_pred ecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCcccccCCCCCCccccccccccccccc--CCccCccccCCccccee
Q psy8879 343 DLSHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIYVGFNTMDLELIYSGVWRHSTLL--IPVMLSLCTRSSVVTRY 420 (694)
Q Consensus 343 ~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~~NpCdC~l~~~~~wl~~~~~--~~~~~~~C~~~~~~~~~ 420 (694)
||++|+|+.+++..|..+++|+.|+|++|+|. |||++.||+.|++...+ .....+.|..|...++.
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~------------CDC~L~WL~~WL~~~~v~v~~~~~i~CasP~~LrG~ 68 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFE------------CDCGLARLPRWAEEKGVKVRQPEAALCAGPGALAGQ 68 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccc------------cccccHHHHHHHHhcCccccCCcccCCCCChHHCCC
Confidence 68999999999999999999999999999999 99999999999975432 23457889988755554
Q ss_pred eEE
Q psy8879 421 RYC 423 (694)
Q Consensus 421 ~~~ 423 (694)
...
T Consensus 69 ~L~ 71 (2740)
T TIGR00864 69 PLL 71 (2740)
T ss_pred Ccc
Confidence 433
No 51
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=97.95 E-value=1.4e-05 Score=73.46 Aligned_cols=77 Identities=16% Similarity=0.391 Sum_probs=29.7
Q ss_pred ccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEecc
Q psy8879 145 LQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQ 224 (694)
Q Consensus 145 L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls 224 (694)
|+.+.+.. .+..++..+|.++ ++|+.+.+.++ +..+....|.++++|+.+.+.+ .+..+....|..+++|+.+.+.
T Consensus 14 l~~i~~~~-~~~~I~~~~F~~~-~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l~~i~~~ 89 (129)
T PF13306_consen 14 LESITFPN-TIKKIGENAFSNC-TSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNLKNIDIP 89 (129)
T ss_dssp --EEEETS-T--EE-TTTTTT--TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTECEEEET
T ss_pred CCEEEECC-CeeEeChhhcccc-ccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccccccccC
Confidence 44444442 3444444444444 44555554442 4444444455544455555533 3334444444444455555444
Q ss_pred C
Q psy8879 225 G 225 (694)
Q Consensus 225 ~ 225 (694)
.
T Consensus 90 ~ 90 (129)
T PF13306_consen 90 S 90 (129)
T ss_dssp T
T ss_pred c
Confidence 3
No 52
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=97.77 E-value=1.1e-05 Score=82.13 Aligned_cols=87 Identities=18% Similarity=0.116 Sum_probs=39.0
Q ss_pred cccceecccCCcccccc----chhhhcccccccccCCCCccccccccchh------cccccCeeecCCCCCCCc-C----
Q psy8879 289 DKLTSLSCHHNQIDVLE----DHSFRALSTLSHLDLAHNRIVAVSGASLA------HLSNLTTLDLSHNFLRAL-T---- 353 (694)
Q Consensus 289 ~~L~~L~Ls~N~L~~i~----~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~------~l~~L~~L~Ls~N~L~~l-~---- 353 (694)
.+|+.|+|++|-++... ..++..++.|+.|.+.+|-++.-...++- ..++|..|-+.+|.+.+- .
T Consensus 214 ~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~ 293 (388)
T COG5238 214 HSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDIS 293 (388)
T ss_pred CcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeec
Confidence 44555555555443222 22333444555555555555443322211 235555555555554321 0
Q ss_pred --hhhhCCCCCCCEEEccCCCCCC
Q psy8879 354 --QDLITPLKSLQELRLDDNDISM 375 (694)
Q Consensus 354 --~~~~~~l~~L~~L~Ls~N~L~~ 375 (694)
.-.=..++-|..|.+.||+|..
T Consensus 294 l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 294 LNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred hhhhhhcccHHHHHHHHccCcchh
Confidence 0001234555666666666664
No 53
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=97.77 E-value=2.6e-06 Score=86.53 Aligned_cols=234 Identities=18% Similarity=0.160 Sum_probs=119.4
Q ss_pred cCCCCccEEEccCCCCCCCCcchhcCC---CCCccEEEccCCCCCCC----C------ccccccCCCCccEEEccCCCCC
Q psy8879 115 LEGVTLHGLVISSGELKNISDGAFIGL---SSPLQALGLPNNLLSVV----P------TSALAPLAPNLDRLDLSHNQLY 181 (694)
Q Consensus 115 ~~~~~L~~L~Ls~n~i~~i~~~~F~~l---~~~L~~L~Ls~N~L~~l----p------~~~~~~l~~~L~~L~Ls~N~L~ 181 (694)
..+..++.++||+|.|..-....+... -.+|+..++++--.+.. + ..++.++ ++|+.++||+|.+.
T Consensus 27 ~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkc-p~l~~v~LSDNAfg 105 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKC-PRLQKVDLSDNAFG 105 (388)
T ss_pred HhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcC-CcceeeeccccccC
Confidence 345567778888887765333322221 23466666665322211 1 1234444 67777777777655
Q ss_pred CCCcc----cccCCCCccEEEecCCCCCCCCccccC-------------CCCCCcEEeccCCcccchhhh----hhccCc
Q psy8879 182 KLENT----SFKGLSSLNFLDLSYNKLMTLSQDCLA-------------PLVTLRVLRLQGNRLTVSVVA----ALQGLR 240 (694)
Q Consensus 182 ~i~~~----~f~~L~~L~~L~Ls~N~l~~i~~~~f~-------------~L~~L~~L~Ls~N~l~~~~~~----~~~~L~ 240 (694)
.-.+. .++.-+.|++|.+++|.+..+..+.++ .-|.|+......|++...... .+..-.
T Consensus 106 ~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~ 185 (388)
T COG5238 106 SEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHE 185 (388)
T ss_pred cccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhc
Confidence 43222 234456677777777665544332221 235667777776666532211 122224
Q ss_pred ccccccCCCCcCCCCCCCCC--------CCCccccceeeccCCcccccc----cccccCCcccceecccCCccccccchh
Q psy8879 241 SVTDLDLSHNLLAGPLGPST--------VPRLSSLKVLSIAHNQFSSVR----RGALAGLDKLTSLSCHHNQIDVLEDHS 308 (694)
Q Consensus 241 ~L~~L~Ls~N~l~~~i~p~~--------~~~l~~L~~L~Ls~N~L~~i~----~~~~~~L~~L~~L~Ls~N~L~~i~~~~ 308 (694)
+|+.+.+..|.+. |.. +..+.+|+.|||.+|.++... ...+...+.|++|.+.+|-++.-...+
T Consensus 186 ~lk~vki~qNgIr----pegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~ 261 (388)
T COG5238 186 NLKEVKIQQNGIR----PEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKS 261 (388)
T ss_pred CceeEEeeecCcC----cchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHH
Confidence 5666666666654 221 223456677777777665322 223444455666766666655333221
Q ss_pred ----hh--cccccccccCCCCccccccc-----cch--hcccccCeeecCCCCCCCcC
Q psy8879 309 ----FR--ALSTLSHLDLAHNRIVAVSG-----ASL--AHLSNLTTLDLSHNFLRALT 353 (694)
Q Consensus 309 ----f~--~l~~L~~L~Ls~N~L~~i~~-----~~f--~~l~~L~~L~Ls~N~L~~l~ 353 (694)
|. ..++|..|...+|.+.+-.. ..+ ..+|-|..|.+.+|++....
T Consensus 262 v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E~~ 319 (388)
T COG5238 262 VLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKELA 319 (388)
T ss_pred HHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchhHH
Confidence 11 23566666666665443111 011 24556666666666666543
No 54
>KOG2120|consensus
Probab=97.77 E-value=9.2e-07 Score=90.77 Aligned_cols=176 Identities=20% Similarity=0.154 Sum_probs=86.0
Q ss_pred CccEEEccCCCCCCCC-cccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCc-ccch-hhhhhccCcccccc
Q psy8879 169 NLDRLDLSHNQLYKLE-NTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNR-LTVS-VVAALQGLRSVTDL 245 (694)
Q Consensus 169 ~L~~L~Ls~N~L~~i~-~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~-l~~~-~~~~~~~L~~L~~L 245 (694)
.|++||||...|+.-. ...++.+.+|+.|.|.++++.+-....++.-.+|+.|+++.+. ++.. ..-.+.+++.|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 3555555554443211 0123344555555555555555444445555555555555532 2211 11234455556666
Q ss_pred cCCCCcCCCCCCCCCCCC-ccccceeeccCCcc----cccccccccCCcccceecccCCc-cccccchhhhccccccccc
Q psy8879 246 DLSHNLLAGPLGPSTVPR-LSSLKVLSIAHNQF----SSVRRGALAGLDKLTSLSCHHNQ-IDVLEDHSFRALSTLSHLD 319 (694)
Q Consensus 246 ~Ls~N~l~~~i~p~~~~~-l~~L~~L~Ls~N~L----~~i~~~~~~~L~~L~~L~Ls~N~-L~~i~~~~f~~l~~L~~L~ 319 (694)
+++.+.+....-...... -++|+.|+|++..- +.+ ..-...+++|.+|||++|. ++.--...|-.++.|++|.
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~-~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lS 344 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHL-STLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLS 344 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHH-HHHHHhCCceeeeccccccccCchHHHHHHhcchheeee
Confidence 666555442110001111 13555666655421 111 1112456777777777763 3322223455667777777
Q ss_pred CCCCccccccccc---hhcccccCeeecCCC
Q psy8879 320 LAHNRIVAVSGAS---LAHLSNLTTLDLSHN 347 (694)
Q Consensus 320 Ls~N~L~~i~~~~---f~~l~~L~~L~Ls~N 347 (694)
++.|. +++|+. +...|.|.+||..+.
T Consensus 345 lsRCY--~i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 345 LSRCY--DIIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred hhhhc--CCChHHeeeeccCcceEEEEeccc
Confidence 77765 344443 345678888887765
No 55
>KOG1644|consensus
Probab=97.75 E-value=3e-05 Score=76.00 Aligned_cols=103 Identities=25% Similarity=0.313 Sum_probs=57.0
Q ss_pred cEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccC
Q psy8879 146 QALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQG 225 (694)
Q Consensus 146 ~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~ 225 (694)
+.++|.+.++..+.. ++....+...+||++|.+..+. .|..++.|.+|.|++|+|+.+.+..-.-+++|+.|.|.+
T Consensus 22 ~e~~LR~lkip~ien--lg~~~d~~d~iDLtdNdl~~l~--~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~Ltn 97 (233)
T KOG1644|consen 22 RELDLRGLKIPVIEN--LGATLDQFDAIDLTDNDLRKLD--NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTN 97 (233)
T ss_pred cccccccccccchhh--ccccccccceecccccchhhcc--cCCCccccceEEecCCcceeeccchhhhccccceEEecC
Confidence 455555555554443 2222245666777777666554 366666777777777777777665444456666666666
Q ss_pred Ccccchh-hhhhccCcccccccCCCCcC
Q psy8879 226 NRLTVSV-VAALQGLRSVTDLDLSHNLL 252 (694)
Q Consensus 226 N~l~~~~-~~~~~~L~~L~~L~Ls~N~l 252 (694)
|.|.... -..+..+++|++|.+-+|..
T Consensus 98 Nsi~~l~dl~pLa~~p~L~~Ltll~Npv 125 (233)
T KOG1644|consen 98 NSIQELGDLDPLASCPKLEYLTLLGNPV 125 (233)
T ss_pred cchhhhhhcchhccCCccceeeecCCch
Confidence 6665211 12233444455554444444
No 56
>KOG4579|consensus
Probab=97.69 E-value=6.3e-06 Score=75.98 Aligned_cols=118 Identities=24% Similarity=0.246 Sum_probs=79.9
Q ss_pred cceeeccCCcccccccc--cccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeec
Q psy8879 267 LKVLSIAHNQFSSVRRG--ALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDL 344 (694)
Q Consensus 267 L~~L~Ls~N~L~~i~~~--~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~L 344 (694)
+..++|+.+++-.+... .+.....|+..+|++|.+..+++..-..++.++.|+|++|.|++++.+ +..++.|+.|++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl 107 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNL 107 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhccc
Confidence 44566666665544321 233445677777888888777776555566777888888888887555 777788888888
Q ss_pred CCCCCCCcChhhhCCCCCCCEEEccCCCCCCCCcccccCCCC
Q psy8879 345 SHNFLRALTQDLITPLKSLQELRLDDNDISMEPECIYVGFNT 386 (694)
Q Consensus 345 s~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~~Np 386 (694)
+.|.+...+.-.+ ++.+|..|+..+|.+..+|...|...+|
T Consensus 108 ~~N~l~~~p~vi~-~L~~l~~Lds~~na~~eid~dl~~s~~~ 148 (177)
T KOG4579|consen 108 RFNPLNAEPRVIA-PLIKLDMLDSPENARAEIDVDLFYSSLP 148 (177)
T ss_pred ccCccccchHHHH-HHHhHHHhcCCCCccccCcHHHhccccH
Confidence 8888777665433 3777777888888887777776664443
No 57
>KOG2120|consensus
Probab=97.65 E-value=1.9e-06 Score=88.47 Aligned_cols=223 Identities=20% Similarity=0.188 Sum_probs=144.2
Q ss_pred ccEEEccCCCCCCCCccccccCCCCccEEEccCCCCCCC-CcccccCC-CCccEEEecCCCCCCCC-ccccCCCCCCcEE
Q psy8879 145 LQALGLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLYKL-ENTSFKGL-SSLNFLDLSYNKLMTLS-QDCLAPLVTLRVL 221 (694)
Q Consensus 145 L~~L~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~~i-~~~~f~~L-~~L~~L~Ls~N~l~~i~-~~~f~~L~~L~~L 221 (694)
=+.||+.+-.|.......+.. .....+.+....+..- ....+.-. +.|++|||++..|+.-. -..++.+.+|+.|
T Consensus 138 W~~lDl~~r~i~p~~l~~l~~--rgV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~stl~~iLs~C~kLk~l 215 (419)
T KOG2120|consen 138 WQTLDLTGRNIHPDVLGRLLS--RGVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVSTLHGILSQCSKLKNL 215 (419)
T ss_pred eeeeccCCCccChhHHHHHHh--CCeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHHHHHHHHHHHhhhhc
Confidence 456677666555433222221 3455566653322211 11112111 35999999998877432 2346778899999
Q ss_pred eccCCcccchhhhhhccCcccccccCCCCc-CCCCCCCCCCCCccccceeeccCCcccccccc-cccC-CcccceecccC
Q psy8879 222 RLQGNRLTVSVVAALQGLRSVTDLDLSHNL-LAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRG-ALAG-LDKLTSLSCHH 298 (694)
Q Consensus 222 ~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~-l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~-~~~~-L~~L~~L~Ls~ 298 (694)
.+.++++...+...+.+-.+|+.|+++.+. ++..-..-.+.+++.|.+|+|+.+.+..-.-. .... -++|+.|+|++
T Consensus 216 SlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG 295 (419)
T KOG2120|consen 216 SLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAHISETLTQLNLSG 295 (419)
T ss_pred cccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhhHHHhhhchhhhhhhhhh
Confidence 999999998888899999999999999874 33211122367789999999999977642211 1111 25788899987
Q ss_pred Cccc--ccc-chhhhcccccccccCCCCcc-ccccccchhcccccCeeecCCCCCCCcChhh---hCCCCCCCEEEccCC
Q psy8879 299 NQID--VLE-DHSFRALSTLSHLDLAHNRI-VAVSGASLAHLSNLTTLDLSHNFLRALTQDL---ITPLKSLQELRLDDN 371 (694)
Q Consensus 299 N~L~--~i~-~~~f~~l~~L~~L~Ls~N~L-~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~---~~~l~~L~~L~Ls~N 371 (694)
..-. .-. ......+++|..|||++|.. +.-....|-+++.|++|.|+.+. +++|+. +...++|.+||+.+.
T Consensus 296 ~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY--~i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 296 YRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCY--DIIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred hHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhc--CCChHHeeeeccCcceEEEEeccc
Confidence 6321 111 12235689999999998763 33233556788999999998875 455544 456789999999874
No 58
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.55 E-value=7.2e-05 Score=55.87 Aligned_cols=38 Identities=39% Similarity=0.542 Sum_probs=20.0
Q ss_pred ccCeeecCCCCCCCcChhhhCCCCCCCEEEccCCCCCCC
Q psy8879 338 NLTTLDLSHNFLRALTQDLITPLKSLQELRLDDNDISME 376 (694)
Q Consensus 338 ~L~~L~Ls~N~L~~l~~~~~~~l~~L~~L~Ls~N~L~~l 376 (694)
+|++|++++|+|+.+++. +..+++|+.|++++|+|+.+
T Consensus 2 ~L~~L~l~~N~i~~l~~~-l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPE-LSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp T-SEEEETSSS-SSHGGH-GTTCTTSSEEEETSSCCSBE
T ss_pred cceEEEccCCCCcccCch-HhCCCCCCEEEecCCCCCCC
Confidence 455555555555555442 45556666666666655543
No 59
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.51 E-value=0.00011 Score=54.96 Aligned_cols=37 Identities=41% Similarity=0.575 Sum_probs=16.2
Q ss_pred CccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCC
Q psy8879 169 NLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMT 206 (694)
Q Consensus 169 ~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~ 206 (694)
+|++|++++|+|+.+++ .++++++|++|++++|+++.
T Consensus 2 ~L~~L~l~~N~i~~l~~-~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPP-ELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp T-SEEEETSSS-SSHGG-HGTTCTTSSEEEETSSCCSB
T ss_pred cceEEEccCCCCcccCc-hHhCCCCCCEEEecCCCCCC
Confidence 34444444444444432 24444444444444444443
No 60
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.24 E-value=0.0011 Score=72.65 Aligned_cols=51 Identities=16% Similarity=0.217 Sum_probs=25.3
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccC-CCCCCCCcchhcCCCCCccEEEccCC
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISS-GELKNISDGAFIGLSSPLQALGLPNN 153 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~-n~i~~i~~~~F~~l~~~L~~L~Ls~N 153 (694)
.++.|+++++.++.+| .+. .+|++|.+++ +.++.++. .++.+|++|++++|
T Consensus 53 ~l~~L~Is~c~L~sLP-~LP--~sLtsL~Lsnc~nLtsLP~----~LP~nLe~L~Ls~C 104 (426)
T PRK15386 53 ASGRLYIKDCDIESLP-VLP--NELTEITIENCNNLTTLPG----SIPEGLEKLTVCHC 104 (426)
T ss_pred CCCEEEeCCCCCcccC-CCC--CCCcEEEccCCCCcccCCc----hhhhhhhheEccCc
Confidence 5566666666666665 221 2466666654 33333321 12334555555555
No 61
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.22 E-value=0.0011 Score=72.68 Aligned_cols=134 Identities=20% Similarity=0.293 Sum_probs=90.1
Q ss_pred CCCCccEEEccCCCCCCCCcchhcCCCCCccEEEccC-CCCCCCCccccccCCCCccEEEccCC-CCCCCCcccccCCCC
Q psy8879 116 EGVTLHGLVISSGELKNISDGAFIGLSSPLQALGLPN-NLLSVVPTSALAPLAPNLDRLDLSHN-QLYKLENTSFKGLSS 193 (694)
Q Consensus 116 ~~~~L~~L~Ls~n~i~~i~~~~F~~l~~~L~~L~Ls~-N~L~~lp~~~~~~l~~~L~~L~Ls~N-~L~~i~~~~f~~L~~ 193 (694)
.+.+++.|++++|.++.++ .++.+|++|.+++ +.++.+|.. + +++|++|++++| .+..++ .+
T Consensus 50 ~~~~l~~L~Is~c~L~sLP-----~LP~sLtsL~Lsnc~nLtsLP~~-L---P~nLe~L~Ls~Cs~L~sLP-------~s 113 (426)
T PRK15386 50 EARASGRLYIKDCDIESLP-----VLPNELTEITIENCNNLTTLPGS-I---PEGLEKLTVCHCPEISGLP-------ES 113 (426)
T ss_pred HhcCCCEEEeCCCCCcccC-----CCCCCCcEEEccCCCCcccCCch-h---hhhhhheEccCcccccccc-------cc
Confidence 4577899999999998886 3566799999988 467776642 2 368999999998 665554 35
Q ss_pred ccEEEecCCCCCCCCccccCCC-CCCcEEeccCCccc-c-hhhhhhccCcccccccCCCCcCCCCCCCCCCCCcccccee
Q psy8879 194 LNFLDLSYNKLMTLSQDCLAPL-VTLRVLRLQGNRLT-V-SVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVL 270 (694)
Q Consensus 194 L~~L~Ls~N~l~~i~~~~f~~L-~~L~~L~Ls~N~l~-~-~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L 270 (694)
|+.|++.++....+ ..+ ++|+.|.+.+++.. . ..+..+ .++|++|++++|.... + |..+. .+|+.|
T Consensus 114 Le~L~L~~n~~~~L-----~~LPssLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i~-L-P~~LP--~SLk~L 182 (426)
T PRK15386 114 VRSLEIKGSATDSI-----KNVPNGLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNII-L-PEKLP--ESLQSI 182 (426)
T ss_pred cceEEeCCCCCccc-----ccCcchHhheecccccccccccccccc--CCcccEEEecCCCccc-C-ccccc--ccCcEE
Confidence 88888887765433 223 35778887543311 0 111111 1589999999887653 2 44344 588999
Q ss_pred eccCCc
Q psy8879 271 SIAHNQ 276 (694)
Q Consensus 271 ~Ls~N~ 276 (694)
+++.+.
T Consensus 183 ~ls~n~ 188 (426)
T PRK15386 183 TLHIEQ 188 (426)
T ss_pred Eecccc
Confidence 988764
No 62
>KOG3665|consensus
Probab=97.21 E-value=0.0002 Score=84.38 Aligned_cols=182 Identities=18% Similarity=0.166 Sum_probs=105.7
Q ss_pred CeeEEEcCCCCCCCCCccccCCCCccEEEccCCCCCC--------CCcchh------cCCCCCccEEEccCCCC-CCCCc
Q psy8879 96 RVSLLDCTLSNVTVLPGKFLEGVTLHGLVISSGELKN--------ISDGAF------IGLSSPLQALGLPNNLL-SVVPT 160 (694)
Q Consensus 96 ~L~~Ldls~n~l~~lp~~~~~~~~L~~L~Ls~n~i~~--------i~~~~F------~~l~~~L~~L~Ls~N~L-~~lp~ 160 (694)
.++.+++.+..+..-.........|++|.+.+-.... ++--.+ .....+|++|++++... ..-.+
T Consensus 61 ~ltki~l~~~~~~~~~~~~l~~~~L~sl~LGnl~~~k~~~~~~~~idi~~lL~~~Ln~~sr~nL~~LdI~G~~~~s~~W~ 140 (699)
T KOG3665|consen 61 NLTKIDLKNVTLQHQTLEMLRKQDLESLKLGNLDKIKQDYLDDATIDIISLLKDLLNEESRQNLQHLDISGSELFSNGWP 140 (699)
T ss_pred eeEEeeccceecchhHHHHHhhccccccCCcchHhhhhhhhhhhhccHHHHHHHHHhHHHHHhhhhcCccccchhhccHH
Confidence 4666677666665444344333446777765432211 110001 01123588888888642 22222
Q ss_pred cccccCCCCccEEEccCCCCCCCC-cccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccc-hhhhhhcc
Q psy8879 161 SALAPLAPNLDRLDLSHNQLYKLE-NTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTV-SVVAALQG 238 (694)
Q Consensus 161 ~~~~~l~~~L~~L~Ls~N~L~~i~-~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~-~~~~~~~~ 238 (694)
..++.++|+|+.|.+++-.+..-. .....++++|..||+|+.+++.+ ..++.+++|+.|.+.+=.+.. ..-..+.+
T Consensus 141 ~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~LF~ 218 (699)
T KOG3665|consen 141 KKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLIDLFN 218 (699)
T ss_pred HHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHHHhc
Confidence 334444588888888876554322 12346778888888888888877 347788888888888766653 23345667
Q ss_pred CcccccccCCCCcCCCCC--C---CCCCCCccccceeeccCCcccc
Q psy8879 239 LRSVTDLDLSHNLLAGPL--G---PSTVPRLSSLKVLSIAHNQFSS 279 (694)
Q Consensus 239 L~~L~~L~Ls~N~l~~~i--~---p~~~~~l~~L~~L~Ls~N~L~~ 279 (694)
|++|+.||+|.......- . -+.-..+|+|+.||.|++.+.+
T Consensus 219 L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~ 264 (699)
T KOG3665|consen 219 LKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINE 264 (699)
T ss_pred ccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhH
Confidence 888888888877654310 0 0111235677777777665543
No 63
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=97.17 E-value=0.00034 Score=58.21 Aligned_cols=38 Identities=8% Similarity=-0.001 Sum_probs=31.7
Q ss_pred eeeEEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 463 LRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 463 ~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.++.+..+|+| |.+|+..|+|.|+|.|+|..+.+....
T Consensus 31 ~r~~~~~~g~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~ 69 (73)
T cd05852 31 SRISIWDDGSLEILNITKLDEGSYTCFAENNRGKANSTG 69 (73)
T ss_pred CCEEEcCCCEEEECcCChhHCEEEEEEEECCCCceeEEE
Confidence 45666777888 999999999999999999988776544
No 64
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=97.16 E-value=0.00068 Score=59.62 Aligned_cols=60 Identities=13% Similarity=-0.030 Sum_probs=36.8
Q ss_pred EEEEeccCcccc-ccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEe-eeccceeEEe
Q psy8879 444 EILALVPTLTSQ-PLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITL-YIDGDVIVQK 503 (694)
Q Consensus 444 ~i~~l~~~~~~~-~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~-~~~~~~~~~~ 503 (694)
.+.|..+++... ...+...+..+-...++| |.+|+.+|+|.|+|.|+|.. ..++..+..+
T Consensus 32 ~i~W~~~~g~~l~~~~~r~~v~~~~~~~~~L~I~~v~~~D~G~YtC~A~N~~~g~~~~s~~l~ 94 (96)
T cd05865 32 DISWFSPNGEKLTPNQQRISVVRNDDYSSTLTIYNANIDDAGIYKCVVSNEDEGESEATVNVK 94 (96)
T ss_pred EEEEECCCCcCccccCCeEEEEeCCCCceEEEEeccChhhCEEEEEEEEcCCCCcEEEEEEEE
Confidence 377877666532 112111111111112567 99999999999999999986 6666555433
No 65
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=97.00 E-value=0.00083 Score=55.72 Aligned_cols=35 Identities=20% Similarity=0.090 Sum_probs=28.9
Q ss_pred EEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 466 NVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 466 n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.+...++| |.+|+..|+|.|+|.|+|.++......
T Consensus 35 ~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~ 70 (74)
T cd05745 35 LVLSSGTLRISRVALHDQGQYECQAVNIVGSQRTVA 70 (74)
T ss_pred EEccCCeEEEeeCCHHhCEEEEEEEEeCCCceeEEE
Confidence 34456777 999999999999999999998876644
No 66
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=96.99 E-value=0.001 Score=57.99 Aligned_cols=59 Identities=15% Similarity=-0.021 Sum_probs=39.1
Q ss_pred cceeeeeceeE------EEEeccCccccccceeEeeeeEEeccc---EE-EEEEEecCCCcceeEEEEEeeec
Q psy8879 434 DQSALVLGCSE------ILALVPTLTSQPLSYVTSLRANVTGLG---TV-QVYVQLWTNYDPNCLLTITLYID 496 (694)
Q Consensus 434 ~~~~~~l~c~~------i~~l~~~~~~~~~~~i~~~~~n~~~~g---tL-~~~v~~~d~G~YtC~~~n~~~~~ 496 (694)
.+....+.|.. +.|..+++..... ..|+.+..+| +| |.+++.+|+|.|+|.|+|..+..
T Consensus 14 ~G~~v~l~C~~~G~P~~v~W~k~~g~~~~~----~~r~~~~~~g~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~ 82 (92)
T cd05866 14 VGESKFFTCTAIGEPESIDWYNPQGEKIVS----SQRVVVQKEGVRSRLTIYNANIEDAGIYRCQATDAKGQT 82 (92)
T ss_pred CCCeEEEEEEEEEeCCeEEEEeCCCeEecC----CCCEEEEeCCCeeEEEEecCChHHCEEEEEEEEcCCCcE
Confidence 33445555543 6777665543311 1344454444 56 99999999999999999998765
No 67
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=96.95 E-value=0.0011 Score=54.52 Aligned_cols=52 Identities=4% Similarity=-0.191 Sum_probs=35.7
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
+.|........... +..+..++.+ |.+++.+|+|.|+|.|+|.+++......
T Consensus 16 v~W~k~g~~~~~~~-----~~~~~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 68 (71)
T cd05723 16 VKWVKNGDMVIPSD-----YFKIVKEHNLQVLGLVKSDEGFYQCIAENDVGNVQASAQ 68 (71)
T ss_pred EEEEECCeECCCCC-----CEEEEecCCEEEEcCCcccCEEEEEEEEcCCCEEEEEEE
Confidence 56665554443221 2344445555 8899999999999999999988766543
No 68
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=96.94 E-value=0.001 Score=55.70 Aligned_cols=53 Identities=9% Similarity=-0.231 Sum_probs=34.6
Q ss_pred EEEeccCccccccceeEeeeeEEeccc--EE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLG--TV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~g--tL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
+.|...+........ +..+...+.| +| |.+++..|+|.|+|.++|..+++...
T Consensus 15 i~W~k~~~~i~~~~~--r~~~~~~~~g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~ 70 (75)
T cd05892 15 IFWKRNNEMVQYNTD--RISLYQDNSGRVTLLIKNVNKKDAGWYTVSAVNEAGVATCH 70 (75)
T ss_pred EEEEECCEECcCCCC--eEEEEEcCCCcEEEEECCCChhhCEEEEEEEEcCcCeEEEE
Confidence 667776655442211 1222222333 56 99999999999999999998776543
No 69
>KOG3665|consensus
Probab=96.93 E-value=0.00018 Score=84.75 Aligned_cols=134 Identities=22% Similarity=0.195 Sum_probs=78.9
Q ss_pred CccEEEccCCCCC-CCCcchhcCCCCCccEEEccCCCCCCCCc-cccccCCCCccEEEccCCCCCCCCcccccCCCCccE
Q psy8879 119 TLHGLVISSGELK-NISDGAFIGLSSPLQALGLPNNLLSVVPT-SALAPLAPNLDRLDLSHNQLYKLENTSFKGLSSLNF 196 (694)
Q Consensus 119 ~L~~L~Ls~n~i~-~i~~~~F~~l~~~L~~L~Ls~N~L~~lp~-~~~~~l~~~L~~L~Ls~N~L~~i~~~~f~~L~~L~~ 196 (694)
+|++|++++...- .-+......++++|+.|.+++-.+..-.- ....++ ++|..||+|+.+++.+ ..+++|++|+.
T Consensus 123 nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sF-pNL~sLDIS~TnI~nl--~GIS~LknLq~ 199 (699)
T KOG3665|consen 123 NLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASF-PNLRSLDISGTNISNL--SGISRLKNLQV 199 (699)
T ss_pred hhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhcc-CccceeecCCCCccCc--HHHhccccHHH
Confidence 5777777654332 22222334455667877777766543321 123344 7788888888877766 34677777777
Q ss_pred EEecCCCCCCC-CccccCCCCCCcEEeccCCcccchh------hhhhccCcccccccCCCCcCCCC
Q psy8879 197 LDLSYNKLMTL-SQDCLAPLVTLRVLRLQGNRLTVSV------VAALQGLRSVTDLDLSHNLLAGP 255 (694)
Q Consensus 197 L~Ls~N~l~~i-~~~~f~~L~~L~~L~Ls~N~l~~~~------~~~~~~L~~L~~L~Ls~N~l~~~ 255 (694)
|.+.+=.+..- .-..+.+|.+|+.||++..+..... -+.-..+|+|+.||.+++.+.+.
T Consensus 200 L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~~ 265 (699)
T KOG3665|consen 200 LSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINEE 265 (699)
T ss_pred HhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhHH
Confidence 77766554431 1123556778888888776543211 11223477888888887776643
No 70
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=96.88 E-value=0.00061 Score=55.73 Aligned_cols=37 Identities=11% Similarity=0.046 Sum_probs=30.5
Q ss_pred eeEEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 464 RANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 464 ~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
+..+...++| |.+++..|+|.|+|.|+|.++.+...+
T Consensus 29 ~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 66 (69)
T cd05746 29 KFHISPEGYLAIRDVGVADQGRYECVARNTIGYASVSM 66 (69)
T ss_pred CEEECCCCEEEECcCChhhCEEEEEEEECCCCcEEEEE
Confidence 3455667788 999999999999999999998876543
No 71
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=96.83 E-value=0.0012 Score=54.65 Aligned_cols=52 Identities=13% Similarity=-0.100 Sum_probs=36.3
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
+.|......... ..+..+..+++| |.+|+.+|+|.|+|.++|..+.....+.
T Consensus 18 v~W~k~~~~~~~-----~~~~~~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 70 (73)
T cd04969 18 ISWSKGTELLTN-----SSRICIWPDGSLEILNVTKSDEGKYTCFAENFFGKANSTGS 70 (73)
T ss_pred EEEEECCEEccc-----CCCEEECCCCeEEEccCChhHCEEEEEEEECCCCceEEEEE
Confidence 455555443331 223345566777 9999999999999999999888766554
No 72
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=96.81 E-value=0.0011 Score=53.97 Aligned_cols=50 Identities=10% Similarity=-0.152 Sum_probs=34.9
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
+.|....+... ..+..+.+.++| |.+++.+|+|.|+|.++|.++......
T Consensus 15 v~W~k~~~~~~------~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~ 65 (69)
T cd05725 15 VLWRKEDGELP------KGRAEILDDKSLKIRNVTAGDEGSYTCEAENMVGKIEASA 65 (69)
T ss_pred EEEEECCccCC------CCcEEEeeCCEEEECcCChhHCEEEEEEEEcCCCcEEEEE
Confidence 55655543332 223344466777 999999999999999999988766543
No 73
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=96.75 E-value=0.0015 Score=54.65 Aligned_cols=51 Identities=8% Similarity=-0.244 Sum_probs=34.4
Q ss_pred EEEeccCccccccceeEeeeeEEec--cc--EE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTG--LG--TV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~--~g--tL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
+.|...+....... .++.+.. .| +| |.+++..|+|.|+|.|+|..+++...
T Consensus 15 v~W~k~~~~l~~~~----~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~ 70 (75)
T cd05893 15 IFWKKENESLTHNT----DRVSMHQDNCGYICLLIQGATKEDAGWYTVSAKNEAGIVSCT 70 (75)
T ss_pred EEEEECCEECCCCC----CeEEEEEcCCCEEEEEECCCCHHHCEEEEEEEEcCCCEEEEE
Confidence 66766665544211 2333332 23 46 99999999999999999998877553
No 74
>KOG2123|consensus
Probab=96.71 E-value=0.00011 Score=75.31 Aligned_cols=82 Identities=27% Similarity=0.297 Sum_probs=39.3
Q ss_pred CccEEEccCCCCCCCCcccccCCCCccEEEecCCCCCCCCccccCCCCCCcEEeccCCcccchh-hhhhccCcccccccC
Q psy8879 169 NLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKLMTLSQDCLAPLVTLRVLRLQGNRLTVSV-VAALQGLRSVTDLDL 247 (694)
Q Consensus 169 ~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l~~i~~~~f~~L~~L~~L~Ls~N~l~~~~-~~~~~~L~~L~~L~L 247 (694)
+.+.|+..++.|+.|. ....++.|+.|.|+-|.|+.+.+ |..+.+|++|+|+.|.|.... ..-+.++++|+.|.|
T Consensus 20 ~vkKLNcwg~~L~DIs--ic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~LWL 95 (388)
T KOG2123|consen 20 NVKKLNCWGCGLDDIS--ICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTLWL 95 (388)
T ss_pred HhhhhcccCCCccHHH--HHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhHhh
Confidence 3444555555444443 23345555555555555555443 445555555555555554321 122445555555555
Q ss_pred CCCcCCC
Q psy8879 248 SHNLLAG 254 (694)
Q Consensus 248 s~N~l~~ 254 (694)
..|.-.|
T Consensus 96 ~ENPCc~ 102 (388)
T KOG2123|consen 96 DENPCCG 102 (388)
T ss_pred ccCCccc
Confidence 5554443
No 75
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=96.71 E-value=0.002 Score=52.99 Aligned_cols=34 Identities=9% Similarity=-0.174 Sum_probs=28.2
Q ss_pred ecccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 468 TGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 468 ~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
...++| |.+++.+|+|.|+|.|+|.++.+...+.
T Consensus 33 ~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 67 (71)
T cd05876 33 NNNKTLQLDNVLESDDGEYVCTAENSEGSARHHYT 67 (71)
T ss_pred cCCCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEE
Confidence 345677 9999999999999999999988766543
No 76
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=96.71 E-value=0.0035 Score=54.52 Aligned_cols=25 Identities=12% Similarity=-0.078 Sum_probs=21.8
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
++| |.+|+..|+|.|+|.++|..+.
T Consensus 57 ~~L~I~~v~~~D~G~Y~C~A~N~~g~ 82 (92)
T cd04977 57 STLTIYNANIEDAGIYKCVATDAKGT 82 (92)
T ss_pred EEEEEecCCcccCEEEEEEEEcCCCC
Confidence 356 9999999999999999998654
No 77
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=96.66 E-value=0.0013 Score=56.50 Aligned_cols=29 Identities=14% Similarity=0.106 Sum_probs=24.8
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeecc
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDG 497 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~ 497 (694)
.+|.| |.+|+..|+|.|||.|+|++-+..
T Consensus 45 ~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~ 74 (85)
T cd05853 45 SAGDLMIRSIQLKHAGKYVCMVQTSVDKLS 74 (85)
T ss_pred CCCcEEEecCCHHHCEEEEEEEEcccCceE
Confidence 45666 999999999999999999886653
No 78
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=96.65 E-value=0.002 Score=56.55 Aligned_cols=28 Identities=11% Similarity=0.107 Sum_probs=24.8
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeec
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYID 496 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~ 496 (694)
.+|.| |.+|+.+|+|.|+|.|+|.+-+.
T Consensus 58 ~~G~L~fs~v~~~D~g~Y~C~A~n~~~~~ 86 (96)
T cd05727 58 TNGNLYIAKVEASDRGNYSCFVSSPSSTK 86 (96)
T ss_pred CCCcEEEeecCHhhCceeEEEEEecccCC
Confidence 47999 99999999999999999987444
No 79
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=96.65 E-value=0.0014 Score=54.40 Aligned_cols=36 Identities=11% Similarity=-0.034 Sum_probs=28.5
Q ss_pred eeEEecccEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 464 RANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 464 ~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
++.....|+| |.+++.+|+|.|+|.|+|..+..-..
T Consensus 31 ~~~~~~~g~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~ 67 (74)
T cd05738 31 RIKQLRSGALQIENSEESDQGKYECVATNSAGTRYSA 67 (74)
T ss_pred CEEEcCCcEEEECCCChhhCEEEEEEEECCCCceEcc
Confidence 3445566777 88999999999999999999875443
No 80
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=96.65 E-value=0.0034 Score=54.52 Aligned_cols=31 Identities=16% Similarity=0.045 Sum_probs=26.6
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
++| |.+|+.+|+|.|+|.|+|.++.+...+.
T Consensus 62 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~s~~ 93 (96)
T cd05732 62 SSLTLKDVQLTDAGRYDCEASNRIGGDQQSMY 93 (96)
T ss_pred EEEEECcCCcCcCEEeEEEEEeCCCCcEEEEE
Confidence 456 9999999999999999999998866543
No 81
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=96.64 E-value=0.0033 Score=54.21 Aligned_cols=34 Identities=12% Similarity=-0.110 Sum_probs=27.7
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeEEee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
++| |.+++.+|+|.|+|.|+|..+.....+...+
T Consensus 47 s~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~L~V 81 (88)
T cd05735 47 STLQILPTVREDSGFFSCHAINSYGEDRGIIQLTV 81 (88)
T ss_pred EEEEECCCCcccCEEEEEEEEcCCCcceEEEEEEE
Confidence 445 8889999999999999999998876655443
No 82
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=96.63 E-value=0.0031 Score=55.28 Aligned_cols=32 Identities=16% Similarity=0.155 Sum_probs=27.4
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
++| |.+|+..|+|.|+|.|+|.++.+...+..
T Consensus 63 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 95 (97)
T cd05869 63 SSLTLKYIQYTDAGEYLCTASNTIGQDSQSMYL 95 (97)
T ss_pred EEEEEecCccCcCEEEEEEEecCCCCeeEEEEE
Confidence 456 99999999999999999999988776543
No 83
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=96.61 E-value=0.0026 Score=53.42 Aligned_cols=36 Identities=14% Similarity=-0.021 Sum_probs=29.2
Q ss_pred eeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 463 LRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 463 ~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
.+..+..+|+| |.+++.+|+|.|+|.|+|.++.+.+
T Consensus 36 ~r~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~s 72 (79)
T cd05734 36 GRIQLLSNGSLLIKHVLEEDSGYYLCKVSNDVGADAS 72 (79)
T ss_pred CCEEEecCCeEEECcCCcccCEEEEEEEEeCCCCCCc
Confidence 34555566887 9999999999999999999887633
No 84
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=96.60 E-value=0.0035 Score=51.76 Aligned_cols=53 Identities=15% Similarity=0.040 Sum_probs=36.3
Q ss_pred EEEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 444 EILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 444 ~i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.+.|..+++...... .+..+...++| |.+++.+|.|.|+|.|+|..+++...+
T Consensus 17 ~v~W~~~~~~~~~~~----~~~~~~~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~ 70 (74)
T cd05764 17 AIHWISPDGKLISNS----SRTLVYDNGTLDILITTVKDTGSFTCIASNAAGEATATV 70 (74)
T ss_pred EEEEEeCCCEEecCC----CeEEEecCCEEEEEECChhhCEEEEEEEECCCCeEEEEE
Confidence 367776554433111 12334456777 999999999999999999988765543
No 85
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=96.54 E-value=0.0032 Score=53.63 Aligned_cols=30 Identities=13% Similarity=-0.007 Sum_probs=25.1
Q ss_pred ecccEE-EEEEEecCCCcceeEEEEEeeecc
Q psy8879 468 TGLGTV-QVYVQLWTNYDPNCLLTITLYIDG 497 (694)
Q Consensus 468 ~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~ 497 (694)
...|+| |.+++..|+|.|+|.|+|.+....
T Consensus 44 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~ 74 (85)
T cd04970 44 DSNGDLMIRNAQLKHAGKYTCTAQTVVDSLS 74 (85)
T ss_pred cccceEEEccCCHHhCeeeEEEEecCCCcEE
Confidence 456777 999999999999999999776543
No 86
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=96.52 E-value=0.0031 Score=52.61 Aligned_cols=27 Identities=0% Similarity=-0.430 Sum_probs=23.5
Q ss_pred EE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
+| |.+++.+|+|.|+|.++|.++....
T Consensus 42 ~L~I~~~~~~D~G~Y~C~a~N~~G~~~~ 69 (75)
T cd05744 42 CLLIQNANKEDAGWYTVSAVNEAGVVSC 69 (75)
T ss_pred EEEECCCCcccCEEEEEEEEcCCCcEEE
Confidence 45 9999999999999999998876554
No 87
>KOG2739|consensus
Probab=96.51 E-value=0.0017 Score=66.38 Aligned_cols=15 Identities=40% Similarity=0.727 Sum_probs=6.9
Q ss_pred CCCccccceeeccCC
Q psy8879 261 VPRLSSLKVLSIAHN 275 (694)
Q Consensus 261 ~~~l~~L~~L~Ls~N 275 (694)
+..+++|+.|.++.|
T Consensus 61 ~P~Lp~LkkL~lsdn 75 (260)
T KOG2739|consen 61 FPKLPKLKKLELSDN 75 (260)
T ss_pred CCCcchhhhhcccCC
Confidence 334444444444444
No 88
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=96.50 E-value=0.0036 Score=53.97 Aligned_cols=38 Identities=18% Similarity=-0.134 Sum_probs=30.7
Q ss_pred eeeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 462 SLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 462 ~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
..++.+...++| |.+|+.+|+|.|+|.++|.++.....
T Consensus 38 ~~r~~v~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 76 (90)
T cd05726 38 SSRFSVSQTGDLTITNVQRSDVGYYICQTLNVAGSILTK 76 (90)
T ss_pred CCeEEECCCCeEEEeeCChhhCEEEEEEEEcCCCceEEE
Confidence 345666667788 99999999999999999988765443
No 89
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=96.50 E-value=0.0038 Score=53.48 Aligned_cols=33 Identities=15% Similarity=0.104 Sum_probs=26.9
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
..|+| |.+|+..|+|.|+|.|+|.++++.....
T Consensus 45 ~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~~~~ 78 (85)
T cd05854 45 TIGDLVIVNAQLSHAGTYTCTAQTVVDSASASAT 78 (85)
T ss_pred eEeEEEEccCChhhCeEEEEEEecCCCCEEEEEE
Confidence 34677 9999999999999999998876655433
No 90
>KOG2123|consensus
Probab=96.49 E-value=0.00031 Score=71.98 Aligned_cols=84 Identities=27% Similarity=0.323 Sum_probs=48.4
Q ss_pred CcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceecccCCccccccc-hhhhccccccc
Q psy8879 239 LRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHNQIDVLED-HSFRALSTLSH 317 (694)
Q Consensus 239 L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~-~~f~~l~~L~~ 317 (694)
+.+.+.|++.++.+.+ -..+..++.|+.|.|+-|+|+.+.+ |..|++|++|+|..|.|..+.. .-+.++++|+.
T Consensus 18 l~~vkKLNcwg~~L~D---Isic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~ 92 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDD---ISICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRT 92 (388)
T ss_pred HHHhhhhcccCCCccH---HHHHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhh
Confidence 4456666666666654 2334556666666666666666543 5566666666666666655442 22345555555
Q ss_pred ccCCCCcccc
Q psy8879 318 LDLAHNRIVA 327 (694)
Q Consensus 318 L~Ls~N~L~~ 327 (694)
|.|..|.-.+
T Consensus 93 LWL~ENPCc~ 102 (388)
T KOG2123|consen 93 LWLDENPCCG 102 (388)
T ss_pred HhhccCCccc
Confidence 5555555433
No 91
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=96.46 E-value=0.005 Score=52.17 Aligned_cols=55 Identities=5% Similarity=-0.110 Sum_probs=34.4
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
+.|...........+....+.. .+.++| |.+++.+|+|.|+|.|+|..+.....+
T Consensus 26 i~W~k~g~~l~~~~~~~~~~~~-~~~~~l~i~~~~~~D~G~Y~C~a~N~~G~~~~~~ 81 (85)
T cd05857 26 MRWLKNGKEFKQEHRIGGYKVR-NQHWSLIMESVVPSDKGNYTCVVENEYGSINHTY 81 (85)
T ss_pred EEEEECCEECCCCCceeeeEEe-CCceEEEEccCCcccCEEEEEEEEeCCCEEEEEE
Confidence 5666544443322222222222 233455 889999999999999999998866544
No 92
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=96.41 E-value=0.0051 Score=50.97 Aligned_cols=31 Identities=13% Similarity=-0.161 Sum_probs=25.3
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.+.| |.+++.+|+|.|+|.|+|..+....-.
T Consensus 39 ~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~ 70 (75)
T cd05763 39 DDVFFIVDVKIEDTGVYSCTAQNTAGSISANA 70 (75)
T ss_pred CCEEEEeeCCcccCEEEEEEEEcCCCEEEeeE
Confidence 3556 899999999999999999987655433
No 93
>KOG2739|consensus
Probab=96.38 E-value=0.002 Score=65.81 Aligned_cols=104 Identities=25% Similarity=0.295 Sum_probs=64.2
Q ss_pred CccccceeeccCCcccccccccccCCcccceecccCC--ccccccchhhhcccccccccCCCCccccccc-cchhccccc
Q psy8879 263 RLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLSCHHN--QIDVLEDHSFRALSTLSHLDLAHNRIVAVSG-ASLAHLSNL 339 (694)
Q Consensus 263 ~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~Ls~N--~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~-~~f~~l~~L 339 (694)
....|+.|.+.+..++.+. .|..+++|++|.++.| ++..--......+++|++|++++|+|..+.. ..+..+.+|
T Consensus 41 ~~~~le~ls~~n~gltt~~--~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL 118 (260)
T KOG2739|consen 41 EFVELELLSVINVGLTTLT--NFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENL 118 (260)
T ss_pred cccchhhhhhhccceeecc--cCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcch
Confidence 3445666666666666553 4567788888888888 4332112223445888888888888775321 224566777
Q ss_pred CeeecCCCCCCCcCh---hhhCCCCCCCEEEc
Q psy8879 340 TTLDLSHNFLRALTQ---DLITPLKSLQELRL 368 (694)
Q Consensus 340 ~~L~Ls~N~L~~l~~---~~~~~l~~L~~L~L 368 (694)
..|++.+|..+.+.. ..|.-+++|+.||-
T Consensus 119 ~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD~ 150 (260)
T KOG2739|consen 119 KSLDLFNCSVTNLDDYREKVFLLLPSLKYLDG 150 (260)
T ss_pred hhhhcccCCccccccHHHHHHHHhhhhccccc
Confidence 788888887666442 34455666666643
No 94
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=96.34 E-value=0.0083 Score=52.63 Aligned_cols=30 Identities=10% Similarity=0.007 Sum_probs=26.1
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
++| |.+|+.+|+|.|+|.|+|.++.+.+.+
T Consensus 64 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~ 94 (98)
T cd05870 64 SSLHIKDVKLSDSGRYDCEAASRIGGHQKSM 94 (98)
T ss_pred eEEEEeeCCcCCCEEEEEEEeccCCcceeEE
Confidence 466 999999999999999999999876644
No 95
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=96.33 E-value=0.0063 Score=51.56 Aligned_cols=38 Identities=8% Similarity=0.015 Sum_probs=29.6
Q ss_pred eEEecccEE-EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 465 ANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 465 ~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
..+..+++| |.+++..|+|.|+|.++|.++......++
T Consensus 45 ~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~ 83 (86)
T cd05724 45 VRIVDDGNLLIAEARKSDEGTYKCVATNMVGERESAAAR 83 (86)
T ss_pred EEEccCCEEEEeECCcccCEEEEEEEEeccCceeeeeEE
Confidence 344446778 99999999999999999998876554433
No 96
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=96.31 E-value=0.0059 Score=53.55 Aligned_cols=58 Identities=17% Similarity=0.170 Sum_probs=41.7
Q ss_pred cceeeeeceeE--------EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCC-cceeEEEEEeee
Q psy8879 434 DQSALVLGCSE--------ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNY-DPNCLLTITLYI 495 (694)
Q Consensus 434 ~~~~~~l~c~~--------i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G-~YtC~~~n~~~~ 495 (694)
++-...|.|.. +.|........ ..+.|+.+..+|.| |.+|+.+|.| .|+|.|+|.+-.
T Consensus 17 eG~~~~L~C~pP~g~P~P~i~W~~~~~~~i----~~~~Ri~~~~~GnL~fs~v~~~D~g~~Y~C~a~~~~~~ 84 (95)
T cd05845 17 EGDSVVLPCNPPKSAVPLRIYWMNSDLLHI----TQDERVSMGQNGNLYFANVEEQDSHPDYICHAHFPGLR 84 (95)
T ss_pred cCCCEEEEecCCCCCCCCEEEEECCCCccc----cccccEEECCCceEEEEEEehhhCCCCeEEEEEccccc
Confidence 34445566752 77775432222 13678899999999 9999999999 799999998633
No 97
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=96.25 E-value=0.0054 Score=52.08 Aligned_cols=32 Identities=13% Similarity=-0.079 Sum_probs=26.8
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
.+.| |.+++..|+|.|+|+|+|..+++..-++
T Consensus 45 ~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~ 77 (81)
T cd04971 45 HGCLQFDNPTHVNNGNYTLVASNEYGQDSKSIS 77 (81)
T ss_pred EEEEEECCCCcccCeEEEEEEEeCCCCeeeEEE
Confidence 3456 8999999999999999999988776554
No 98
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=96.19 E-value=0.01 Score=51.25 Aligned_cols=29 Identities=10% Similarity=-0.011 Sum_probs=24.6
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
+.| |.+|+..|+|.|+|+|+|..+.....
T Consensus 55 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~s 84 (90)
T cd04974 55 EVLYLRNVSFDDAGEYTCLAGNSIGPSHHS 84 (90)
T ss_pred ceEEEeccccccCcEEEEEeecccCcccCC
Confidence 345 99999999999999999999876553
No 99
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=96.14 E-value=0.007 Score=52.43 Aligned_cols=30 Identities=3% Similarity=-0.242 Sum_probs=25.6
Q ss_pred EE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
+| |.+++..|+|.|+|.++|..+.+...+.
T Consensus 59 ~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 89 (92)
T cd05737 59 SLTIKGVSSEDSGKYGIVVKNKYGGETVDVT 89 (92)
T ss_pred EEEEccCChhhCEEEEEEEEECCCcceEEEE
Confidence 55 9999999999999999998887766544
No 100
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=96.12 E-value=0.0067 Score=52.72 Aligned_cols=55 Identities=2% Similarity=-0.194 Sum_probs=35.5
Q ss_pred EEEeccCccccccceeEeeeeEEec--ccEE-EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTG--LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~--~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
+.|...++......+ ....... .++| |.+++.+|+|.|+|.|+|..+.+..-+..
T Consensus 33 i~W~k~~~~~~~~~~---~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~v 90 (92)
T cd05891 33 VIWFKNDQDIELSEH---YSVKLEQGKYASLTIKGVTSEDSGKYSINVKNKYGGETVDVTV 90 (92)
T ss_pred EEEEECCEECCCCCC---EEEEEcCCCEEEEEECCCChhhCEEEEEEEEeCCCceeeEEEE
Confidence 667666554442221 1122222 2355 99999999999999999988887765543
No 101
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=96.12 E-value=0.0066 Score=51.37 Aligned_cols=57 Identities=9% Similarity=-0.113 Sum_probs=37.1
Q ss_pred EEEeccCccccccceeEeeee---EEecccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRA---NVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~---n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
+.|........+..++..... +....++| |.+++..|+|.|+|.|+|..+.+.+-+.
T Consensus 15 i~W~kng~~l~~~~~~~~~~~~~~~~~~~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~ 75 (79)
T cd05855 15 LQWFHEGAILNESEYICTKIHVINNTEYHGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVS 75 (79)
T ss_pred eEEEECCEECCCCcceeeeeEeecccceEEEEEECCCCcccCEEEEEEEEcCCcccceEEE
Confidence 566666655543332211111 11234566 9999999999999999999998776554
No 102
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=96.09 E-value=0.008 Score=51.76 Aligned_cols=61 Identities=10% Similarity=-0.070 Sum_probs=39.7
Q ss_pred cceeeeeceeE-------EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 434 DQSALVLGCSE-------ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 434 ~~~~~~l~c~~-------i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
++....+.|.+ +.|.......... .++... .+.| |.+++..|+|.|+|.|+|.++.+....
T Consensus 15 ~G~~v~l~C~~~G~P~P~v~W~k~~~~~~~~-----~~~~~~-~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~ 83 (88)
T cd05851 15 KGQNVTLECFALGNPVPVIRWRKILEPMPAT-----AEISMS-GAVLKIFNIQPEDEGTYECEAENIKGKDKHQA 83 (88)
T ss_pred CCCcEEEEEEecccCCCEEEEEECCcCCCCC-----CEEecC-CCEEEECcCChhhCEEEEEEEEcCCCceEEEE
Confidence 33445566766 5666654433211 122232 3455 999999999999999999998866544
No 103
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=96.07 E-value=0.0066 Score=50.42 Aligned_cols=30 Identities=17% Similarity=0.127 Sum_probs=25.4
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
.++| |.+++..|+|.|+|.|+|..+.++..
T Consensus 43 ~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~ 73 (76)
T cd05895 43 SSELQISKASLADNGEYKCMVSSKLGNDSVT 73 (76)
T ss_pred EEEEEECcCCcccCEEEEEEEEeCCCceeEE
Confidence 3555 99999999999999999999776554
No 104
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=96.05 E-value=0.008 Score=49.68 Aligned_cols=33 Identities=15% Similarity=-0.163 Sum_probs=26.7
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
..+.| |.+|+..|+|.|+|.|+|..+....-+.
T Consensus 39 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 72 (76)
T cd04978 39 DGGTLILSNVQPNDTAVYQCNASNVHGYLLANAF 72 (76)
T ss_pred cCCEEEECCCChhhCEEEEEEEEccCCeEEEeEE
Confidence 34666 9999999999999999999877655443
No 105
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=96.02 E-value=0.0075 Score=52.39 Aligned_cols=28 Identities=11% Similarity=-0.127 Sum_probs=24.4
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
++| |.+|+..|+|.|+|.|+|.++...+
T Consensus 55 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~S 83 (91)
T cd05740 55 RTLTFNNVTRSDTGHYQCEASNEVSNMTS 83 (91)
T ss_pred CEEEECcCChhhCEEEEEEEEcCCCCEEe
Confidence 466 9999999999999999999986544
No 106
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=95.99 E-value=0.0098 Score=51.28 Aligned_cols=29 Identities=14% Similarity=0.072 Sum_probs=24.6
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
++| |.+|+.+|+|.|+|+|+|.++....-
T Consensus 55 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~ 84 (90)
T cd05858 55 EVLYLRNVTFEDAGEYTCLAGNSIGISHHS 84 (90)
T ss_pred eEEEEccCCHHHCEEEEEEEEeCCCcccce
Confidence 456 99999999999999999999865443
No 107
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=95.97 E-value=0.007 Score=49.23 Aligned_cols=32 Identities=16% Similarity=-0.017 Sum_probs=26.2
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
.++| |.+|+..|+|.|+|.|+|..+.....+.
T Consensus 35 ~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 67 (71)
T cd05731 35 NKTLKIDNVSEEDDGEYRCTASNSLGSARHTIS 67 (71)
T ss_pred CCEEEECCCCHHHCEEEEEEEEeCCceEEEEEE
Confidence 3566 9999999999999999999887655443
No 108
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=95.91 E-value=0.0099 Score=49.44 Aligned_cols=31 Identities=13% Similarity=-0.213 Sum_probs=25.8
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.++| |.+++..|+|.|+|.++|..+......
T Consensus 40 ~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 71 (76)
T cd05867 40 SGALILTDVQPSDTAVYQCEARNRHGNLLANA 71 (76)
T ss_pred CCEEEECCCChhhCEEEEEEEECCCCeEEEEE
Confidence 4666 999999999999999999887765443
No 109
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=95.85 E-value=0.014 Score=50.05 Aligned_cols=31 Identities=6% Similarity=-0.211 Sum_probs=26.7
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
++| |.+++..|+|.|+|.|+|..+.+..-+.
T Consensus 52 ~~L~I~~~~~~D~G~Y~c~a~N~~G~~~~~~~ 83 (86)
T cd05894 52 SSFVIEGAEREDEGVYTITVTNPVGEDHASLF 83 (86)
T ss_pred EEEEECCCccCcCEEEEEEEEeCCCcEEEEEE
Confidence 456 9999999999999999999998776554
No 110
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=95.80 E-value=0.015 Score=50.05 Aligned_cols=31 Identities=6% Similarity=-0.049 Sum_probs=26.2
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.++| |.+++..|.|.|+|+|+|..++....+
T Consensus 55 ~~~L~I~~v~~~D~g~Y~C~A~N~~G~~~~~~ 86 (90)
T cd04972 55 IYNLQLSNITSETQTTVTCTAENPVGQANVSV 86 (90)
T ss_pred EEEEEEecCCcccCEEEEEEEECCCCceeEEE
Confidence 3456 999999999999999999998866654
No 111
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=95.78 E-value=0.012 Score=49.89 Aligned_cols=29 Identities=10% Similarity=-0.016 Sum_probs=24.6
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
++| |.+|+.+|+|.|+|.|+|.+.+..+.
T Consensus 49 s~L~I~~v~~~DsG~Y~C~a~n~~~~~~~s 78 (84)
T cd05742 49 STLTIPNATLKDSGTYTCAASSGTMDQKES 78 (84)
T ss_pred EEEEECCCChhhCEEEEEEEccCCCceEEE
Confidence 456 99999999999999999998765543
No 112
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=95.77 E-value=0.013 Score=48.96 Aligned_cols=35 Identities=14% Similarity=-0.062 Sum_probs=28.5
Q ss_pred EEecccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 466 NVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 466 n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.+.+.++| |.+++.+|+|.|+|.++|.++....-+
T Consensus 42 ~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 77 (81)
T cd05765 42 VVTNIGQLVIYNAQPQDAGLYTCTARNSGGLLRANF 77 (81)
T ss_pred EEccccEEEEccCCcccCEEEEEEEecCCceEEEEE
Confidence 44455777 999999999999999999988765544
No 113
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=95.76 E-value=0.012 Score=48.85 Aligned_cols=31 Identities=13% Similarity=0.079 Sum_probs=27.0
Q ss_pred EE-EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
+| |.+++..|.|.|+|.++|..+.++..++.
T Consensus 40 ~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 71 (76)
T cd05736 40 ELHISNVRYEDTGAYTCIAKNEAGVDEDISSL 71 (76)
T ss_pred EEEECcCCcccCEEEEEEEEcCCCCcceEEEE
Confidence 45 99999999999999999999888876654
No 114
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=95.71 E-value=0.014 Score=50.53 Aligned_cols=30 Identities=10% Similarity=-0.113 Sum_probs=25.1
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
.++| |.+++.+|+|.|+|+++|..+.....
T Consensus 58 ~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~ 88 (92)
T cd05747 58 KSTFEISKVQMSDEGNYTVVVENSEGKQEAQ 88 (92)
T ss_pred eeEEEECCCCcccCEeEEEEEEcCCCCEeEE
Confidence 3566 99999999999999999988776554
No 115
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=95.69 E-value=0.012 Score=49.39 Aligned_cols=30 Identities=10% Similarity=-0.134 Sum_probs=24.5
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
++| |.+++..|+|.|+|+++|..+.+...+
T Consensus 45 ~~L~I~~~~~~DsG~Y~C~a~n~~g~~~~~~ 75 (79)
T cd04973 45 EEVQIKDAVPRDSGLYACVTSSPSGSDTTYF 75 (79)
T ss_pred CEEEECCCChhhCEEEEEEEeCCCCcccEEE
Confidence 455 999999999999999999876654443
No 116
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=95.69 E-value=0.018 Score=49.38 Aligned_cols=29 Identities=17% Similarity=0.040 Sum_probs=23.9
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
++| |.+++.+|+|.|+|.++|........
T Consensus 50 s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~ 79 (86)
T cd05862 50 STLTIENVTLSDLGRYTCTASSGQMIAKNS 79 (86)
T ss_pred eEEEEecCCcccCEEEEEEEeecceEeccc
Confidence 566 89999999999999999976655443
No 117
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=95.69 E-value=0.011 Score=49.28 Aligned_cols=34 Identities=12% Similarity=-0.161 Sum_probs=27.2
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeEEee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
++| +.+++..|+|.|+|.|+|..+...+.....+
T Consensus 41 ~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 75 (76)
T cd05868 41 DTIIFSKVQERSSAVYQCNASNEYGYLLANAFVNV 75 (76)
T ss_pred CEEEECCCCHhhCEEEEEEEEcCCCEEEEEEEEEe
Confidence 455 8899999999999999999887766555443
No 118
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=95.63 E-value=0.025 Score=47.29 Aligned_cols=27 Identities=7% Similarity=-0.310 Sum_probs=23.5
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeec
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYID 496 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~ 496 (694)
.++| |.+++.+|+|.|+|.|+|..+..
T Consensus 37 ~~~L~I~~~~~~D~G~Y~C~a~N~~G~~ 64 (77)
T cd05760 37 ERTLTLRSAGPDDSGLYYCCAHNAFGSV 64 (77)
T ss_pred CCEEEEeeCCcccCEEEEEEEEeCCCeE
Confidence 4566 99999999999999999987764
No 119
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=95.60 E-value=0.03 Score=49.08 Aligned_cols=31 Identities=13% Similarity=-0.045 Sum_probs=24.0
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
+++| |.+|+.+|+|.|+|.+.. .+..+..++
T Consensus 61 ~~~L~I~nV~~~D~G~YtC~~~t--~~~~~~~~~ 92 (95)
T cd05882 61 ELIISISNVQLSDEGEYTCSIFT--MPVRTAKAT 92 (95)
T ss_pred eEEEEECCCCcccCEEEEEEEEe--eccccEEEE
Confidence 4566 999999999999999988 444444443
No 120
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=95.58 E-value=0.02 Score=48.95 Aligned_cols=30 Identities=10% Similarity=-0.095 Sum_probs=25.5
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
..++| |.+|+.+|+|.|+|.+.|.++....
T Consensus 51 ~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~ 81 (88)
T cd04968 51 SGAVLKIPNIQFEDEGTYECEAENIKGKDTH 81 (88)
T ss_pred eCCEEEECCCCcccCEEEEEEEEECCCcEEE
Confidence 45676 9999999999999999998887543
No 121
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=95.57 E-value=0.016 Score=47.78 Aligned_cols=54 Identities=6% Similarity=-0.183 Sum_probs=35.2
Q ss_pred EEEeccCccccccceeEeeeeEEe-cccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVT-GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~-~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
+.|...........+ ..+... ..++| |.+++.+|+|.|+|.|+|..+.+...+.
T Consensus 16 v~W~k~g~~l~~~~~---~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 71 (74)
T cd05748 16 VTWSKDGKPLKLSGR---VQIETTASSTSLVIKNAERSDSGKYTLTLKNPAGEKSATIN 71 (74)
T ss_pred EEEEECCEEcCCCCe---EEEEECCCeEEEEECCCCcCcCEEEEEEEECCCccEEEEEE
Confidence 667665554432221 122222 23456 9999999999999999999887766544
No 122
>KOG3513|consensus
Probab=95.55 E-value=0.013 Score=70.27 Aligned_cols=66 Identities=14% Similarity=0.034 Sum_probs=51.9
Q ss_pred eeeeeceeE-------EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccceeEEeecc
Q psy8879 436 SALVLGCSE-------ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKNTN 506 (694)
Q Consensus 436 ~~~~l~c~~-------i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~~ 506 (694)
....+.|.. +.|+...+. .....|+.+..+|+| |.+++-+|+|.|||.|+|..+.+..-.+....+
T Consensus 442 ~~v~i~C~~~asP~p~~~W~k~~~~-----~~~~~r~~i~edGtL~I~n~t~~DaG~YtC~A~N~~G~a~~~~~L~Vkd 515 (1051)
T KOG3513|consen 442 GTVTIDCKPFASPKPKVSWLKGGEK-----LLQSGRIRILEDGTLEISNVTRSDAGKYTCVAENKLGKAESTGNLIVKD 515 (1051)
T ss_pred CeEEEeeccCCCCcceEEEEcCCcc-----cccCceEEECCCCcEEecccCcccCcEEEEEEEcccCccceEEEEEEec
Confidence 445667755 667776653 446788899999999 999999999999999999998887766555443
No 123
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=95.54 E-value=0.021 Score=50.21 Aligned_cols=35 Identities=6% Similarity=-0.337 Sum_probs=28.3
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeEEee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
.+.| |.+++..|+|.|+|.|+|..+.+...+....
T Consensus 55 ~s~L~I~~~~~~D~G~Ytc~a~N~~G~~~~~~~l~V 90 (98)
T cd05762 55 SSKLTITEGQQEHCGCYTLEVENKLGSRQAQVNLTV 90 (98)
T ss_pred eeEEEECCCChhhCEEEEEEEEcCCCceeEEEEEEE
Confidence 4555 9999999999999999999988776554433
No 124
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=95.50 E-value=0.013 Score=48.27 Aligned_cols=33 Identities=9% Similarity=-0.236 Sum_probs=26.6
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
.++| |.+++..|+|.|+|.++|..+...+.+..
T Consensus 34 ~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~ 67 (71)
T cd04976 34 GHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTF 67 (71)
T ss_pred CCEEEECcCCHHHCEEEEEEEEcCCccEEEEEEE
Confidence 4566 99999999999999999988766554443
No 125
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=95.46 E-value=0.016 Score=50.30 Aligned_cols=33 Identities=12% Similarity=0.035 Sum_probs=27.3
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeEEe
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQK 503 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~ 503 (694)
++| |.+++..|+|.|+|.|+|.++.....+...
T Consensus 58 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~ 91 (95)
T cd05730 58 SEMTILDVDKLDEAEYTCIAENKAGEQEAEIHLK 91 (95)
T ss_pred CEEEECCCChhhCEEEEEEEEcCCCeEEEEEEEE
Confidence 345 899999999999999999999876655544
No 126
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=95.40 E-value=0.019 Score=50.95 Aligned_cols=31 Identities=6% Similarity=-0.185 Sum_probs=26.2
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
++| |..|+.+|+|.|||+|+|..+.+...+.
T Consensus 65 ~~L~i~~v~~~D~G~Ytc~A~N~~G~~~~t~~ 96 (101)
T cd04975 65 SELKLVRLKESEAGTYTFLASNSDASKSLTFE 96 (101)
T ss_pred EEEEEeecCHhhCeeEEEEEECCCccEEEEEE
Confidence 556 9999999999999999999987665443
No 127
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=95.40 E-value=0.012 Score=48.57 Aligned_cols=30 Identities=10% Similarity=-0.156 Sum_probs=25.2
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
.+.| |.+++.+|+|.|+|.|+|.++..+..
T Consensus 33 ~~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~ 63 (70)
T cd05864 33 GVHLTIYEVTEKDAGNYTVVLTNPITKEEQR 63 (70)
T ss_pred CCEEEECcCCHHHCEEEEEEEEECCCceeeE
Confidence 4456 89999999999999999999876543
No 128
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=95.37 E-value=0.022 Score=46.83 Aligned_cols=31 Identities=13% Similarity=0.009 Sum_probs=25.7
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.++| |.+++..|.|.|+|.|+|.++.+...+
T Consensus 42 ~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~ 73 (75)
T cd05750 42 NSELQINKAKLADSGEYTCVVENILGNDTVTA 73 (75)
T ss_pred eEEEEEccCCcccCeEEEEEEEEcCCceeEEE
Confidence 3455 999999999999999999998765543
No 129
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=95.35 E-value=0.0075 Score=49.30 Aligned_cols=31 Identities=10% Similarity=-0.261 Sum_probs=25.9
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
++| |.++..+|+|.|+|.|+|..+..+.-+.
T Consensus 31 ~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~ 62 (67)
T cd05863 31 HSLQIKDVTEASAGTYTLVLWNSAAGLEKRIS 62 (67)
T ss_pred CEEEECCCCHHHCEEEEEEEEECCccEEEEEE
Confidence 455 9999999999999999999987655444
No 130
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=95.33 E-value=0.021 Score=47.70 Aligned_cols=31 Identities=6% Similarity=-0.184 Sum_probs=25.4
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
.++| |.+++..|+|.|+|.++|..+.....+
T Consensus 47 ~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~ 78 (82)
T cd05856 47 KWTLSLKNLKPEDSGKYTCHVSNRAGEINATY 78 (82)
T ss_pred eEEEEEccCChhhCEEEEEEEEcCCccEEEEE
Confidence 3556 899999999999999999988655443
No 131
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=95.25 E-value=0.027 Score=49.13 Aligned_cols=38 Identities=11% Similarity=-0.095 Sum_probs=27.4
Q ss_pred eEEecccEE-EEEEE-ecCCCcceeEEEEEeeeccceeEEe
Q psy8879 465 ANVTGLGTV-QVYVQ-LWTNYDPNCLLTITLYIDGDVIVQK 503 (694)
Q Consensus 465 ~n~~~~gtL-~~~v~-~~d~G~YtC~~~n~~~~~~~~~~~~ 503 (694)
..+.+ |.| |.++. ..|+|.|+|.|+|.++...+..++.
T Consensus 53 ~~~~~-g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~s~~a~l 92 (94)
T cd05850 53 YTLVA-GNLVINNPQKARDAGSYQCLAINRCGTVVSREANL 92 (94)
T ss_pred EEEEC-CeEEEccCCccCcCEEEEEEEEcCcCcEEEEEEEE
Confidence 33443 555 66755 6999999999999999876655443
No 132
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=95.21 E-value=0.026 Score=48.74 Aligned_cols=49 Identities=12% Similarity=0.012 Sum_probs=32.6
Q ss_pred EEEeccCccccccceeEeeeeEEecccEEEEEEEecCCCcceeEEEEE----eeecc
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTVQVYVQLWTNYDPNCLLTIT----LYIDG 497 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL~~~v~~~d~G~YtC~~~n~----~~~~~ 497 (694)
+.|........... .+..+.+.+.+|.+|+.+|+|.|+|.+.+- .|...
T Consensus 27 i~W~~ng~~i~~~~----~r~~~~~~~L~I~nv~~~DsG~Y~C~a~e~~~~~~~~~~ 79 (87)
T cd05873 27 VVWKFDGKVLTPES----AKYLLYRDGLLIFNASEADAGRYQCLSVEKSKAKLFTQT 79 (87)
T ss_pred EEEEECCEECCCCC----ceEEEECCcEEEeCCCHHHCEEEEEEEEecccCceeEeE
Confidence 55555544443221 234455555559999999999999999987 66543
No 133
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=95.16 E-value=0.029 Score=48.91 Aligned_cols=60 Identities=8% Similarity=-0.054 Sum_probs=37.1
Q ss_pred eeeceeE-------EEEeccCccccccceeEeeeeEEecccEE-EEEEE-ecCCCcceeEEEEEeeeccceeEE
Q psy8879 438 LVLGCSE-------ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQ-LWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 438 ~~l~c~~-------i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~-~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
..+.|.+ +.|...+....... .+..+. .|.| |.++. ..|+|.|+|.|+|.++.....-++
T Consensus 22 v~l~C~a~G~P~P~i~W~k~~~~i~~~~----~~~~~~-~g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~s~~a~ 90 (93)
T cd05849 22 VSVNCRARANPFPIYKWRKNNLDIDLTN----DRYSMV-GGNLVINNPDKYKDAGRYVCIVSNIYGKVRSREAT 90 (93)
T ss_pred EEEeCcCccCCCCEEEEEECCEEccCCC----CeEEEE-CCEEEECcCCcCCCCEEEEEEEEeCcceEEEccEE
Confidence 5566665 66655443332111 123333 4666 77774 689999999999998876554433
No 134
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=95.04 E-value=0.03 Score=47.68 Aligned_cols=55 Identities=5% Similarity=-0.098 Sum_probs=34.3
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
+.|...........+ ....... ...+| |.+|+.+|+|.|+|.|+|..+....-+.
T Consensus 32 v~W~~~~~~l~~~~~-~~~~~~~-~~~~L~I~~v~~~D~G~Y~C~~~n~~g~~~~~~~ 87 (90)
T PF07679_consen 32 VTWYKNGRPLTSSQR-YQIESDG-GSSSLTIKNVTREDAGTYTCVASNSSGEATASVN 87 (90)
T ss_dssp EEEEETTEEEESSSS-EEEEEET-TEEEEEESSESGGGSEEEEEEEEETTEEEEEEEE
T ss_pred ccccccccceeeeee-eeeeccc-ceeEEccCCCChhhCEEEEEEEEECCCEEEEEEE
Confidence 666666444442111 1111111 34455 9999999999999999998776655443
No 135
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=95.02 E-value=0.024 Score=47.40 Aligned_cols=27 Identities=19% Similarity=-0.037 Sum_probs=22.9
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeec
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYID 496 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~ 496 (694)
.++| |.+++..|+|.|+|.++|..+..
T Consensus 41 ~~~L~I~~v~~~D~G~Y~C~a~N~~G~~ 68 (78)
T cd05743 41 YGTLTIRDVKESDQGAYTCEAINTRGMV 68 (78)
T ss_pred EEEEEECCCChHHCEEEEEEEEecCCEE
Confidence 3567 88999999999999999976643
No 136
>KOG1947|consensus
Probab=94.99 E-value=0.0082 Score=67.48 Aligned_cols=109 Identities=26% Similarity=0.182 Sum_probs=51.5
Q ss_pred CCccEEEccCC-CCCCCC-ccccccCCCCccEEEccCC--CCCCCC---cccccCCCCccEEEecCCC-CCCCCccccCC
Q psy8879 143 SPLQALGLPNN-LLSVVP-TSALAPLAPNLDRLDLSHN--QLYKLE---NTSFKGLSSLNFLDLSYNK-LMTLSQDCLAP 214 (694)
Q Consensus 143 ~~L~~L~Ls~N-~L~~lp-~~~~~~l~~~L~~L~Ls~N--~L~~i~---~~~f~~L~~L~~L~Ls~N~-l~~i~~~~f~~ 214 (694)
+.|+.|.+..+ .+.... ....... +.|+.|+++++ .+.... ......+.+|+.|+++.+. +++..-..+..
T Consensus 188 ~~L~~l~l~~~~~~~~~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~~ 266 (482)
T KOG1947|consen 188 PLLKRLSLSGCSKITDDSLDALALKC-PNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALAS 266 (482)
T ss_pred chhhHhhhcccccCChhhHHHHHhhC-chhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHHh
Confidence 34666666554 333311 1122233 56666666652 111111 1122344566666666655 44443333332
Q ss_pred -CCCCcEEeccCCc-ccchh-hhhhccCcccccccCCCCcC
Q psy8879 215 -LVTLRVLRLQGNR-LTVSV-VAALQGLRSVTDLDLSHNLL 252 (694)
Q Consensus 215 -L~~L~~L~Ls~N~-l~~~~-~~~~~~L~~L~~L~Ls~N~l 252 (694)
+++|++|.+.++. ++... ......+++|++|+++++..
T Consensus 267 ~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~~ 307 (482)
T KOG1947|consen 267 RCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCHG 307 (482)
T ss_pred hCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCcc
Confidence 5667776655555 33322 22233456677777765544
No 137
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=94.95 E-value=0.031 Score=47.94 Aligned_cols=51 Identities=16% Similarity=-0.074 Sum_probs=33.2
Q ss_pred EEEeccCccccccceeEeeeeEEecccEEEEEEEecCCCcceeEEEEEeeec
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTVQVYVQLWTNYDPNCLLTITLYID 496 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL~~~v~~~d~G~YtC~~~n~~~~~ 496 (694)
+.|........... ....+......+..|.+++.+|+|.|+|++++..++.
T Consensus 27 i~W~k~~~~~~~~~-~~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~~~~~~~ 77 (89)
T cd04979 27 VVWLFQGGPLQRKE-EPEERLLVTEDGLLIRSVSPADAGVYTCQSVEHGFKQ 77 (89)
T ss_pred EEEEECCccccccc-CcCceEEEcCCCEEEccCCHHHCEEEEEEEecCccce
Confidence 55655554333111 1123445555566699999999999999999987743
No 138
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=94.93 E-value=0.03 Score=49.68 Aligned_cols=54 Identities=13% Similarity=-0.147 Sum_probs=33.8
Q ss_pred EEEeccCcccccccee-EeeeeEE---ecccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 445 ILALVPTLTSQPLSYV-TSLRANV---TGLGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i-~~~~~n~---~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
+.|...+....+.... .....++ ...++| |..++.+|+|.|||.|+|..+....
T Consensus 35 v~W~kdg~~l~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~D~G~Ytc~A~N~~g~~~~ 93 (101)
T cd05859 35 IRWLKDNRTLIENLTEITTSEHNVQETRYVSKLKLIRAKEEDSGLYTALAQNEDAVKSY 93 (101)
T ss_pred eEEEECCEECcCCcceEEeccccccceeeccEEEEeeCCHHHCEEEEEEEEcCCceEEE
Confidence 6677766655533221 1111111 112456 9999999999999999999776543
No 139
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=94.92 E-value=0.046 Score=47.24 Aligned_cols=20 Identities=10% Similarity=-0.224 Sum_probs=17.6
Q ss_pred EecCCCcceeEEEEEeeecc
Q psy8879 478 QLWTNYDPNCLLTITLYIDG 497 (694)
Q Consensus 478 ~~~d~G~YtC~~~n~~~~~~ 497 (694)
+.+|+|.|+|.++|.++...
T Consensus 72 ~~~D~G~Y~C~a~N~~G~~~ 91 (100)
T cd07693 72 GRSDEGVYVCVAHNSLGEAV 91 (100)
T ss_pred CcCcCEEEEEEEEcccccee
Confidence 68899999999999998743
No 140
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=94.81 E-value=0.048 Score=47.34 Aligned_cols=52 Identities=13% Similarity=-0.126 Sum_probs=32.0
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEE-----EecCCCcceeEEEEE-eeeccce
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYV-----QLWTNYDPNCLLTIT-LYIDGDV 499 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v-----~~~d~G~YtC~~~n~-~~~~~~~ 499 (694)
+.|........... ..+.....+|++ +.++ +..|+|.|+|.|+|. .+...+.
T Consensus 31 i~W~k~g~~l~~~~---~~~~~~~~~~~l~i~~v~~~~~~~~D~G~Y~C~a~N~~~G~~~s~ 89 (95)
T cd05722 31 IEWKKDGVLLNLVS---DERRQQLPNGSLLITSVVHSKHNKPDEGFYQCVAQNDSLGSIVSR 89 (95)
T ss_pred EEEEECCeECcccc---CcceEEccCCeEEEeeeeccCCCCCcCEEEEEEEECCccCcEEEe
Confidence 56665444333111 122334556666 6666 478999999999999 7765443
No 141
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=94.75 E-value=0.041 Score=47.98 Aligned_cols=57 Identities=14% Similarity=0.083 Sum_probs=35.2
Q ss_pred eeeeceeE-------EEEeccCccccccceeEeeeeEEecccEE-EEEEE-ecCCCcceeEEEEEeeecc
Q psy8879 437 ALVLGCSE-------ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQ-LWTNYDPNCLLTITLYIDG 497 (694)
Q Consensus 437 ~~~l~c~~-------i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~-~~d~G~YtC~~~n~~~~~~ 497 (694)
...+.|.+ +.|........ ... ..+..+.+ |.| |.++. ..|+|.|+|.|+|.++...
T Consensus 21 ~v~l~C~~~G~P~P~i~W~k~g~~l~-~~~--~~~~~~~~-g~L~i~~~~~~~D~G~Y~C~A~N~~G~~~ 86 (94)
T cd05848 21 KVILNCEARGNPVPTYRWLRNGTEID-TES--DYRYSLID-GNLIISNPSEVKDSGRYQCLATNSIGSIL 86 (94)
T ss_pred EEEEEEEeeecCCCEEEEEECCeECc-cCC--CceEEeeC-CeEEEccCCccCcCEEEEEEEEcCCCeEE
Confidence 35566665 66665443332 111 12344444 555 77774 6899999999999998763
No 142
>KOG4341|consensus
Probab=94.74 E-value=0.0019 Score=69.78 Aligned_cols=133 Identities=20% Similarity=0.146 Sum_probs=63.8
Q ss_pred cCcccccccCCCCcCCCCCC-CCCCCCccccceeeccCCc-ccccccccc-cCCcccceecccCCcccccc--chhhhcc
Q psy8879 238 GLRSVTDLDLSHNLLAGPLG-PSTVPRLSSLKVLSIAHNQ-FSSVRRGAL-AGLDKLTSLSCHHNQIDVLE--DHSFRAL 312 (694)
Q Consensus 238 ~L~~L~~L~Ls~N~l~~~i~-p~~~~~l~~L~~L~Ls~N~-L~~i~~~~~-~~L~~L~~L~Ls~N~L~~i~--~~~f~~l 312 (694)
++..|+.|+.+++.-.+... ...-.+.++|+.|.++.++ ++..-...+ .+.+.|+.+++.......-. ...-.++
T Consensus 292 ~c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C 371 (483)
T KOG4341|consen 292 GCHALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNC 371 (483)
T ss_pred hhhHhhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCC
Confidence 34556666666554321100 0111334667777776664 222211111 24456777776666442111 0111245
Q ss_pred cccccccCCCCcccccc-----ccchhcccccCeeecCCCCCC-CcChhhhCCCCCCCEEEccC
Q psy8879 313 STLSHLDLAHNRIVAVS-----GASLAHLSNLTTLDLSHNFLR-ALTQDLITPLKSLQELRLDD 370 (694)
Q Consensus 313 ~~L~~L~Ls~N~L~~i~-----~~~f~~l~~L~~L~Ls~N~L~-~l~~~~~~~l~~L~~L~Ls~ 370 (694)
+.|+.|.|+++.+..-. ...-..+..|+.+.|++.... +-.-+.+..+++|+.+++-+
T Consensus 372 ~~lr~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~ 435 (483)
T KOG4341|consen 372 PRLRVLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELID 435 (483)
T ss_pred chhccCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeec
Confidence 66777777766532211 111124456667777776543 22334455566677666654
No 143
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=94.65 E-value=0.03 Score=46.49 Aligned_cols=28 Identities=18% Similarity=-0.198 Sum_probs=22.9
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
++| |.+|+.+|+|.|+|.++|..+...+
T Consensus 36 ~~L~I~~v~~~D~G~YtC~a~~~~~~~~~ 64 (72)
T cd07702 36 YSLVIKDVTEEDAGIYTILLGIKQYNLFK 64 (72)
T ss_pred CEEEECcCCHHHCEEEEEEEEccccceEe
Confidence 456 9999999999999999997554433
No 144
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=94.53 E-value=0.067 Score=45.55 Aligned_cols=24 Identities=8% Similarity=-0.067 Sum_probs=21.2
Q ss_pred cEE-EEEEEecCCCcceeEEEEEee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLY 494 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~ 494 (694)
.+| |.+++..|+|.|+|.++|...
T Consensus 46 s~L~I~~~~~~DsG~Y~C~a~n~~~ 70 (84)
T cd05861 46 STLTFPHATVEDSGTYECAAHESTQ 70 (84)
T ss_pred EEEEECCCCcCCCEEEEEEEEECcc
Confidence 456 999999999999999999765
No 145
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=94.51 E-value=0.049 Score=45.59 Aligned_cols=32 Identities=9% Similarity=-0.175 Sum_probs=22.9
Q ss_pred ecccEE-EEEEEe----cCCCcceeEEEEEeeeccce
Q psy8879 468 TGLGTV-QVYVQL----WTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 468 ~~~gtL-~~~v~~----~d~G~YtC~~~n~~~~~~~~ 499 (694)
.++|+| |..+.. .|+|+|+|.|+|.++...+.
T Consensus 36 ~~~g~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05874 36 PNTGTLVINIMNGEKAEAYEGVYQCTARNERGAAVSN 72 (77)
T ss_pred CCCceEEEeccccCCCCCCCEEEEEEEEcCCCeEEee
Confidence 346777 444543 47899999999988875543
No 146
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=94.37 E-value=0.06 Score=48.18 Aligned_cols=41 Identities=12% Similarity=-0.142 Sum_probs=33.6
Q ss_pred ceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 458 SYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 458 ~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
+...+.|..+..+|+| |.+|+..|+|.|+|.+.+.-+..++
T Consensus 57 gp~~~gR~~~~~ngSL~I~~v~~~D~G~Y~~~v~~~~~~~~~ 98 (105)
T cd05774 57 GPAYSGRETIYPNGSLLIQNVTQKDTGFYTLQTITTNFQVEQ 98 (105)
T ss_pred CcccCCcEEEeCCCcEEEecCCcccCEEEEEEEEeCCccEEE
Confidence 3345678888989988 9999999999999999998755443
No 147
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=94.34 E-value=0.026 Score=44.82 Aligned_cols=45 Identities=9% Similarity=-0.057 Sum_probs=26.9
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLL 489 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~ 489 (694)
+.|...++.............+......| |.+|+..|+|.|+|+|
T Consensus 19 ~~W~~~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 19 VTWSKNGQSLPEGSTTNRSTNSVSSTSRLTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp EEEEETTTTTSEEEEEEEEETTTEEEEEEEESSCTGGGTEEEEEEE
T ss_pred EEEEECCccccCcceeEeecccceeeeEEEEccCCHHHCEEEEEEC
Confidence 67777776665222222111111111125 9999999999999987
No 148
>KOG4308|consensus
Probab=94.33 E-value=0.0023 Score=72.44 Aligned_cols=182 Identities=30% Similarity=0.290 Sum_probs=93.9
Q ss_pred ccEEEccCCCCCCCCc----ccccCCCCccEEEecCCCCCCCCcc----ccCCC-CCCcEEeccCCcccch----hhhhh
Q psy8879 170 LDRLDLSHNQLYKLEN----TSFKGLSSLNFLDLSYNKLMTLSQD----CLAPL-VTLRVLRLQGNRLTVS----VVAAL 236 (694)
Q Consensus 170 L~~L~Ls~N~L~~i~~----~~f~~L~~L~~L~Ls~N~l~~i~~~----~f~~L-~~L~~L~Ls~N~l~~~----~~~~~ 236 (694)
+..|.|.+|.+..-.. ..+..++.|+.|++++|.+.+.... .+... ..+++|++..|.++.. +...+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 4455555555543322 2334455666666666666532221 12222 4456666666666532 33445
Q ss_pred ccCcccccccCCCCcCCCC---CCCC----CCCCccccceeeccCCcccccc----cccccCCcc-cceecccCCccccc
Q psy8879 237 QGLRSVTDLDLSHNLLAGP---LGPS----TVPRLSSLKVLSIAHNQFSSVR----RGALAGLDK-LTSLSCHHNQIDVL 304 (694)
Q Consensus 237 ~~L~~L~~L~Ls~N~l~~~---i~p~----~~~~l~~L~~L~Ls~N~L~~i~----~~~~~~L~~-L~~L~Ls~N~L~~i 304 (694)
.....++.++++.|.+... ..+. .+....++++|.+++|.++... ...+...+. +.+|++..|++...
T Consensus 169 ~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~ 248 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDV 248 (478)
T ss_pred hcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchH
Confidence 5566677777777766310 0011 1223456677777777665321 122333344 55677777776533
Q ss_pred c----chhhhcc-cccccccCCCCcccccccc----chhcccccCeeecCCCCCCC
Q psy8879 305 E----DHSFRAL-STLSHLDLAHNRIVAVSGA----SLAHLSNLTTLDLSHNFLRA 351 (694)
Q Consensus 305 ~----~~~f~~l-~~L~~L~Ls~N~L~~i~~~----~f~~l~~L~~L~Ls~N~L~~ 351 (694)
. ...+..+ +.++.++++.|.|++-... .+..++.++.|.+++|.+..
T Consensus 249 g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L~~~l~~~~~l~~l~l~~n~l~~ 304 (478)
T KOG4308|consen 249 GVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDLAEVLVSCRQLEELSLSNNPLTD 304 (478)
T ss_pred HHHHHHHHhcccchhhhhhhhhcCCccccchHHHHHHHhhhHHHHHhhcccCcccc
Confidence 1 1122333 4557777777777654433 23345667777777777654
No 149
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=94.28 E-value=0.062 Score=45.71 Aligned_cols=29 Identities=10% Similarity=-0.088 Sum_probs=24.2
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
.+.| |.+++..|+|.|+|.|+|..+....
T Consensus 50 ~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~ 79 (85)
T cd05728 50 AGDLRITKLSLSDSGMYQCVAENKHGTIYA 79 (85)
T ss_pred CCEEEEeeCCHHHCEEEEEEEECCCCeEEE
Confidence 3456 9999999999999999998876544
No 150
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=94.20 E-value=0.096 Score=47.01 Aligned_cols=34 Identities=15% Similarity=-0.044 Sum_probs=27.2
Q ss_pred cEE-EEEEE-ecCCCcceeEEEEEeeeccceeEEee
Q psy8879 471 GTV-QVYVQ-LWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 471 gtL-~~~v~-~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
++| |.+++ .+|.|.|+|.|+|.++.+...+...+
T Consensus 69 s~L~I~~v~~~~D~G~Y~C~A~N~~G~~~~~i~L~~ 104 (109)
T cd05773 69 SILTIINVSAALDYALFTCTAHNSLGEDSLDIQLVS 104 (109)
T ss_pred eEEEECcCCccCCCEEEEEEEEeCCccCcEEEEEEe
Confidence 456 77887 58999999999999999876665544
No 151
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=94.13 E-value=0.04 Score=48.12 Aligned_cols=31 Identities=13% Similarity=-0.003 Sum_probs=26.5
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
+++| |.+++.+|+|.|+|.++|..+.+...+
T Consensus 59 ~~~L~I~~~~~~DsG~Y~C~~~N~~g~~~~~~ 90 (94)
T cd05756 59 KDLLWFLPAALEDSGLYTCVVRNSTYCMKVSI 90 (94)
T ss_pred CCeEEEccCCcccCeEEEEEEcCCCccEEEEE
Confidence 4676 999999999999999999887766554
No 152
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=94.12 E-value=0.092 Score=42.93 Aligned_cols=27 Identities=7% Similarity=0.167 Sum_probs=20.9
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
+.| |.++ +|+|.|+|.|+|.++.....
T Consensus 38 ~~L~i~~~--~d~G~Y~C~A~N~~G~~~~~ 65 (69)
T cd05739 38 NVLELTNI--YESANYTCVAISSLGMIEAT 65 (69)
T ss_pred cEEEEecc--ccCeeEEEEEEeCCCEEEEE
Confidence 345 6665 58999999999999876544
No 153
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=93.91 E-value=0.11 Score=45.30 Aligned_cols=31 Identities=13% Similarity=-0.098 Sum_probs=23.4
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
++.+| |.+|+.+|+|.|+|.+.+ +......+
T Consensus 60 ~~~sL~I~~v~~~DsG~Y~C~~~t--~~~~~~~~ 91 (95)
T cd07701 60 HELSISISDVSLSDEGQYTCSLFT--MPVKTSKA 91 (95)
T ss_pred CcEEEEECcCCcccCEEEEEEeEe--ecCccEEE
Confidence 34566 999999999999999997 34444433
No 154
>KOG1947|consensus
Probab=93.63 E-value=0.015 Score=65.32 Aligned_cols=110 Identities=25% Similarity=0.161 Sum_probs=52.4
Q ss_pred CCccEEEccCC-CCCCCC-cccccCCCCccEEEecCC-C-CCCCC---ccccCCCCCCcEEeccCCc-ccchhhhhhcc-
Q psy8879 168 PNLDRLDLSHN-QLYKLE-NTSFKGLSSLNFLDLSYN-K-LMTLS---QDCLAPLVTLRVLRLQGNR-LTVSVVAALQG- 238 (694)
Q Consensus 168 ~~L~~L~Ls~N-~L~~i~-~~~f~~L~~L~~L~Ls~N-~-l~~i~---~~~f~~L~~L~~L~Ls~N~-l~~~~~~~~~~- 238 (694)
+.|+.|.+..+ .+.... .......+.|+.|+++++ . +.... ......+++|+.|+++.+. ++...-..+..
T Consensus 188 ~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~~~ 267 (482)
T KOG1947|consen 188 PLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALASR 267 (482)
T ss_pred chhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHHhh
Confidence 56666666655 233211 123345667777777652 1 11111 1122334566677776665 44333333332
Q ss_pred CcccccccCCCCc-CCCCCCCCCCCCccccceeeccCCcc
Q psy8879 239 LRSVTDLDLSHNL-LAGPLGPSTVPRLSSLKVLSIAHNQF 277 (694)
Q Consensus 239 L~~L~~L~Ls~N~-l~~~i~p~~~~~l~~L~~L~Ls~N~L 277 (694)
+++|+.|.+.++. +++.--......+++|++|+++++..
T Consensus 268 c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~~ 307 (482)
T KOG1947|consen 268 CPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCHG 307 (482)
T ss_pred CCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCcc
Confidence 5666666655554 33211011223455666666665543
No 155
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=93.63 E-value=0.069 Score=44.53 Aligned_cols=32 Identities=13% Similarity=-0.058 Sum_probs=23.8
Q ss_pred ecccEE-EEEEE----ecCCCcceeEEEEEeeeccce
Q psy8879 468 TGLGTV-QVYVQ----LWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 468 ~~~gtL-~~~v~----~~d~G~YtC~~~n~~~~~~~~ 499 (694)
.+.|+| |.+++ .+|+|.|+|.|+|.++.+.+.
T Consensus 36 ~~~g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05733 36 PDSGTLVIDNMNGGRAEDYEGEYQCYASNELGTAISN 72 (77)
T ss_pred CCCCEEEEeccCCCCCcCCCEEEEEEEEcCCCcEEcc
Confidence 346777 55554 368999999999999876543
No 156
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=93.51 E-value=0.075 Score=46.29 Aligned_cols=25 Identities=20% Similarity=0.017 Sum_probs=21.7
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEe
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~ 493 (694)
..+.| |.+|+..|+|.|+|.++|..
T Consensus 50 ~~~~L~I~~v~~~DsG~YtC~~~n~~ 75 (92)
T cd05757 50 KGSKLLIQNVTEEDAGNYTCKLTFTH 75 (92)
T ss_pred cCCEEEEeeCChhhCEEEEEEEEecC
Confidence 55666 99999999999999999863
No 157
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=93.31 E-value=0.17 Score=42.20 Aligned_cols=25 Identities=8% Similarity=-0.128 Sum_probs=21.7
Q ss_pred EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 474 QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
|.+++..|.|.|+|.++|..+....
T Consensus 55 i~~~~~~d~g~Y~C~~~n~~g~~~~ 79 (85)
T cd05729 55 LESVVPSDSGKYTCIVENKYGSINH 79 (85)
T ss_pred EeECCcccCEEEEEEEEECCceEEE
Confidence 8899999999999999998766544
No 158
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=93.23 E-value=0.12 Score=45.24 Aligned_cols=30 Identities=17% Similarity=0.022 Sum_probs=25.3
Q ss_pred EE-EEEEEecC-CCcceeEEEEEeeeccceeE
Q psy8879 472 TV-QVYVQLWT-NYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 472 tL-~~~v~~~d-~G~YtC~~~n~~~~~~~~~~ 501 (694)
+| |.+|+.+| .|.|+|.|+|..+.+...+.
T Consensus 65 ~L~I~~v~~~d~~G~Y~C~A~N~~G~~~~~~~ 96 (98)
T cd05758 65 TLTISNTQESDFQTSYNCTAWNSFGSGTAIIS 96 (98)
T ss_pred EEEECCccccccceeEEEEEEcCCCcccEEEE
Confidence 55 88999855 89999999999999877654
No 159
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=93.12 E-value=0.098 Score=45.04 Aligned_cols=27 Identities=11% Similarity=-0.076 Sum_probs=21.6
Q ss_pred cEE-EEEEE-ecCCCcceeEEEEEeeecc
Q psy8879 471 GTV-QVYVQ-LWTNYDPNCLLTITLYIDG 497 (694)
Q Consensus 471 gtL-~~~v~-~~d~G~YtC~~~n~~~~~~ 497 (694)
+.| |.++. ..|+|.|+|.|+|.++...
T Consensus 58 ~~L~i~~~~~~~d~G~Y~C~a~N~~G~~~ 86 (91)
T cd04967 58 GNLVISNPSKAKDAGRYQCLASNIVGTVL 86 (91)
T ss_pred CEEEEecCCccCCCEEEEEEEEcCCCEEE
Confidence 455 77776 4899999999999988644
No 160
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=93.10 E-value=0.17 Score=43.95 Aligned_cols=33 Identities=15% Similarity=-0.064 Sum_probs=24.7
Q ss_pred eeeEEecccEEEEEEEecCCCcceeEEEEEeee
Q psy8879 463 LRANVTGLGTVQVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 463 ~~~n~~~~gtL~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
.+....+.+..|.+++..|+|+|+|.+++-.+.
T Consensus 46 ~r~~~~~~~L~I~~~~~~DsG~Y~C~a~~~~~~ 78 (91)
T cd05871 46 ERLIHTERGLLLRSLQRSDAGVYTCTAVEHSFS 78 (91)
T ss_pred ccEEEecCeEEEeeCChhHCEEEEEEEEccCCe
Confidence 344555445459999999999999999965444
No 161
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=93.02 E-value=0.23 Score=42.15 Aligned_cols=38 Identities=8% Similarity=-0.111 Sum_probs=30.7
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccceeEEeecc
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKNTN 506 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~~ 506 (694)
-.++| |..+...|.|.|+|.|.|..+..+..-.+.+|+
T Consensus 41 ~~s~L~~~~~~~Ddg~~~~C~A~n~a~~~~~~~~~~~l~ 79 (80)
T cd05885 41 VSNTIRFPVDRKDDGAILSCEASHPALVSQKKQTQYSLD 79 (80)
T ss_pred EEEEEEEEeeeccCCcEEEEEEEChhhCCCCeeEEEEEe
Confidence 34667 777777778889999999999988887777765
No 162
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=92.97 E-value=0.13 Score=41.41 Aligned_cols=28 Identities=18% Similarity=0.137 Sum_probs=21.7
Q ss_pred eeEEecccEE-EEEEEecCCCcceeEEEE
Q psy8879 464 RANVTGLGTV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 464 ~~n~~~~gtL-~~~v~~~d~G~YtC~~~n 491 (694)
+......++| +.+|+.+|.|.|+|+|+|
T Consensus 47 ~~~~~~~~~L~i~~v~~~~~g~y~C~a~N 75 (75)
T PF13927_consen 47 RGSSSSNSTLTISNVTRSDNGTYTCIASN 75 (75)
T ss_dssp EEEEEEEEEEEESSCCGGGTEEEEEEEEE
T ss_pred eeccceeeEEEEccCCHHhCcEEEEEEEC
Confidence 3344445566 778999999999999997
No 163
>KOG4341|consensus
Probab=92.90 E-value=0.013 Score=63.57 Aligned_cols=274 Identities=18% Similarity=0.086 Sum_probs=155.7
Q ss_pred CeeEEEcCCCC---CCCCCccccCCCCccEEEccCCC-CCCCCcchhcCCCCCccEEEccCC-CCCCCCccccccCCCCc
Q psy8879 96 RVSLLDCTLSN---VTVLPGKFLEGVTLHGLVISSGE-LKNISDGAFIGLSSPLQALGLPNN-LLSVVPTSALAPLAPNL 170 (694)
Q Consensus 96 ~L~~Ldls~n~---l~~lp~~~~~~~~L~~L~Ls~n~-i~~i~~~~F~~l~~~L~~L~Ls~N-~L~~lp~~~~~~l~~~L 170 (694)
.++.|.+.+.. ...+-..-...+++++|.+.++. +++..-..+......|++|+|..+ .++...-..+..-+++|
T Consensus 139 ~lk~LSlrG~r~v~~sslrt~~~~CpnIehL~l~gc~~iTd~s~~sla~~C~~l~~l~L~~c~~iT~~~Lk~la~gC~kL 218 (483)
T KOG4341|consen 139 FLKELSLRGCRAVGDSSLRTFASNCPNIEHLALYGCKKITDSSLLSLARYCRKLRHLNLHSCSSITDVSLKYLAEGCRKL 218 (483)
T ss_pred ccccccccccccCCcchhhHHhhhCCchhhhhhhcceeccHHHHHHHHHhcchhhhhhhcccchhHHHHHHHHHHhhhhH
Confidence 45555555433 23333444567888888887664 333333445556777999999884 45554333222223889
Q ss_pred cEEEccCC-CCCCCCc-ccccCCCCccEEEec--------------------------CC-CCCCCCc-cccCCCCCCcE
Q psy8879 171 DRLDLSHN-QLYKLEN-TSFKGLSSLNFLDLS--------------------------YN-KLMTLSQ-DCLAPLVTLRV 220 (694)
Q Consensus 171 ~~L~Ls~N-~L~~i~~-~~f~~L~~L~~L~Ls--------------------------~N-~l~~i~~-~~f~~L~~L~~ 220 (694)
++|+++.+ .|++-.. ..+.+...++.+.+. ++ .+++..- ..-..+..|+.
T Consensus 219 ~~lNlSwc~qi~~~gv~~~~rG~~~l~~~~~kGC~e~~le~l~~~~~~~~~i~~lnl~~c~~lTD~~~~~i~~~c~~lq~ 298 (483)
T KOG4341|consen 219 KYLNLSWCPQISGNGVQALQRGCKELEKLSLKGCLELELEALLKAAAYCLEILKLNLQHCNQLTDEDLWLIACGCHALQV 298 (483)
T ss_pred HHhhhccCchhhcCcchHHhccchhhhhhhhcccccccHHHHHHHhccChHhhccchhhhccccchHHHHHhhhhhHhhh
Confidence 99999877 3433110 112333333333333 32 1222221 11123457788
Q ss_pred EeccCCcc-cchhhhhh-ccCcccccccCCCCcCCCCCCCCCC-CCccccceeeccCCcccccc--cccccCCcccceec
Q psy8879 221 LRLQGNRL-TVSVVAAL-QGLRSVTDLDLSHNLLAGPLGPSTV-PRLSSLKVLSIAHNQFSSVR--RGALAGLDKLTSLS 295 (694)
Q Consensus 221 L~Ls~N~l-~~~~~~~~-~~L~~L~~L~Ls~N~l~~~i~p~~~-~~l~~L~~L~Ls~N~L~~i~--~~~~~~L~~L~~L~ 295 (694)
|..+++.. +.....++ .+..+|+.|.++.++.-+......+ .+++.|+.+++.++...... ...-.+++.|++|.
T Consensus 299 l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C~~lr~ls 378 (483)
T KOG4341|consen 299 LCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNCPRLRVLS 378 (483)
T ss_pred hcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCCchhccCC
Confidence 88776543 32333333 3568999999998874322212222 35688999999887654221 11224678999999
Q ss_pred ccCCcccccc-----chhhhcccccccccCCCCcccc-ccccchhcccccCeeecCCCCC-CC-cChhhhCCCCCCCEEE
Q psy8879 296 CHHNQIDVLE-----DHSFRALSTLSHLDLAHNRIVA-VSGASLAHLSNLTTLDLSHNFL-RA-LTQDLITPLKSLQELR 367 (694)
Q Consensus 296 Ls~N~L~~i~-----~~~f~~l~~L~~L~Ls~N~L~~-i~~~~f~~l~~L~~L~Ls~N~L-~~-l~~~~~~~l~~L~~L~ 367 (694)
|+++.+-.-. ...-..+..|+.+.|+++.... ..-+.+..+++|+.++|-+.+- +. -....-..++++++..
T Consensus 379 lshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q~vtk~~i~~~~~~lp~i~v~a 458 (483)
T KOG4341|consen 379 LSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQDVTKEAISRFATHLPNIKVHA 458 (483)
T ss_pred hhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechhhhhhhhhHHHHhhCccceehh
Confidence 9988543221 1222456789999999998643 3334567789999999888753 22 2222334577777665
Q ss_pred cc
Q psy8879 368 LD 369 (694)
Q Consensus 368 Ls 369 (694)
+-
T Consensus 459 ~~ 460 (483)
T KOG4341|consen 459 YF 460 (483)
T ss_pred hc
Confidence 54
No 164
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=92.89 E-value=0.14 Score=39.29 Aligned_cols=25 Identities=16% Similarity=0.069 Sum_probs=20.8
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEe
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~ 493 (694)
..+.| +.+++..|+|.|+|.++|..
T Consensus 37 ~~~~L~i~~~~~~d~G~Y~C~~~n~~ 62 (63)
T smart00408 37 SGSTLTIKSVSLEDSGEYTCVAENSA 62 (63)
T ss_pred CCcEEEEeeCCcccCEEEEEEEecCC
Confidence 34455 99999999999999998854
No 165
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=92.84 E-value=0.16 Score=42.45 Aligned_cols=32 Identities=13% Similarity=-0.039 Sum_probs=22.9
Q ss_pred ecccEE-EEEEE----ecCCCcceeEEEEEeeeccce
Q psy8879 468 TGLGTV-QVYVQ----LWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 468 ~~~gtL-~~~v~----~~d~G~YtC~~~n~~~~~~~~ 499 (694)
..+|+| |.++. ..|+|+|+|.|+|.++...+-
T Consensus 36 ~~~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05875 36 RRSGTLVIDFSGGGRPEDYEGEYQCFARNNLGTALSN 72 (77)
T ss_pred CCCceEEEeccCCCCCCCCCEEEEEEEEeccceEEEE
Confidence 345777 55553 246999999999999865543
No 166
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=92.47 E-value=0.22 Score=44.34 Aligned_cols=36 Identities=14% Similarity=-0.049 Sum_probs=27.4
Q ss_pred eeEEecccEEEEEEEecCCCcceeEEEEEeeeccce
Q psy8879 464 RANVTGLGTVQVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 464 ~~n~~~~gtL~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
|+...++-..|.+++.+|+|.|+|+++|.-+-+.--
T Consensus 64 Ri~~~~~~Lwf~Pa~~eDSG~Y~C~~rN~t~C~~~~ 99 (104)
T cd05896 64 RMSKEEDSIWFRPAELQDSGLYTCVLRNSTYCMKVS 99 (104)
T ss_pred eEEEeCCEEEEEeCChhhCeEEEEEECCCCcceEEE
Confidence 555554444499999999999999999987655433
No 167
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=92.15 E-value=0.16 Score=44.62 Aligned_cols=25 Identities=24% Similarity=0.165 Sum_probs=21.6
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEe
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~ 493 (694)
+.++| |.+|+.+|+|.|||.+++..
T Consensus 53 ~~~~L~I~~v~~~D~G~YtC~~~~~~ 78 (95)
T cd05897 53 GSTYLHIIDVSLNDSGYYTCKLQFTH 78 (95)
T ss_pred CCCEEEEEEcChhhCEEEEEEEEEee
Confidence 34566 99999999999999999984
No 168
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=92.12 E-value=0.14 Score=43.93 Aligned_cols=55 Identities=13% Similarity=0.056 Sum_probs=40.1
Q ss_pred eeeeeceeE------EEEeccCccccccceeEeeeeEEecccEEEEEEEecCCCcceeEEEEEeee
Q psy8879 436 SALVLGCSE------ILALVPTLTSQPLSYVTSLRANVTGLGTVQVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 436 ~~~~l~c~~------i~~l~~~~~~~~~~~i~~~~~n~~~~gtL~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
....|.|.. +.|...+.... .+.++..+.+|.+|..++.+|+|.|.|.+.--.|.
T Consensus 12 ~~v~L~C~~~s~~A~v~W~~ng~~l~-----~~~r~~~~~~GLlI~~~~~~dsG~Y~C~s~E~gf~ 72 (85)
T cd05872 12 ADVVLPCQLRSNLASPVWLFNGTPLN-----AQFSYRVGTDGLLILVTSPEHSGTYRCYSEEEGFQ 72 (85)
T ss_pred CCEEEECCCCCCCccEEEEECCcccC-----CCcceEEeCCCCEEEECCHhhCEEEEEEEecCCCe
Confidence 334556654 67777665554 23567788999999999999999999998754443
No 169
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=91.90 E-value=0.33 Score=42.85 Aligned_cols=32 Identities=13% Similarity=-0.019 Sum_probs=26.4
Q ss_pred cEE-EEEEEecC-CCcceeEEEEEeeeccceeEE
Q psy8879 471 GTV-QVYVQLWT-NYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 471 gtL-~~~v~~~d-~G~YtC~~~n~~~~~~~~~~~ 502 (694)
++| |.++..+| .|.|.|.|+|+.+++...+..
T Consensus 64 S~L~I~~~~~~d~~g~Y~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 64 STLTINNIMEADFQTHYNCTAWNSFGSGTAIIQL 97 (98)
T ss_pred EEEEECCCccccCCcEEEEEEEeCCccceEEEEe
Confidence 345 88888777 799999999999999887653
No 170
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=91.79 E-value=0.11 Score=45.93 Aligned_cols=23 Identities=17% Similarity=0.075 Sum_probs=20.9
Q ss_pred cccEE-EEEEEecCCCcceeEEEE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n 491 (694)
+|++| |.+++.+|+|.|+|.+.+
T Consensus 61 ~daSi~i~nl~~~D~G~Y~C~v~t 84 (99)
T cd05886 61 EDGTISLSRLELEDEGVYICEFAT 84 (99)
T ss_pred CcceEEEcCCccccCEEEEEEEEe
Confidence 45677 999999999999999999
No 171
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=91.78 E-value=0.29 Score=50.03 Aligned_cols=23 Identities=13% Similarity=-0.091 Sum_probs=20.4
Q ss_pred ccEE-EEEEEecCCCcceeEEEEE
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTIT 492 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~ 492 (694)
.++| |.+|+.+|+|.|+|.++..
T Consensus 187 ~~~L~I~~V~~~DsG~YtC~a~~~ 210 (227)
T PHA02826 187 NSTLVIKSATHDDSGIYTCNLRFN 210 (227)
T ss_pred CCEEEECcCCHHhCEEEEEEEEEe
Confidence 3466 9999999999999999986
No 172
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=91.67 E-value=0.22 Score=43.13 Aligned_cols=24 Identities=17% Similarity=-0.006 Sum_probs=20.2
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEe
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~ 493 (694)
+.+| |.+|+.+|+|.|+|.+++..
T Consensus 61 ~~~L~I~~v~~~DsG~Y~C~~~~~~ 85 (95)
T cd05717 61 ELSISISNVSLSDEGRYTCSLYTMP 85 (95)
T ss_pred eeEEEEccCCcccCEEEEEEEecCC
Confidence 3455 99999999999999998654
No 173
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=91.59 E-value=0.073 Score=47.21 Aligned_cols=36 Identities=11% Similarity=0.047 Sum_probs=27.1
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccceeEEee
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
++.+| |.+|+.+|+|+|.|.+.+..+...+.+..+.
T Consensus 66 ~~~sL~I~~v~~sD~G~Y~C~v~~~~~~~~~~v~L~V 102 (106)
T cd05714 66 GDASLVITDLRLEDSGRYRCEVIDGIEDEQDTVELEV 102 (106)
T ss_pred CcceEEECCCCHHHCEEEEEEEEcCCCceEEEEEEEE
Confidence 34455 9999999999999999987655555554443
No 174
>smart00082 LRRCT Leucine rich repeat C-terminal domain.
Probab=91.52 E-value=0.075 Score=40.46 Aligned_cols=31 Identities=23% Similarity=0.282 Sum_probs=23.4
Q ss_pred CCccccccccccccc-ccCCccCccccCCccc
Q psy8879 387 MDLELIYSGVWRHST-LLIPVMLSLCTRSSVV 417 (694)
Q Consensus 387 CdC~l~~~~~wl~~~-~~~~~~~~~C~~~~~~ 417 (694)
|||++.||..|+... .+.....+.|..+...
T Consensus 5 CdC~l~~~~~w~~~~~~~~~~~~~~C~~P~~~ 36 (51)
T smart00082 5 CDCELRWLLRWLQANEHLQDPVSLRCASPSSL 36 (51)
T ss_pred CcCCchHHHHHHHhCCccCCCCCCEeCCcHHH
Confidence 999999999999762 2334457999877654
No 175
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=91.32 E-value=0.077 Score=33.26 Aligned_cols=11 Identities=55% Similarity=0.637 Sum_probs=4.3
Q ss_pred cEEEccCCCCC
Q psy8879 171 DRLDLSHNQLY 181 (694)
Q Consensus 171 ~~L~Ls~N~L~ 181 (694)
++|||++|+|+
T Consensus 3 ~~Ldls~n~l~ 13 (22)
T PF00560_consen 3 EYLDLSGNNLT 13 (22)
T ss_dssp SEEEETSSEES
T ss_pred cEEECCCCcCE
Confidence 33333333333
No 176
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=91.09 E-value=0.082 Score=44.79 Aligned_cols=29 Identities=24% Similarity=0.057 Sum_probs=24.8
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
+++| |.+++.+|+|.|+|.++|..+....
T Consensus 51 ~~~L~I~~v~~~DsG~Y~C~a~n~~g~~~~ 80 (85)
T cd05754 51 NGILTIRNVQLSDAGTYVCTGSNMLDTDEA 80 (85)
T ss_pred CCEEEECCCCHHHCEEEEEEEeccCCeEeE
Confidence 4667 9999999999999999998876654
No 177
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=91.08 E-value=0.17 Score=32.87 Aligned_cols=22 Identities=32% Similarity=0.504 Sum_probs=14.1
Q ss_pred CCCCEEEccCCCCCCCCccccc
Q psy8879 361 KSLQELRLDDNDISMEPECIYV 382 (694)
Q Consensus 361 ~~L~~L~Ls~N~L~~l~~~~f~ 382 (694)
++|+.|+|++|+|+.+|+++|.
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHcc
Confidence 4566666666666666666653
No 178
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=91.08 E-value=0.17 Score=32.87 Aligned_cols=22 Identities=32% Similarity=0.504 Sum_probs=14.1
Q ss_pred CCCCEEEccCCCCCCCCccccc
Q psy8879 361 KSLQELRLDDNDISMEPECIYV 382 (694)
Q Consensus 361 ~~L~~L~Ls~N~L~~l~~~~f~ 382 (694)
++|+.|+|++|+|+.+|+++|.
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHcc
Confidence 4566666666666666666653
No 179
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=91.07 E-value=0.11 Score=45.94 Aligned_cols=36 Identities=11% Similarity=-0.027 Sum_probs=28.4
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeEEeec
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKNT 505 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~ 505 (694)
+.+| |.+++.+|+|+|.|.+++...+....+..++-
T Consensus 67 ~~sL~I~~v~~~DsG~Y~C~v~~~~~~~~~~~~l~v~ 103 (106)
T cd05877 67 DASLVITDLRLEDYGRYRCEVIDGLEDESVVVALRLR 103 (106)
T ss_pred cEEEEEccCChHHCEEEEEEEEecccceEEEEEEEEE
Confidence 4456 99999999999999999877776666655443
No 180
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=90.83 E-value=0.15 Score=44.60 Aligned_cols=26 Identities=8% Similarity=0.014 Sum_probs=21.2
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeec
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYID 496 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~ 496 (694)
.+| |.+|+.+|+|+|+|.+.+.-.-.
T Consensus 65 ~sL~I~~v~~~D~G~Y~C~v~~~~~~~ 91 (100)
T cd05713 65 VALRIHNVRASDEGLYTCFFQSDGFYE 91 (100)
T ss_pred EEEEEEcCChhhCEEEEEEEecCCcEE
Confidence 345 99999999999999999854433
No 181
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=90.78 E-value=0.17 Score=44.56 Aligned_cols=22 Identities=9% Similarity=-0.022 Sum_probs=19.8
Q ss_pred ccEE-EEEEEecCCCcceeEEEE
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n 491 (694)
++.| |.+|+.+|+|+|+|.+.+
T Consensus 63 ~~sL~I~nv~~sD~GtY~C~v~~ 85 (100)
T cd05888 63 DGALILRNAVQADEGKYKCRVIT 85 (100)
T ss_pred ceEEEEecCccccceEEEEEEEe
Confidence 4556 999999999999999988
No 182
>KOG4308|consensus
Probab=90.56 E-value=0.0084 Score=67.91 Aligned_cols=182 Identities=27% Similarity=0.258 Sum_probs=84.0
Q ss_pred ccEEEccCCCCCCCCc----cccccCCCCccEEEccCCCCCCCCcc----cccCC-CCccEEEecCCCCCCCCc----cc
Q psy8879 145 LQALGLPNNLLSVVPT----SALAPLAPNLDRLDLSHNQLYKLENT----SFKGL-SSLNFLDLSYNKLMTLSQ----DC 211 (694)
Q Consensus 145 L~~L~Ls~N~L~~lp~----~~~~~l~~~L~~L~Ls~N~L~~i~~~----~f~~L-~~L~~L~Ls~N~l~~i~~----~~ 211 (694)
+..|.|.+|.+..-.. .++... +.|+.|++++|.+...... .+... ..|++|++..|.++.... ..
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~-~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~ 167 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTL-PTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAV 167 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhccc-ccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHH
Confidence 4445555555443222 122233 4555555555555421111 11111 344555555555544322 22
Q ss_pred cCCCCCCcEEeccCCcccc----hhhhhh----ccCcccccccCCCCcCCCCCC---CCCCCCccc-cceeeccCCcccc
Q psy8879 212 LAPLVTLRVLRLQGNRLTV----SVVAAL----QGLRSVTDLDLSHNLLAGPLG---PSTVPRLSS-LKVLSIAHNQFSS 279 (694)
Q Consensus 212 f~~L~~L~~L~Ls~N~l~~----~~~~~~----~~L~~L~~L~Ls~N~l~~~i~---p~~~~~l~~-L~~L~Ls~N~L~~ 279 (694)
+.....++.++++.|.+.. ..+..+ ....+++.|.+.++.++.... ...+...+. +.+|++..|.+.+
T Consensus 168 L~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d 247 (478)
T KOG4308|consen 168 LEKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGD 247 (478)
T ss_pred HhcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcch
Confidence 3334556666666665521 112222 235566666666666542100 011222233 4556666666654
Q ss_pred cc----cccccCC-cccceecccCCccccccch----hhhcccccccccCCCCcccc
Q psy8879 280 VR----RGALAGL-DKLTSLSCHHNQIDVLEDH----SFRALSTLSHLDLAHNRIVA 327 (694)
Q Consensus 280 i~----~~~~~~L-~~L~~L~Ls~N~L~~i~~~----~f~~l~~L~~L~Ls~N~L~~ 327 (694)
.. ...+..+ ..+++++++.|.|+..... .+..++.++.|.+++|.+..
T Consensus 248 ~g~~~L~~~l~~~~~~l~~l~l~~nsi~~~~~~~L~~~l~~~~~l~~l~l~~n~l~~ 304 (478)
T KOG4308|consen 248 VGVEKLLPCLSVLSETLRVLDLSRNSITEKGVRDLAEVLVSCRQLEELSLSNNPLTD 304 (478)
T ss_pred HHHHHHHHHhcccchhhhhhhhhcCCccccchHHHHHHHhhhHHHHHhhcccCcccc
Confidence 31 1123333 4566777777776644332 23345567777777776654
No 183
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=90.40 E-value=0.23 Score=44.80 Aligned_cols=46 Identities=9% Similarity=0.083 Sum_probs=33.5
Q ss_pred eeEeeeeEEec------ccEE-EEEEEecCCCcceeEEEEEeeeccceeEEee
Q psy8879 459 YVTSLRANVTG------LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 459 ~i~~~~~n~~~------~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
..+..|+.+.+ +-+| +.+|+.+|+|+|.|.+.....+.++.+..+.
T Consensus 54 ~~y~gRvsl~~~~~~~~~asL~i~nv~~~D~G~Y~C~v~~g~~~~~~~v~L~V 106 (110)
T cd05902 54 KAFQGRVSLPGYPKNRYNASLVLSRLRYSDSGTYRCEVVLGINDEQDTVPLEV 106 (110)
T ss_pred hhcccEEEeecCCCCCceEEEEECCCCHHHCEEEEEEEEECCcccEEEEEEEE
Confidence 33455555543 3355 9999999999999999997777776665543
No 184
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=90.25 E-value=0.31 Score=41.27 Aligned_cols=29 Identities=3% Similarity=-0.173 Sum_probs=21.2
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
+.| +..+ .|+|+|+|+|+|.++......+
T Consensus 49 s~L~i~~~--~d~g~Y~C~A~N~~G~~~s~~a 78 (81)
T cd05749 49 SVLNVPGL--NETSKFSCEAHNAKGVTTSRTG 78 (81)
T ss_pred CEEEEccc--cCCeEEEEEEEeccCcEEeeeE
Confidence 445 4444 6899999999999887665444
No 185
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=90.23 E-value=0.13 Score=46.89 Aligned_cols=31 Identities=16% Similarity=0.059 Sum_probs=24.4
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccce
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDV 499 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~ 499 (694)
++.++ |.+|+.+|.|+|+|.+.|.--..+..
T Consensus 78 ~daSI~I~nv~~sD~G~Y~C~v~n~p~~~~~~ 109 (116)
T cd05879 78 KDGSIVIHNLDYTDNGTFTCDVKNPPDIVGKS 109 (116)
T ss_pred CeeEEEEccCCcccCEEEEEEEEcCCCcCCce
Confidence 45556 99999999999999999866544443
No 186
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=90.17 E-value=0.28 Score=41.61 Aligned_cols=25 Identities=16% Similarity=0.040 Sum_probs=21.7
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
+.+ |.+++.+|+|.|+|.+++..+.
T Consensus 48 ~~l~I~~~~~~dsG~Y~C~~~~~~~~ 73 (83)
T cd05753 48 SNLSIPQATLSDSGSYHCSGIIGSYD 73 (83)
T ss_pred ceEEECccCHHHCEEEEEEEEeCCce
Confidence 445 8899999999999999998764
No 187
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=90.14 E-value=0.36 Score=43.99 Aligned_cols=36 Identities=11% Similarity=0.003 Sum_probs=29.9
Q ss_pred cccEE-EEEEEecCCCcceeEEEEEeeeccceeEEee
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
++-+| |.+++.+|+|.|.|.+..-.++.++.+..+.
T Consensus 77 g~asL~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V 113 (117)
T cd05901 77 GDASLTIVKLRASDAGVYRCEVMHGIEDTQDTVSLDV 113 (117)
T ss_pred CceEEEEcccccccCEEEEEEEEECCcccEEEEEEEE
Confidence 34555 9999999999999999999888888776554
No 188
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=90.13 E-value=0.16 Score=43.41 Aligned_cols=33 Identities=12% Similarity=-0.105 Sum_probs=27.9
Q ss_pred EeeeeEEecccEE-EEEEEecCCCcceeEEEEEe
Q psy8879 461 TSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 461 ~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~ 493 (694)
...|.++..+++| |.+++.+|+|.|+|.+....
T Consensus 47 ~~~R~~~~~~~sL~I~~l~~~DsG~Y~c~v~~~~ 80 (92)
T cd05741 47 YSGRETIYPNGSLLIQNLTKEDSGTYTLQIISTN 80 (92)
T ss_pred cCCeEEEcCCceEEEccCCchhcEEEEEEEEcCC
Confidence 4556777777888 99999999999999998764
No 189
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=89.92 E-value=0.17 Score=31.62 Aligned_cols=16 Identities=25% Similarity=0.486 Sum_probs=8.0
Q ss_pred cceeeccCCccccccc
Q psy8879 267 LKVLSIAHNQFSSVRR 282 (694)
Q Consensus 267 L~~L~Ls~N~L~~i~~ 282 (694)
|++|+|++|+++.+++
T Consensus 2 L~~Ldls~n~l~~ip~ 17 (22)
T PF00560_consen 2 LEYLDLSGNNLTSIPS 17 (22)
T ss_dssp ESEEEETSSEESEEGT
T ss_pred ccEEECCCCcCEeCCh
Confidence 4555555555554443
No 190
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=89.53 E-value=0.3 Score=42.31 Aligned_cols=23 Identities=13% Similarity=0.059 Sum_probs=19.9
Q ss_pred cccEE-EEEEEecCCCcceeEEEE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n 491 (694)
++.+| |.+|+.+|+|.|.|.+..
T Consensus 60 ~~~sL~I~~v~~~D~G~Y~C~v~~ 83 (98)
T cd05718 60 EDATISISNLRLEDEGNYICEFAT 83 (98)
T ss_pred CceEEEEccCCcccCEEEEEEEEe
Confidence 35566 999999999999999874
No 191
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=89.44 E-value=0.3 Score=31.71 Aligned_cols=23 Identities=43% Similarity=0.550 Sum_probs=17.9
Q ss_pred ccccCeeecCCCCCCCcChhhhC
Q psy8879 336 LSNLTTLDLSHNFLRALTQDLIT 358 (694)
Q Consensus 336 l~~L~~L~Ls~N~L~~l~~~~~~ 358 (694)
+++|+.|+|++|+|+.+++..|.
T Consensus 1 L~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00370 1 LPNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCCEEECCCCcCCcCCHHHcc
Confidence 35788888888888888877664
No 192
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=89.44 E-value=0.3 Score=31.71 Aligned_cols=23 Identities=43% Similarity=0.550 Sum_probs=17.9
Q ss_pred ccccCeeecCCCCCCCcChhhhC
Q psy8879 336 LSNLTTLDLSHNFLRALTQDLIT 358 (694)
Q Consensus 336 l~~L~~L~Ls~N~L~~l~~~~~~ 358 (694)
+++|+.|+|++|+|+.+++..|.
T Consensus 1 L~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00369 1 LPNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCCEEECCCCcCCcCCHHHcc
Confidence 35788888888888888877664
No 193
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=88.89 E-value=0.48 Score=39.76 Aligned_cols=20 Identities=5% Similarity=-0.232 Sum_probs=17.4
Q ss_pred EEEEEEEecCCCcceeEEEEE
Q psy8879 472 TVQVYVQLWTNYDPNCLLTIT 492 (694)
Q Consensus 472 tL~~~v~~~d~G~YtC~~~n~ 492 (694)
..+.++ ..|+|+|+|.+.|.
T Consensus 49 l~i~~~-~~dsG~Y~C~a~~~ 68 (78)
T cd05752 49 YRIRAA-NNDSGEYRCQTQGS 68 (78)
T ss_pred EEEeec-ccCCEEeEEECCCC
Confidence 348888 99999999999885
No 194
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=88.73 E-value=0.11 Score=45.48 Aligned_cols=24 Identities=4% Similarity=-0.212 Sum_probs=21.6
Q ss_pred EEEEEecCCCcceeEEEEEeeecc
Q psy8879 474 QVYVQLWTNYDPNCLLTITLYIDG 497 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~~~~~ 497 (694)
|.+++.+|+|+|+|.|.|+..+++
T Consensus 69 I~~l~~sDsgtY~C~v~~~~~~~~ 92 (94)
T cd07690 69 IKNLKIEDSDTYICEVEDKKEEVE 92 (94)
T ss_pred ECCCCHHHCEEEEEEECCccceEE
Confidence 999999999999999999876654
No 195
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=88.59 E-value=0.27 Score=28.81 Aligned_cols=15 Identities=27% Similarity=0.452 Sum_probs=5.7
Q ss_pred CCCEEEccCCCCCCC
Q psy8879 362 SLQELRLDDNDISME 376 (694)
Q Consensus 362 ~L~~L~Ls~N~L~~l 376 (694)
+|+.|+|++|+|+.+
T Consensus 2 ~L~~L~l~~n~L~~l 16 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSL 16 (17)
T ss_dssp T-SEEEETSS--SSE
T ss_pred ccCEEECCCCCCCCC
Confidence 344555555554433
No 196
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=88.16 E-value=0.49 Score=42.81 Aligned_cols=33 Identities=9% Similarity=-0.064 Sum_probs=25.3
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
+-+| |++++.+|+|+|.|.+..-+-+....+..
T Consensus 73 ~asL~I~nl~~sDsG~Y~C~V~~g~~~~~~~v~l 106 (112)
T cd05900 73 DATLEITELRSNDSGTYRCEVMHGIEDNYDTVEV 106 (112)
T ss_pred CcEEEEeecccccCEEEEEEEecCCCCceeEEEE
Confidence 4455 99999999999999999665555555443
No 197
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=88.15 E-value=0.29 Score=28.67 Aligned_cols=16 Identities=63% Similarity=0.746 Sum_probs=7.9
Q ss_pred ccCeeecCCCCCCCcC
Q psy8879 338 NLTTLDLSHNFLRALT 353 (694)
Q Consensus 338 ~L~~L~Ls~N~L~~l~ 353 (694)
+|+.|+|++|+++++|
T Consensus 2 ~L~~L~l~~n~L~~lP 17 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSLP 17 (17)
T ss_dssp T-SEEEETSS--SSE-
T ss_pred ccCEEECCCCCCCCCc
Confidence 5666777777666553
No 198
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=88.12 E-value=0.27 Score=43.25 Aligned_cols=23 Identities=13% Similarity=-0.201 Sum_probs=19.9
Q ss_pred cccEE-EEEEEecCCCcceeEEEE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n 491 (694)
++++| |.+|+.+|+|.|+|.+..
T Consensus 58 ~d~sl~i~nv~~~D~G~Y~C~v~t 81 (96)
T cd05887 58 LDATIMLENVGFSDIGVYICKAVT 81 (96)
T ss_pred CccEEEEeCCCccccEEEEEEEEe
Confidence 46677 999999999999999865
No 199
>smart00409 IG Immunoglobulin.
Probab=87.96 E-value=1.5 Score=35.47 Aligned_cols=24 Identities=17% Similarity=-0.057 Sum_probs=20.0
Q ss_pred cEE-EEEEEecCCCcceeEEEEEee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLY 494 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~ 494 (694)
.+| +.+++..|+|.|+|.+.+...
T Consensus 51 ~~l~i~~~~~~d~G~Y~C~v~~~~~ 75 (86)
T smart00409 51 STLTISNVTPEDSGTYTCAATNSSG 75 (86)
T ss_pred eEEEEEeeccccCeEEEEEEEcCCC
Confidence 455 999999999999999995543
No 200
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=87.96 E-value=1.5 Score=35.47 Aligned_cols=24 Identities=17% Similarity=-0.057 Sum_probs=20.0
Q ss_pred cEE-EEEEEecCCCcceeEEEEEee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLY 494 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~ 494 (694)
.+| +.+++..|+|.|+|.+.+...
T Consensus 51 ~~l~i~~~~~~d~G~Y~C~v~~~~~ 75 (86)
T smart00410 51 STLTISNVTPEDSGTYTCAATNSSG 75 (86)
T ss_pred eEEEEEeeccccCeEEEEEEEcCCC
Confidence 455 999999999999999995543
No 201
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=87.51 E-value=0.29 Score=44.33 Aligned_cols=26 Identities=12% Similarity=-0.024 Sum_probs=21.4
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
+.+| |.+++.+|+|+|+|.|.|.--.
T Consensus 78 ~~sL~I~~v~~~D~G~Y~C~v~~~~~~ 104 (115)
T cd05880 78 DASILIWQLQPTDNGTYTCQVKNPPDV 104 (115)
T ss_pred ceEEEEeeCChhhCEEEEEEEEeCCCC
Confidence 3455 9999999999999999985543
No 202
>KOG0473|consensus
Probab=87.33 E-value=0.06 Score=54.35 Aligned_cols=95 Identities=16% Similarity=0.174 Sum_probs=65.8
Q ss_pred ccccccccccCCcccceecccCCccccccchhhhcccccccccCCCCccccccccchhcccccCeeecCCCCCCCcChhh
Q psy8879 277 FSSVRRGALAGLDKLTSLSCHHNQIDVLEDHSFRALSTLSHLDLAHNRIVAVSGASLAHLSNLTTLDLSHNFLRALTQDL 356 (694)
Q Consensus 277 L~~i~~~~~~~L~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~i~~~~f~~l~~L~~L~Ls~N~L~~l~~~~ 356 (694)
+++++-..+......+.||++.|++-.+.. -|+-++.|..||++.|.+.-. |..+.....+..+++.+|..+..|-.
T Consensus 30 ~s~~~v~ei~~~kr~tvld~~s~r~vn~~~-n~s~~t~~~rl~~sknq~~~~-~~d~~q~~e~~~~~~~~n~~~~~p~s- 106 (326)
T KOG0473|consen 30 LSEIPVREIASFKRVTVLDLSSNRLVNLGK-NFSILTRLVRLDLSKNQIKFL-PKDAKQQRETVNAASHKNNHSQQPKS- 106 (326)
T ss_pred hcccchhhhhccceeeeehhhhhHHHhhcc-chHHHHHHHHHhccHhhHhhC-hhhHHHHHHHHHHHhhccchhhCCcc-
Confidence 344444445555667777777777765554 366677778888888877666 45567777777788888887777643
Q ss_pred hCCCCCCCEEEccCCCCC
Q psy8879 357 ITPLKSLQELRLDDNDIS 374 (694)
Q Consensus 357 ~~~l~~L~~L~Ls~N~L~ 374 (694)
+...++++.+++.+|++.
T Consensus 107 ~~k~~~~k~~e~k~~~~~ 124 (326)
T KOG0473|consen 107 QKKEPHPKKNEQKKTEFF 124 (326)
T ss_pred ccccCCcchhhhccCcch
Confidence 667888888888887754
No 203
>KOG4222|consensus
Probab=87.12 E-value=0.57 Score=56.69 Aligned_cols=66 Identities=9% Similarity=-0.038 Sum_probs=45.0
Q ss_pred eceeEEEEeccCccccccceeEeeeeEEecccEEEEEEEecCCCcceeEEEEEeeeccceeEEeeccC
Q psy8879 440 LGCSEILALVPTLTSQPLSYVTSLRANVTGLGTVQVYVQLWTNYDPNCLLTITLYIDGDVIVQKNTNC 507 (694)
Q Consensus 440 l~c~~i~~l~~~~~~~~~~~i~~~~~n~~~~gtL~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~~~ 507 (694)
.-+..+.|+....-.. ..-...++.+++-..+|.||+-+|+|+|+|+++|.++..++..++-.++-
T Consensus 159 hpeptvSw~Kdg~pl~--~~~~~~~~lisgG~LlIsnvrksD~GtY~CVatNmvG~ReS~~A~lsv~e 224 (1281)
T KOG4222|consen 159 HPEPTVSWVKDGKPLD--HYDVPIIALISGGNLLISNVRKSDEGTYACVATNMVGERESIPARLSVQE 224 (1281)
T ss_pred CCCCcceeecCCCccc--cccceeEEEecCCcEEEeccccCCCceeeeeecccccccccccceeeecc
Confidence 3444566666554433 11222333455444559999999999999999999999988887766653
No 204
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=86.79 E-value=0.29 Score=50.11 Aligned_cols=29 Identities=7% Similarity=-0.159 Sum_probs=23.6
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
.++| |.+|+.+|+|.|+|+|+|....++.
T Consensus 97 ~~~L~I~~v~~~DsG~Y~C~a~N~~~~~~~ 126 (227)
T PHA02826 97 SENLWIGNVINIDEGIYICTISSGNICEES 126 (227)
T ss_pred CCeEEECCCChHHCEEEEEEEEECCcceEE
Confidence 4566 9999999999999999996654433
No 205
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=86.47 E-value=0.76 Score=40.28 Aligned_cols=18 Identities=22% Similarity=0.041 Sum_probs=16.9
Q ss_pred EEEEEecCCCcceeEEEE
Q psy8879 474 QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n 491 (694)
|.+|+.+|+|.|+|++..
T Consensus 66 I~~vq~~D~G~Y~Cqv~t 83 (95)
T cd05881 66 LSNVSLSDEGRYFCQLYT 83 (95)
T ss_pred ECcCCcccCEEEEEEEEc
Confidence 999999999999999965
No 206
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=86.37 E-value=0.36 Score=42.44 Aligned_cols=24 Identities=8% Similarity=-0.307 Sum_probs=20.4
Q ss_pred cccEE-EEEEEecCCCcceeEEEEE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLTIT 492 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~n~ 492 (694)
.+.++ |.||+..|+|.|+|.+...
T Consensus 58 ~d~sI~i~nvt~~D~G~Y~C~~~t~ 82 (96)
T cd05889 58 EDMSLSFNNATEEDVGLYCCSLVTY 82 (96)
T ss_pred CccEEEEcCCCcccCEEEEEEEEeC
Confidence 35666 9999999999999999763
No 207
>PHA02633 hypothetical protein; Provisional
Probab=86.30 E-value=0.59 Score=37.30 Aligned_cols=30 Identities=10% Similarity=-0.105 Sum_probs=23.9
Q ss_pred EEEEEEEecCCCcceeEEEEEeeeccceeE
Q psy8879 472 TVQVYVQLWTNYDPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 472 tL~~~v~~~d~G~YtC~~~n~~~~~~~~~~ 501 (694)
..|.++..+|+|.|.|.++|.-|-.+--+.
T Consensus 20 Lwilpa~~sDSGiYiC~~rn~t~c~~~si~ 49 (63)
T PHA02633 20 MLILNPTQSDSGIYMCITKNETYSDMMKFD 49 (63)
T ss_pred EEEeccccccCcEEEEEEcCCCeeEEEEEE
Confidence 339999999999999999987776554433
No 208
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=85.66 E-value=0.44 Score=42.83 Aligned_cols=35 Identities=6% Similarity=-0.072 Sum_probs=27.1
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccceeEEee
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKN 504 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~ 504 (694)
+..| |.+++.+|+|+|.|.++......++.+..+.
T Consensus 71 ~asL~I~~l~~sD~G~Y~C~v~~~~~~~~~~v~l~V 106 (110)
T cd05878 71 DASLEISRLRSSDSGVYRCEVMHGIEDEQDTVPLEV 106 (110)
T ss_pred cEEEEECCCChhhCEEEEEEEEeCCCcceEEEEEEE
Confidence 3455 9999999999999999987666666555443
No 209
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=85.22 E-value=0.49 Score=42.74 Aligned_cols=24 Identities=13% Similarity=0.025 Sum_probs=20.5
Q ss_pred cEE-EEEEEecCCCcceeEEEEEee
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLY 494 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~ 494 (694)
.+| |.+++.+|+|+|+|.+.|.--
T Consensus 80 ~sL~I~~v~~~D~G~Y~C~v~~~~~ 104 (116)
T cd05715 80 ASIVIHNLQFTDNGTYTCDVKNPPD 104 (116)
T ss_pred eEEEEeeCCcccCEEEEEEEEeCCC
Confidence 455 999999999999999998633
No 210
>PHA02785 IL-beta-binding protein; Provisional
Probab=85.14 E-value=1.4 Score=47.60 Aligned_cols=23 Identities=9% Similarity=-0.077 Sum_probs=21.1
Q ss_pred cEE-EEEEEecCCCcceeEEEEEe
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~ 493 (694)
+.| |.+|+..|.|.|+|.|+|..
T Consensus 292 ~~L~I~~V~~~D~G~Y~C~A~n~~ 315 (326)
T PHA02785 292 SRLNINPVKEEDATTFTCMAFTIP 315 (326)
T ss_pred EEEEECCcchhcCeeeEEEEEecc
Confidence 556 99999999999999999987
No 211
>KOG3513|consensus
Probab=85.13 E-value=1 Score=54.83 Aligned_cols=67 Identities=15% Similarity=0.077 Sum_probs=43.7
Q ss_pred ceeeeeceeE-------EEEeccCccccccceeEeeeeEEeccc-EE-EEEEEecCCCcceeEEEEEeeeccceeEEeec
Q psy8879 435 QSALVLGCSE-------ILALVPTLTSQPLSYVTSLRANVTGLG-TV-QVYVQLWTNYDPNCLLTITLYIDGDVIVQKNT 505 (694)
Q Consensus 435 ~~~~~l~c~~-------i~~l~~~~~~~~~~~i~~~~~n~~~~g-tL-~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~ 505 (694)
+-...|.|.+ +.|.+..++.. .. +....+.| +| |.+|+..|+|.|+|.+.|+.+. ..++-.+
T Consensus 256 G~~v~LECfA~G~P~P~i~W~k~~g~~~-~~-----r~~~~~~~~vL~I~nv~~~D~G~Y~C~AeN~~G~---~~~~~~v 326 (1051)
T KOG3513|consen 256 GQSVKLECFALGNPTPQIKWRKVDGKPP-PR-----RATYSNYGKVLKIPNVQYEDAGEYECIAENSRGS---ATHSGHV 326 (1051)
T ss_pred CCeEEEEEEecCCCCCcEEEEeCCCCCC-Cc-----ceeeeccccEEEecccCcCCCeEEEEEEeccccc---ceeeEEE
Confidence 3556778877 77777777533 22 22233333 44 9999999999999999999883 3344444
Q ss_pred cCCCC
Q psy8879 506 NCSRP 510 (694)
Q Consensus 506 ~~~~~ 510 (694)
+..++
T Consensus 327 ~v~a~ 331 (1051)
T KOG3513|consen 327 TVYAP 331 (1051)
T ss_pred EEecC
Confidence 44443
No 212
>PHA03376 BARF1; Provisional
Probab=85.05 E-value=3.9 Score=40.28 Aligned_cols=30 Identities=10% Similarity=0.103 Sum_probs=22.2
Q ss_pred EEEEEecCCCcceeEEEEEeeeccceeEEeecc
Q psy8879 474 QVYVQLWTNYDPNCLLTITLYIDGDVIVQKNTN 506 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~~ 506 (694)
|.+++++|.|+|+|.+.--. ..+.+++-|.
T Consensus 91 I~~l~lSDdGtY~C~fQkge---~~~~k~ehLt 120 (221)
T PHA03376 91 VTAANISHDGNYLCRMKLGE---TEVTKQEHLS 120 (221)
T ss_pred EEeeeecCCceEEEEEEcCC---Cceeeeeeee
Confidence 99999999999999987622 4445554443
No 213
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=83.53 E-value=0.61 Score=40.80 Aligned_cols=32 Identities=6% Similarity=-0.089 Sum_probs=25.2
Q ss_pred eeeeEEecc-cEE-EEEEEecCCCcceeEEEEEe
Q psy8879 462 SLRANVTGL-GTV-QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 462 ~~~~n~~~~-gtL-~~~v~~~d~G~YtC~~~n~~ 493 (694)
..|..+.++ +.| |.+++.+|+|.|.|.+.+.-
T Consensus 51 ~~R~~~~~~~~sL~I~~~~~~DsG~Y~c~v~~~~ 84 (97)
T cd05775 51 KERVNFSQNDYSLQISNLKMEDAGSYRAEINTKN 84 (97)
T ss_pred eeeEEecCCceeEEECCCchHHCEEEEEEEEcCC
Confidence 345666553 667 99999999999999998765
No 214
>KOG0473|consensus
Probab=83.53 E-value=0.059 Score=54.43 Aligned_cols=82 Identities=20% Similarity=0.163 Sum_probs=40.7
Q ss_pred CCCcEEeccCCcccchhhhhhccCcccccccCCCCcCCCCCCCCCCCCccccceeeccCCcccccccccccCCcccceec
Q psy8879 216 VTLRVLRLQGNRLTVSVVAALQGLRSVTDLDLSHNLLAGPLGPSTVPRLSSLKVLSIAHNQFSSVRRGALAGLDKLTSLS 295 (694)
Q Consensus 216 ~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~i~p~~~~~l~~L~~L~Ls~N~L~~i~~~~~~~L~~L~~L~ 295 (694)
...+.|+++.|++. ..-..|+.++.|..|+++.|.+.- + |..+.....+..+++..|..+..| .++...+++++++
T Consensus 42 kr~tvld~~s~r~v-n~~~n~s~~t~~~rl~~sknq~~~-~-~~d~~q~~e~~~~~~~~n~~~~~p-~s~~k~~~~k~~e 117 (326)
T KOG0473|consen 42 KRVTVLDLSSNRLV-NLGKNFSILTRLVRLDLSKNQIKF-L-PKDAKQQRETVNAASHKNNHSQQP-KSQKKEPHPKKNE 117 (326)
T ss_pred ceeeeehhhhhHHH-hhccchHHHHHHHHHhccHhhHhh-C-hhhHHHHHHHHHHHhhccchhhCC-ccccccCCcchhh
Confidence 34444444444443 122334444555555555555542 1 455555555555555555555443 2455556666666
Q ss_pred ccCCcc
Q psy8879 296 CHHNQI 301 (694)
Q Consensus 296 Ls~N~L 301 (694)
+.+|.+
T Consensus 118 ~k~~~~ 123 (326)
T KOG0473|consen 118 QKKTEF 123 (326)
T ss_pred hccCcc
Confidence 655553
No 215
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=83.15 E-value=0.49 Score=44.18 Aligned_cols=27 Identities=7% Similarity=-0.011 Sum_probs=22.0
Q ss_pred EEEEEecCCCcceeEEEEEeeecccee
Q psy8879 474 QVYVQLWTNYDPNCLLTITLYIDGDVI 500 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~~~~~~~~ 500 (694)
+.+|+..|+|+|+|.+.+..+..+.-+
T Consensus 5 i~~v~~~D~G~Y~C~~~~~~~~~~~~~ 31 (139)
T cd05771 5 LPGLTVHDEGTYICSVSTPPHQAQQII 31 (139)
T ss_pred ECCCCHHHCEEEEEEEEccCcceeeEE
Confidence 778999999999999998766655444
No 216
>KOG4221|consensus
Probab=82.32 E-value=1.8 Score=52.90 Aligned_cols=43 Identities=14% Similarity=-0.111 Sum_probs=30.1
Q ss_pred EEEeccCccccccceeEeeeeEEeccc-EEEEEEEecCCCcceeEEEE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLG-TVQVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~g-tL~~~v~~~d~G~YtC~~~n 491 (694)
+.|+.........+ .++...+-+ .+|++++..|+|.|||.|+|
T Consensus 269 v~Wlrng~~i~~ds----~rivl~g~~slliS~a~~~dSg~YtC~Atn 312 (1381)
T KOG4221|consen 269 VKWLRNGEKISVDS----YRIVLVGGSSLLISNATDDDSGKYTCRATN 312 (1381)
T ss_pred eEEeeCCeeeeecc----eEEEEecccceEEeccccccCceEEEEecC
Confidence 77887444443222 445555444 45999999999999999999
No 217
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=81.86 E-value=0.77 Score=40.03 Aligned_cols=22 Identities=14% Similarity=0.111 Sum_probs=18.7
Q ss_pred cccEE-EEEEEecCCCcceeEEE
Q psy8879 469 GLGTV-QVYVQLWTNYDPNCLLT 490 (694)
Q Consensus 469 ~~gtL-~~~v~~~d~G~YtC~~~ 490 (694)
++.+| |.+|+.+|+|.|.|.+.
T Consensus 59 ~~~sL~I~nv~~~D~G~Y~C~~~ 81 (97)
T cd05846 59 NSTSITIWNVTLEDEGCYKCIFN 81 (97)
T ss_pred CccEEEEeCCceeeeEEEEEEEE
Confidence 34556 99999999999999984
No 218
>KOG3864|consensus
Probab=81.46 E-value=0.29 Score=48.59 Aligned_cols=34 Identities=38% Similarity=0.372 Sum_probs=16.5
Q ss_pred CCccEEEecCCC-CCCCCccccCCCCCCcEEeccC
Q psy8879 192 SSLNFLDLSYNK-LMTLSQDCLAPLVTLRVLRLQG 225 (694)
Q Consensus 192 ~~L~~L~Ls~N~-l~~i~~~~f~~L~~L~~L~Ls~ 225 (694)
++|+.|++++|. |+.-.-..+..+++|+.|.+.+
T Consensus 151 ~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~l~~ 185 (221)
T KOG3864|consen 151 PSLQDLDLSGCPRITDGGLACLLKLKNLRRLHLYD 185 (221)
T ss_pred cchheeeccCCCeechhHHHHHHHhhhhHHHHhcC
Confidence 455555555443 4444334444455555555543
No 219
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=81.19 E-value=5.1 Score=32.44 Aligned_cols=23 Identities=9% Similarity=-0.188 Sum_probs=18.9
Q ss_pred EEEEEEEecCCCcceeEEEEEee
Q psy8879 472 TVQVYVQLWTNYDPNCLLTITLY 494 (694)
Q Consensus 472 tL~~~v~~~d~G~YtC~~~n~~~ 494 (694)
..+.+++..|.|.|+|.+.+...
T Consensus 47 ~~~~~~~~~~~g~y~C~~~~~~~ 69 (80)
T PF13895_consen 47 LFIPNVSPEDSGNYTCRASNGSG 69 (80)
T ss_dssp EEESSEEGGGTEEEEEEEEETTE
T ss_pred eeeeeeccccCEEEEEEEEeCCC
Confidence 44678999999999999988443
No 220
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=80.96 E-value=2.2 Score=43.91 Aligned_cols=52 Identities=15% Similarity=0.014 Sum_probs=41.2
Q ss_pred eEEEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 443 SEILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 443 ~~i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
....|..|+++.. + -..+++++..|.| +.+...+++|.|||+++-.....+.
T Consensus 13 P~y~W~GP~g~~l-~---gn~~~nIT~TG~L~~~~F~esmSG~YTCtLsYk~i~~~~ 65 (271)
T PF07354_consen 13 PTYLWTGPNGKPL-S---GNSYVNITETGKLMFKNFQESMSGSYTCTLSYKPIKAET 65 (271)
T ss_pred CceEEECCCCccc-C---CCCeEEEccCceEEeeccccccCCceEEEEEEEeccccc
Confidence 3467888887766 2 2456799999999 9999999999999999887755443
No 221
>PHA02785 IL-beta-binding protein; Provisional
Probab=80.46 E-value=1.4 Score=47.51 Aligned_cols=33 Identities=15% Similarity=0.003 Sum_probs=26.1
Q ss_pred eeEEecccEE-EEEEEecCCCcceeEEEEEeeec
Q psy8879 464 RANVTGLGTV-QVYVQLWTNYDPNCLLTITLYID 496 (694)
Q Consensus 464 ~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~~ 496 (694)
++.....|+| |.+|+.+|+|.|+|.++|.....
T Consensus 170 r~~~~~~~~L~i~~v~~~d~G~Y~C~~~n~~g~~ 203 (326)
T PHA02785 170 RLKQRTPGIITIEDVRKNDAGYYTCVLKYIYGDK 203 (326)
T ss_pred ceEecCCCeEEEeecChhhCeEEEEEEEeccCCE
Confidence 4444445777 99999999999999999975543
No 222
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=77.63 E-value=1.5 Score=38.75 Aligned_cols=21 Identities=19% Similarity=0.096 Sum_probs=18.6
Q ss_pred EE-EEEEEecCCCcceeEEEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTIT 492 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n~ 492 (694)
+| |.+++.+|+|.|.|.+.+.
T Consensus 71 ~L~I~~~~~~DsG~Y~C~~~~~ 92 (109)
T cd04983 71 SLHISAAQLSDSAVYFCALSES 92 (109)
T ss_pred EEEECCCCHHHCEEEEEEEecC
Confidence 44 9999999999999999864
No 223
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=76.97 E-value=1.6 Score=38.12 Aligned_cols=19 Identities=11% Similarity=0.043 Sum_probs=17.6
Q ss_pred EEEEEecCCCcceeEEEEE
Q psy8879 474 QVYVQLWTNYDPNCLLTIT 492 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~ 492 (694)
|.+++.+|+|.|.|.+.+.
T Consensus 71 I~~v~~~D~G~Y~C~v~~~ 89 (105)
T cd00099 71 ISSLQPEDSAVYYCAVSLS 89 (105)
T ss_pred ECCCCHHHCEEEEEEEecC
Confidence 9999999999999999863
No 224
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=76.82 E-value=1.5 Score=37.67 Aligned_cols=19 Identities=5% Similarity=-0.143 Sum_probs=17.6
Q ss_pred EEEEEecCCCcceeEEEEE
Q psy8879 474 QVYVQLWTNYDPNCLLTIT 492 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~ 492 (694)
+.+|+.+|+|+|+|.+++.
T Consensus 57 i~~v~~~~~G~Y~C~~~~~ 75 (91)
T cd05751 57 IPSMKREHAGRYRCYYRSG 75 (91)
T ss_pred ccCCChhHCEEEEEEEECC
Confidence 8899999999999999875
No 225
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=76.33 E-value=3 Score=35.97 Aligned_cols=38 Identities=13% Similarity=0.019 Sum_probs=26.5
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE-EEEEEecCCCcceeEEE
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV-QVYVQLWTNYDPNCLLT 490 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~ 490 (694)
+.|+.|..+.. +....++.+| .+.++.+|.|+|||+|+
T Consensus 33 i~w~~P~n~~~--------~~~~~~~ktL~~~qv~~qdSG~WtC~V~ 71 (88)
T cd07694 33 VEWRGPGNKSK--------QILNQDKKTLNLVQLGPNDSGTWDCIVS 71 (88)
T ss_pred EEEeCCCCccc--------eeccCCccEEEeceeCcccCCEEEEEEE
Confidence 56666665433 1122455666 88999999999999997
No 226
>KOG3864|consensus
Probab=76.25 E-value=0.91 Score=45.19 Aligned_cols=81 Identities=23% Similarity=0.276 Sum_probs=47.6
Q ss_pred CccEEEccCCCCCCCCcccccCCCCccEEEecCCCC-CCCCccccC-CCCCCcEEeccCC-cccchhhhhhccCcccccc
Q psy8879 169 NLDRLDLSHNQLYKLENTSFKGLSSLNFLDLSYNKL-MTLSQDCLA-PLVTLRVLRLQGN-RLTVSVVAALQGLRSVTDL 245 (694)
Q Consensus 169 ~L~~L~Ls~N~L~~i~~~~f~~L~~L~~L~Ls~N~l-~~i~~~~f~-~L~~L~~L~Ls~N-~l~~~~~~~~~~L~~L~~L 245 (694)
.++.+|-++..|....-..+.+++.++.|.+.++.- .+..-+.++ ..++|+.|++++| +|+..--..+..+++|+.|
T Consensus 102 ~IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L 181 (221)
T KOG3864|consen 102 KIEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRRL 181 (221)
T ss_pred eEEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHHH
Confidence 577777777776666555666677777777766541 111111111 2367778888766 4555445556666677666
Q ss_pred cCCC
Q psy8879 246 DLSH 249 (694)
Q Consensus 246 ~Ls~ 249 (694)
.+.+
T Consensus 182 ~l~~ 185 (221)
T KOG3864|consen 182 HLYD 185 (221)
T ss_pred HhcC
Confidence 6654
No 227
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=76.15 E-value=6.6 Score=32.69 Aligned_cols=25 Identities=12% Similarity=-0.078 Sum_probs=19.7
Q ss_pred EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 474 QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
+......|.|.|+|.|+|.....+.
T Consensus 50 i~~~~~~~~~~y~C~a~n~~l~~~~ 74 (82)
T cd05759 50 ITPSDHDTGRTFTCRARNEALPTGK 74 (82)
T ss_pred EeCceecCCCEEEEEEcCccCCCCc
Confidence 5556666788999999998887764
No 228
>KOG4242|consensus
Probab=72.18 E-value=21 Score=40.03 Aligned_cols=84 Identities=20% Similarity=0.062 Sum_probs=36.4
Q ss_pred ccEEEccCCCCCCCCccccccC--CCCccEEEccCCCCCC---CCcccccCCCCccEEEecCCCCC--------CCCccc
Q psy8879 145 LQALGLPNNLLSVVPTSALAPL--APNLDRLDLSHNQLYK---LENTSFKGLSSLNFLDLSYNKLM--------TLSQDC 211 (694)
Q Consensus 145 L~~L~Ls~N~L~~lp~~~~~~l--~~~L~~L~Ls~N~L~~---i~~~~f~~L~~L~~L~Ls~N~l~--------~i~~~~ 211 (694)
+.+++|+.|....-.+.....+ ...++.++.+...+.. ..+..++.-++|+..+++.|..+ +-..+.
T Consensus 216 lteldls~n~~Kddip~~~n~~a~~~vl~~ld~s~tgirlD~l~~~l~~g~~tkl~~~kls~ng~s~skg~Egg~~~k~~ 295 (553)
T KOG4242|consen 216 LTELDLSTNGGKDDIPRTLNKKAGTLVLFKLDRSTTGIRLDLLTSPLAAGRTTKLTFGKLSRNGTSPSKGEEGGGAEKDT 295 (553)
T ss_pred ccccccccCCCCccchhHHHHhhhhhhhhcccccccccchhhcccccccccccccchhhhccCCCCcccccccccccccc
Confidence 6666666665543222111111 1235555555443321 12222333455666666655432 111223
Q ss_pred cCCCCCCcEEeccCCccc
Q psy8879 212 LAPLVTLRVLRLQGNRLT 229 (694)
Q Consensus 212 f~~L~~L~~L~Ls~N~l~ 229 (694)
|+.-+++ +|++......
T Consensus 296 fS~~~sg-hln~~~~~~p 312 (553)
T KOG4242|consen 296 FSPDPSG-HLNSRPRYTP 312 (553)
T ss_pred cCcCccc-ccccccccCc
Confidence 4444555 5666555443
No 229
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=70.83 E-value=2.3 Score=37.06 Aligned_cols=21 Identities=10% Similarity=0.034 Sum_probs=19.1
Q ss_pred EE-EEEEEecCCCcceeEEEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTIT 492 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n~ 492 (694)
+| |.+++..|+|.|.|.+...
T Consensus 80 sL~i~~l~~~DsG~Y~C~v~~~ 101 (114)
T PF07686_consen 80 SLTIKNLQPSDSGTYFCQVSTS 101 (114)
T ss_dssp EEEESSESGGGEEEEEEEEEES
T ss_pred EEEECCCCcCcCEEEEEEEEEC
Confidence 45 9999999999999999886
No 230
>smart00406 IGv Immunoglobulin V-Type.
Probab=69.21 E-value=1.6 Score=35.68 Aligned_cols=19 Identities=5% Similarity=0.013 Sum_probs=16.3
Q ss_pred cEE-EEEEEecCCCcceeEE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLL 489 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~ 489 (694)
-+| |.+++.+|+|.|.|.+
T Consensus 62 ~~L~i~~~~~~D~G~Y~C~v 81 (81)
T smart00406 62 VSLTISNLRVEDTGTYYCAV 81 (81)
T ss_pred EEEEEcCCCHHHCEEEEEcC
Confidence 345 9999999999999974
No 231
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=67.02 E-value=5.5 Score=30.02 Aligned_cols=20 Identities=15% Similarity=0.072 Sum_probs=17.6
Q ss_pred EEEEEecCCCcceeEEEEEe
Q psy8879 474 QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~ 493 (694)
+.+++..|.|.|+|.+.+..
T Consensus 47 i~~~~~~d~g~y~C~~~~~~ 66 (74)
T cd00096 47 ISNVTLEDSGTYTCVASNSA 66 (74)
T ss_pred ECccCcccCcEEEEEEecCc
Confidence 78888899999999998765
No 232
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=66.92 E-value=2.8 Score=36.38 Aligned_cols=20 Identities=15% Similarity=-0.049 Sum_probs=17.7
Q ss_pred EE-EEEEEecCCCcceeEEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n 491 (694)
+| |.+++.+|+|+|.|.+.+
T Consensus 64 ~L~I~~~~~~Dsg~Y~C~~~~ 84 (98)
T cd04984 64 SLTISGAQTEDEADYYCQVWD 84 (98)
T ss_pred EEEECCCChhhCEEEEEEEcc
Confidence 44 899999999999999875
No 233
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=66.38 E-value=2.3 Score=37.50 Aligned_cols=28 Identities=18% Similarity=-0.034 Sum_probs=21.2
Q ss_pred EE-EEEEEecCCCcceeEEEEE---eeeccce
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTIT---LYIDGDV 499 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n~---~~~~~~~ 499 (694)
.| |.+++.+|+|.|.|.+.+. .|..|..
T Consensus 72 ~L~I~~~~~~Dsg~Y~Ca~~~~~~~~fg~gT~ 103 (106)
T cd04980 72 TLTISRVEPEDAAVYYCQQYGTFPYTFGGGTK 103 (106)
T ss_pred EEEECCCChHHCEEEEEEEeCCCCCEECCCEE
Confidence 45 8999999999999998653 4544443
No 234
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=64.72 E-value=10 Score=33.65 Aligned_cols=29 Identities=3% Similarity=-0.256 Sum_probs=23.7
Q ss_pred EEEEEecCCCcceeEEEEEeeeccceeEE
Q psy8879 474 QVYVQLWTNYDPNCLLTITLYIDGDVIVQ 502 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~~~~~~~~~~ 502 (694)
..-+..+|.|.|||.|+|...+...-+..
T Consensus 69 L~Rlk~~E~G~YTf~a~N~~~~~s~tF~l 97 (101)
T cd05860 69 LTRLKGTEGGTYTFLVSNSDASASVTFNV 97 (101)
T ss_pred EeecChhhCcEEEEEEECCCCeEEEEEEE
Confidence 78899999999999999987776654443
No 235
>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []. This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.
Probab=64.61 E-value=13 Score=26.67 Aligned_cols=16 Identities=19% Similarity=0.494 Sum_probs=10.5
Q ss_pred HHHHHHhhhcCCCCCcee
Q psy8879 593 ICVLVRKICRTPRNSTIH 610 (694)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~ 610 (694)
+++++.--|+| +++-|
T Consensus 21 i~~~~YaCcyk--k~~~~ 36 (38)
T PF02439_consen 21 ICMFYYACCYK--KHRRQ 36 (38)
T ss_pred HHHHHHHHHHc--ccccc
Confidence 66777777777 55544
No 236
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=63.89 E-value=3.7 Score=25.92 Aligned_cols=19 Identities=26% Similarity=0.303 Sum_probs=9.6
Q ss_pred CCCcEEeccCCcccchhhh
Q psy8879 216 VTLRVLRLQGNRLTVSVVA 234 (694)
Q Consensus 216 ~~L~~L~Ls~N~l~~~~~~ 234 (694)
++|++|+|++|+++.....
T Consensus 2 ~~L~~L~l~~n~i~~~g~~ 20 (24)
T PF13516_consen 2 PNLETLDLSNNQITDEGAS 20 (24)
T ss_dssp TT-SEEE-TSSBEHHHHHH
T ss_pred CCCCEEEccCCcCCHHHHH
Confidence 4566666666666544333
No 237
>PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls. Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 [].
Probab=63.48 E-value=9.2 Score=35.46 Aligned_cols=38 Identities=16% Similarity=0.195 Sum_probs=16.4
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhcCCCCCceeeccccCCC
Q psy8879 580 LCLVLLCVLIVILICVLVRKICRTPRNSTIHHHACFIPV 618 (694)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (694)
++++++++|++++++++-|+--||.+ .-+.-|++..|.
T Consensus 6 ~iii~~i~l~~~~~~~~~rRR~r~G~-~P~~gt~w~~pp 43 (130)
T PF12273_consen 6 AIIIVAILLFLFLFYCHNRRRRRRGL-QPIYGTRWMAPP 43 (130)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCC-CCcCCceecCCC
Confidence 33333333333323333344333322 234456888754
No 238
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=63.12 E-value=6.6 Score=38.66 Aligned_cols=41 Identities=15% Similarity=0.127 Sum_probs=32.4
Q ss_pred cEE-EEEEEecCCCcceeEEEEEeeecc-ceeEEeeccCCCC-eEe
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTITLYIDG-DVIVQKNTNCSRP-WVS 513 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n~~~~~~-~~~~~~~~~~~~~-~~~ 513 (694)
.++ |.+|+.+|+|.|+|.+. .|-.| ..-.+--|+.+++ +++
T Consensus 85 StItIknVt~sDeGcY~C~F~--tfp~G~~~~gt~CLtVt~~~~~~ 128 (189)
T PHA02987 85 STILIKNVSLKDNGCYTCIFN--TLLSKNNEKGVVCLNVTTDSYTT 128 (189)
T ss_pred ceEEEEeCChhhCeEEEEEEE--ecCCCCCceeEEEEEEEchhhcc
Confidence 444 99999999999999984 45556 7777888898888 443
No 239
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=62.41 E-value=3.9 Score=36.28 Aligned_cols=21 Identities=5% Similarity=-0.067 Sum_probs=18.4
Q ss_pred cEE-EEEEEecCCCcceeEEEE
Q psy8879 471 GTV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 471 gtL-~~~v~~~d~G~YtC~~~n 491 (694)
.+| |.+++.+|+|.|.|.+.+
T Consensus 72 ~~L~I~~~~~~Dsg~Y~Ca~~~ 93 (110)
T cd05899 72 SSLTIKSAEPEDSAVYLCASSL 93 (110)
T ss_pred cEEEECCCChhhCEEEEEEeeC
Confidence 345 899999999999999986
No 240
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=61.60 E-value=22 Score=30.05 Aligned_cols=27 Identities=7% Similarity=-0.061 Sum_probs=21.8
Q ss_pred CCCcceeEEEEEeeeccceeEEeeccC
Q psy8879 481 TNYDPNCLLTITLYIDGDVIVQKNTNC 507 (694)
Q Consensus 481 d~G~YtC~~~n~~~~~~~~~~~~~~~~ 507 (694)
|...|+|.|.+...+.....++..|+|
T Consensus 57 ~g~~ytC~v~h~~l~~~~~~~~~~~~~ 83 (83)
T cd05884 57 DGVAIICRVDHESLNATPQIAMQVLEI 83 (83)
T ss_pred CCCEEEEEEechhcCCCChhhEEEeeC
Confidence 355699999999999887777777765
No 241
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=60.67 E-value=6.2 Score=35.73 Aligned_cols=20 Identities=5% Similarity=-0.222 Sum_probs=17.6
Q ss_pred EE-EEEEEecCCCcceeEEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n 491 (694)
.| |.+++.+|+|+|.|.+..
T Consensus 81 sL~I~~l~~~Dsg~Y~C~~~~ 101 (119)
T cd05712 81 SLLISDAQPEDSGKYFFRVEL 101 (119)
T ss_pred EEEEccCChhhCeEEEEEEEc
Confidence 44 999999999999998855
No 242
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=60.64 E-value=11 Score=33.71 Aligned_cols=20 Identities=10% Similarity=-0.082 Sum_probs=17.6
Q ss_pred EE-EEEEEecCCCcceeEEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n 491 (694)
+| |.+++.+|+|.|.|.+..
T Consensus 78 ~L~I~~~~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 78 TLTIQNLEKEDSATYYCAYWE 98 (116)
T ss_pred EEEEEECCHHHCEEEEEEEec
Confidence 45 999999999999999864
No 243
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type.
Probab=58.90 E-value=6.4 Score=25.93 Aligned_cols=17 Identities=41% Similarity=0.708 Sum_probs=11.7
Q ss_pred CCCEEEccCCCCCCCCc
Q psy8879 362 SLQELRLDDNDISMEPE 378 (694)
Q Consensus 362 ~L~~L~Ls~N~L~~l~~ 378 (694)
+|+.|++++|+++.+|+
T Consensus 3 ~L~~L~vs~N~Lt~LPe 19 (26)
T smart00364 3 SLKELNVSNNQLTSLPE 19 (26)
T ss_pred ccceeecCCCccccCcc
Confidence 56677777777776664
No 244
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=58.58 E-value=24 Score=29.49 Aligned_cols=34 Identities=12% Similarity=-0.003 Sum_probs=23.1
Q ss_pred EEEEEEecC-CCcceeEEEEEeeeccceeEEeecc
Q psy8879 473 VQVYVQLWT-NYDPNCLLTITLYIDGDVIVQKNTN 506 (694)
Q Consensus 473 L~~~v~~~d-~G~YtC~~~n~~~~~~~~~~~~~~~ 506 (694)
|....+.+| .++|+|.|.+..+..+.......++
T Consensus 47 l~~~~~~~d~g~~~~C~v~h~~l~~~~~~~~~~~~ 81 (82)
T cd05761 47 LRFQVDREDDGAPIICRVDHPALKSTDKQTQQVLE 81 (82)
T ss_pred EEEEcchhhCCCEEEEEEeChhcCCCCceeEEEEe
Confidence 333444444 4579999999999887666665554
No 245
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily.
Probab=56.95 E-value=8.7 Score=25.27 Aligned_cols=15 Identities=40% Similarity=0.587 Sum_probs=7.6
Q ss_pred CCCCEEEccCCCCCC
Q psy8879 361 KSLQELRLDDNDISM 375 (694)
Q Consensus 361 ~~L~~L~Ls~N~L~~ 375 (694)
.+|+.|++++|+|+.
T Consensus 2 ~~L~~L~L~~NkI~~ 16 (26)
T smart00365 2 TNLEELDLSQNKIKK 16 (26)
T ss_pred CccCEEECCCCccce
Confidence 345555555555543
No 246
>PF15050 SCIMP: SCIMP protein
Probab=56.85 E-value=19 Score=32.66 Aligned_cols=30 Identities=20% Similarity=0.233 Sum_probs=18.7
Q ss_pred HHHHHHHHHHHHHHHHHHhhhcCCCCCceee
Q psy8879 581 CLVLLCVLIVILICVLVRKICRTPRNSTIHH 611 (694)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 611 (694)
|++|..++-++ ++-++||..|+.++-.|-.
T Consensus 16 II~vS~~lglI-lyCvcR~~lRqGkkweiak 45 (133)
T PF15050_consen 16 IILVSVVLGLI-LYCVCRWQLRQGKKWEIAK 45 (133)
T ss_pred HHHHHHHHHHH-HHHHHHHHHHccccceecc
Confidence 44444444444 3445899999988877753
No 247
>KOG3763|consensus
Probab=56.56 E-value=5.3 Score=45.43 Aligned_cols=66 Identities=27% Similarity=0.245 Sum_probs=43.6
Q ss_pred cCCcccceecccCCccccccch--hhhcccccccccCCCC--ccccccccchhcccccCeeecCCCCCCC
Q psy8879 286 AGLDKLTSLSCHHNQIDVLEDH--SFRALSTLSHLDLAHN--RIVAVSGASLAHLSNLTTLDLSHNFLRA 351 (694)
Q Consensus 286 ~~L~~L~~L~Ls~N~L~~i~~~--~f~~l~~L~~L~Ls~N--~L~~i~~~~f~~l~~L~~L~Ls~N~L~~ 351 (694)
.+.+.+..++|++|++..++.- .-...|+|+.|+|++| .+.......=.+...|++|-|.+|.+..
T Consensus 215 ~n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~l~Leel~l~GNPlc~ 284 (585)
T KOG3763|consen 215 ENFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKGLPLEELVLEGNPLCT 284 (585)
T ss_pred cCCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcCCCHHHeeecCCcccc
Confidence 3557788889999998766531 1123478999999999 4433322111233568889999998854
No 248
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=53.31 E-value=22 Score=30.13 Aligned_cols=16 Identities=13% Similarity=0.075 Sum_probs=13.3
Q ss_pred cCCCcceeEEEEEeee
Q psy8879 480 WTNYDPNCLLTITLYI 495 (694)
Q Consensus 480 ~d~G~YtC~~~n~~~~ 495 (694)
.|.|.|+|+|++....
T Consensus 72 ~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 72 NSGDTYTCVVTHESLP 87 (95)
T ss_pred CCCCCEEEEEEeCCCC
Confidence 3899999999987654
No 249
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=52.26 E-value=5.5 Score=35.17 Aligned_cols=19 Identities=11% Similarity=-0.107 Sum_probs=17.2
Q ss_pred EE-EEEEEecCCCcceeEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLT 490 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~ 490 (694)
+| |.+++.+|+|+|.|.+.
T Consensus 70 ~L~I~~~~~sDsgtY~Ca~~ 89 (104)
T cd05720 70 VLTLKNFQKENEGYYFCSVA 89 (104)
T ss_pred EEEECCCCHHHCEEEEEEEc
Confidence 45 99999999999999986
No 250
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=51.64 E-value=6.7 Score=35.15 Aligned_cols=20 Identities=20% Similarity=0.179 Sum_probs=17.8
Q ss_pred EE-EEEEEecCCCcceeEEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n 491 (694)
+| |.+++.+|+|.|.|.+..
T Consensus 73 sL~I~~~~~~Dsg~Y~C~~~~ 93 (116)
T cd07706 73 SLTISALQLEDSAKYFCALST 93 (116)
T ss_pred EEEECCCCHHHCEEEEEEEEC
Confidence 45 899999999999999984
No 251
>PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls. Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 [].
Probab=51.01 E-value=11 Score=34.82 Aligned_cols=11 Identities=18% Similarity=0.483 Sum_probs=4.7
Q ss_pred HHHHHHHHHHH
Q psy8879 581 CLVLLCVLIVI 591 (694)
Q Consensus 581 ~~~~~~~~~~~ 591 (694)
+|+++++++++
T Consensus 4 l~~iii~~i~l 14 (130)
T PF12273_consen 4 LFAIIIVAILL 14 (130)
T ss_pred eHHHHHHHHHH
Confidence 34444444444
No 252
>KOG3763|consensus
Probab=50.89 E-value=7.2 Score=44.37 Aligned_cols=64 Identities=20% Similarity=0.265 Sum_probs=39.0
Q ss_pred CccccceeeccCCcccccccc--cccCCcccceecccCC--ccccccc-hhhhcccccccccCCCCcccc
Q psy8879 263 RLSSLKVLSIAHNQFSSVRRG--ALAGLDKLTSLSCHHN--QIDVLED-HSFRALSTLSHLDLAHNRIVA 327 (694)
Q Consensus 263 ~l~~L~~L~Ls~N~L~~i~~~--~~~~L~~L~~L~Ls~N--~L~~i~~-~~f~~l~~L~~L~Ls~N~L~~ 327 (694)
+.+.+..+.|++|++..+..- .-...|+|+.|+|++| .+..... .-+++ ..|++|-+.+|.+..
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~-l~Leel~l~GNPlc~ 284 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKG-LPLEELVLEGNPLCT 284 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcC-CCHHHeeecCCcccc
Confidence 345677788888887765321 1123468888999988 3332211 12222 347888888888754
No 253
>PTZ00370 STEVOR; Provisional
Probab=50.66 E-value=13 Score=38.93 Aligned_cols=23 Identities=35% Similarity=0.654 Sum_probs=11.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHh
Q psy8879 577 VLSLCLVLLCVLIVILICVLVRK 599 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~ 599 (694)
|-+++++++.|++|+|-+|+||+
T Consensus 259 iaalvllil~vvliilYiwlyrr 281 (296)
T PTZ00370 259 IAALVLLILAVVLIILYIWLYRR 281 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHh
Confidence 34444444455555555555554
No 254
>PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world. Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens [].
Probab=50.05 E-value=22 Score=37.84 Aligned_cols=8 Identities=38% Similarity=0.542 Sum_probs=3.5
Q ss_pred ccchhhhH
Q psy8879 567 HYTSLINL 574 (694)
Q Consensus 567 ~~~~~~~~ 574 (694)
+++++.+.
T Consensus 250 ~~~~~~t~ 257 (299)
T PF02009_consen 250 TYASLTTA 257 (299)
T ss_pred hhhhhHHH
Confidence 34444443
No 255
>KOG4242|consensus
Probab=49.23 E-value=60 Score=36.62 Aligned_cols=101 Identities=15% Similarity=0.070 Sum_probs=47.7
Q ss_pred ccceecccCCccccccch--hhhcccccccccCCCCccccc--ccc---ch----hcccccCeeecCCCCCCCcChh---
Q psy8879 290 KLTSLSCHHNQIDVLEDH--SFRALSTLSHLDLAHNRIVAV--SGA---SL----AHLSNLTTLDLSHNFLRALTQD--- 355 (694)
Q Consensus 290 ~L~~L~Ls~N~L~~i~~~--~f~~l~~L~~L~Ls~N~L~~i--~~~---~f----~~l~~L~~L~Ls~N~L~~l~~~--- 355 (694)
.+++|.+..|.+...... ....-++++.+++.+-.-..+ ++. .. ..-.-+..+.++.|.+..-...
T Consensus 355 R~q~l~~rdnnldgeg~~vgk~~~s~s~r~l~agrs~~kqvm~s~~~a~~v~k~~~~~g~l~el~ls~~~lka~l~s~in 434 (553)
T KOG4242|consen 355 RVQVLLQRDNNLDGEGGAVGKRKQSKSGRILKAGRSGDKQVMDSSTEAPPVSKKSRTHGVLAELSLSPGPLKAGLESAIN 434 (553)
T ss_pred eeeEeeccccccccccccccceeeccccccccccccCCceeccccccchhhhhhhcccccccCcccCCCcccccHHHHHH
Confidence 367777777766533221 222334556666544322111 000 00 0112355666777766543322
Q ss_pred hhCCCCCCCEEEccCCCCCCCCcccccCCCCCCcc
Q psy8879 356 LITPLKSLQELRLDDNDISMEPECIYVGFNTMDLE 390 (694)
Q Consensus 356 ~~~~l~~L~~L~Ls~N~L~~l~~~~f~~~NpCdC~ 390 (694)
.+..-+.+..|++++|.....+.-+....-+-.|.
T Consensus 435 ~l~stqtl~kldisgn~mgd~gap~lpkalq~n~r 469 (553)
T KOG4242|consen 435 KLLSTQTLAKLDISGNGMGDGGAPPLPKALQSNCR 469 (553)
T ss_pred hhccCcccccccccCCCcccCCCCcCccccCCCCc
Confidence 22334667777777777665544444333333443
No 256
>cd05767 IgC_MHC_II_alpha Class II major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_II_alpha: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II alpha chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosom
Probab=49.14 E-value=91 Score=27.09 Aligned_cols=47 Identities=9% Similarity=-0.135 Sum_probs=25.0
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE----EEEEEecCCCcceeEEEEEe
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV----QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL----~~~v~~~d~G~YtC~~~n~~ 493 (694)
+.|+....... .........-.+||+- ...+..++...|+|+|.-..
T Consensus 34 v~W~~~g~~~~--~~~~~~~~~~~~Dgty~~~s~L~v~~~~~~~ytC~V~H~~ 84 (94)
T cd05767 34 VTWLKNGVPVT--DGVSETRYYPRQDLSFQKFSYLNFTPEEGDIYSCIVEHWG 84 (94)
T ss_pred EEEEECCeEcc--CceEEeeeEeCCCCcEEEEEEEEEECCCCCeEEEEEEeCC
Confidence 56664443322 2223334445556655 33445556677999997543
No 257
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=48.49 E-value=6.6 Score=33.91 Aligned_cols=23 Identities=13% Similarity=-0.316 Sum_probs=19.4
Q ss_pred EE-EEEEEecCCCcceeEEEEEee
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTITLY 494 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n~~~ 494 (694)
+| |.+++..|+|.|.|.+....+
T Consensus 65 ~L~I~~v~~~DsG~Y~C~~~~~~~ 88 (98)
T cd05716 65 TVTLNQLRKEDAGWYWCGVGDDGD 88 (98)
T ss_pred EEEEcCCCHHHCEEEEEEcccCCC
Confidence 44 999999999999999877554
No 258
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=47.83 E-value=63 Score=27.16 Aligned_cols=27 Identities=11% Similarity=0.069 Sum_probs=21.6
Q ss_pred cCCCcceeEEEEEeeeccceeEEeecc
Q psy8879 480 WTNYDPNCLLTITLYIDGDVIVQKNTN 506 (694)
Q Consensus 480 ~d~G~YtC~~~n~~~~~~~~~~~~~~~ 506 (694)
.|...|+|.|.+..+...++..+..++
T Consensus 56 d~g~~~tC~v~h~~l~~~~~~~~~~~~ 82 (83)
T cd07705 56 DDGAEITCSVGHESLHDSDRSTSQRIE 82 (83)
T ss_pred hCCCEEEEEEECcccCCCCceeEEEee
Confidence 345779999999999888887777665
No 259
>PF13150 DUF3989: Protein of unknown function (DUF3989)
Probab=45.55 E-value=60 Score=27.88 Aligned_cols=53 Identities=13% Similarity=0.238 Sum_probs=27.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhhcC-CCCCceee-ccccCCCCccccccccCCC
Q psy8879 574 LSNVLSLCLVLLCVLIVILICVLVRKICRT-PRNSTIHH-HACFIPVAQQEDDINRNNS 630 (694)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 630 (694)
+++++.++|+++++-.++ --+..+.|. .++++|++ +|=-+|+ +.+.+++.|+.
T Consensus 30 vvl~ml~~fa~l~ly~~~---~ai~~~Gk~~g~~~~IeHI~~l~l~~-~~DSin~~~~~ 84 (85)
T PF13150_consen 30 VVLVMLVLFAALCLYMTV---SAIYDIGKEDGERMEIEHIRPLELPQ-PKDSINHLKPY 84 (85)
T ss_pred HHHHHHHHHHHHHHHHHH---HHHHHhccCcccCccceeccccCCCC-CCCcccccCCC
Confidence 355555556555544422 222233433 24566663 4555663 67777777543
No 260
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=45.08 E-value=25 Score=30.36 Aligned_cols=18 Identities=11% Similarity=-0.202 Sum_probs=16.0
Q ss_pred EEEEEEecCCCcceeEEE
Q psy8879 473 VQVYVQLWTNYDPNCLLT 490 (694)
Q Consensus 473 L~~~v~~~d~G~YtC~~~ 490 (694)
.|..++..|+|+|.|...
T Consensus 58 ~I~~~~~~~~G~Y~C~~~ 75 (94)
T cd05711 58 PLGPVTPAHAGTYRCYGS 75 (94)
T ss_pred EecCCCcccCEEEEEEEE
Confidence 488899999999999975
No 261
>KOG4221|consensus
Probab=44.42 E-value=34 Score=42.60 Aligned_cols=34 Identities=18% Similarity=0.034 Sum_probs=27.9
Q ss_pred eeeeEEecccEE-EEEEEecCCCcceeEEEEEeee
Q psy8879 462 SLRANVTGLGTV-QVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 462 ~~~~n~~~~gtL-~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
+.|+-+.-+|.| |..++-.|+|.|.|.|++..=+
T Consensus 184 ~~r~i~lpsG~L~I~~~qp~d~g~yrc~vt~g~~~ 218 (1381)
T KOG4221|consen 184 DSRVIVLPSGALEISGLQPSDTGEYRCVVTGGASQ 218 (1381)
T ss_pred CCcEEEcCCCcEEecccccCCCceEEEEEecCCcC
Confidence 336667778888 9999999999999999985433
No 262
>PF07010 Endomucin: Endomucin; InterPro: IPR010740 This family consists of several mammalian endomucin proteins. Endomucin is an early endothelial-specific antigen that is also expressed on putative hematopoietic progenitor cells.
Probab=43.04 E-value=53 Score=33.21 Aligned_cols=33 Identities=27% Similarity=0.430 Sum_probs=17.7
Q ss_pred HHHHhhhcCCCCCceeeccccCCCCccccccccCCCCCceeeeeh
Q psy8879 595 VLVRKICRTPRNSTIHHHACFIPVAQQEDDINRNNSDSRYVKLQA 639 (694)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (694)
+..+++|++- . |. ..+++..+-.+|..-|||++
T Consensus 208 vgLyr~C~k~-d----------Pg-~p~~g~~qpqsdke~vkllt 240 (259)
T PF07010_consen 208 VGLYRMCWKT-D----------PG-TPENGPDQPQSDKESVKLLT 240 (259)
T ss_pred HHHHHHhhcC-C----------CC-CcccCCCCCCccccceeEEE
Confidence 4456788871 2 22 33333444445566788763
No 263
>TIGR01478 STEVOR variant surface antigen, stevor family. This model represents the stevor branch of the rifin/stevor family (pfam02009) of predicted variant surface antigens as found in Plasmodium falciparum. This model is based on a set of stevor sequences kindly provided by Matt Berriman from the Sanger Center. This is a global model and assesses a penalty for incomplete sequence. Additional fragmentary sequences may be found with the fragment model and a cutoff of 8 bits.
Probab=40.02 E-value=35 Score=35.77 Aligned_cols=23 Identities=35% Similarity=0.658 Sum_probs=10.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHh
Q psy8879 577 VLSLCLVLLCVLIVILICVLVRK 599 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~ 599 (694)
|-+++++++.|++|+|-+|++|+
T Consensus 263 iaalvllil~vvliiLYiWlyrr 285 (295)
T TIGR01478 263 IAALVLIILTVVLIILYIWLYRR 285 (295)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHh
Confidence 33444444444445544555543
No 264
>KOG3884|consensus
Probab=39.15 E-value=40 Score=36.13 Aligned_cols=26 Identities=8% Similarity=-0.115 Sum_probs=23.5
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhh
Q psy8879 575 SNVLSLCLVLLCVLIVILICVLVRKI 600 (694)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (694)
++|+++|.+|.++.+|++++|.+.|+
T Consensus 297 vlIla~v~~v~aa~~Vg~la~g~~~~ 322 (437)
T KOG3884|consen 297 VLILAAVGTVMAAGLVGTLAGGTYYY 322 (437)
T ss_pred HHHHHHHHHHHHHHHHHHhhhhheee
Confidence 77999999999999999998887776
No 265
>PF04639 Baculo_E56: Baculoviral E56 protein, specific to ODV envelope; InterPro: IPR006733 This family represents the E56 protein, which is localized to the occlusion derived virus (ODV) envelope, but not to the budded virus (BV) envelope []. Signals necessary for transport and/or retention into this structure are believed to be found within the C-terminal portion of ODV-E56.; GO: 0019031 viral envelope
Probab=38.52 E-value=32 Score=35.95 Aligned_cols=11 Identities=18% Similarity=0.486 Sum_probs=9.0
Q ss_pred CCCCceeEEEe
Q psy8879 534 TDKPLLHCITI 544 (694)
Q Consensus 534 ~~~~~~~~~~~ 544 (694)
....++.|||.
T Consensus 231 ~~nqtI~CiEP 241 (305)
T PF04639_consen 231 APNQTIQCIEP 241 (305)
T ss_pred CCCCeEEEecC
Confidence 56679999997
No 266
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=37.99 E-value=12 Score=33.02 Aligned_cols=19 Identities=11% Similarity=-0.038 Sum_probs=17.0
Q ss_pred EE-EEEEEecCCCcceeEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLT 490 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~ 490 (694)
.| |.+++.+|+|.|.|...
T Consensus 73 ~L~I~~~~~~Dsg~YyCa~~ 92 (107)
T cd07700 73 RLHINRVKPEDSGTYFCMTV 92 (107)
T ss_pred EEEECCCCHHHCEEEEEeEc
Confidence 45 89999999999999985
No 267
>cd05766 IgC_MHC_II_beta Class II major histocompatibility complex (MHC) beta chain immunoglobulin domain. IgC_MHC_II_beta: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II beta chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosome be
Probab=37.96 E-value=1.3e+02 Score=25.95 Aligned_cols=58 Identities=12% Similarity=-0.018 Sum_probs=30.6
Q ss_pred eeeeeceeE---------EEEeccCccccccceeEeeeeEEecccEE----EEEEEecCCCcceeEEEEEeee
Q psy8879 436 SALVLGCSE---------ILALVPTLTSQPLSYVTSLRANVTGLGTV----QVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 436 ~~~~l~c~~---------i~~l~~~~~~~~~~~i~~~~~n~~~~gtL----~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
....|.|.+ +.|.......... .......-.+||+. ...+..++...|+|+|+-....
T Consensus 15 ~~~~L~C~~~gFyP~~i~v~W~~~g~~~~~~--~~~~~~~~~~dgTy~~~s~L~~~~~~~~~ysC~V~H~~l~ 85 (94)
T cd05766 15 HPHLLVCHVWGFYPPEITVKWFKNGQEETEG--VVSTELIPNGDWTYQILVMLETTPSRGDTYTCVVEHSSLQ 85 (94)
T ss_pred CCeEEEEEEeeecCCCCEEEEEECCeecCCC--ceecceEECCCCcEEEEEEEEEcCCCCCEEEEEEEeCCCC
Confidence 334566655 5666655543321 11222223345544 3345555667799999875543
No 268
>PTZ00370 STEVOR; Provisional
Probab=37.95 E-value=13 Score=38.86 Aligned_cols=30 Identities=20% Similarity=0.235 Sum_probs=18.8
Q ss_pred HHHHHH-HHHHHHHHHHHHHHHhhhcCCCCCce
Q psy8879 578 LSLCLV-LLCVLIVILICVLVRKICRTPRNSTI 609 (694)
Q Consensus 578 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 609 (694)
-+.+.+ |+++|.|+ ++++|=|+-|| |+.--
T Consensus 256 Pygiaalvllil~vv-liilYiwlyrr-RK~sw 286 (296)
T PTZ00370 256 PYGIAALVLLILAVV-LIILYIWLYRR-RKNSW 286 (296)
T ss_pred ccHHHHHHHHHHHHH-HHHHHHHHHHh-hcchh
Confidence 455544 44455555 77899999888 44443
No 269
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=37.06 E-value=78 Score=27.05 Aligned_cols=30 Identities=17% Similarity=0.024 Sum_probs=20.0
Q ss_pred EEecccEE----EEEEEecCCCcceeEEEEEeee
Q psy8879 466 NVTGLGTV----QVYVQLWTNYDPNCLLTITLYI 495 (694)
Q Consensus 466 n~~~~gtL----~~~v~~~d~G~YtC~~~n~~~~ 495 (694)
.-.++|+- ...|..+|.+.|+|.|....+.
T Consensus 52 ~~~~d~ty~~~s~l~v~~~~~~~ytC~V~H~~~~ 85 (93)
T cd07698 52 LPNGDGTYQLWVTLEVPPEDKARYSCRVEHSGLK 85 (93)
T ss_pred EECCCCeEEEEEEEEECCCCCCEEEEEEEeCCCC
Confidence 33445544 4556667889999999876553
No 270
>PF07654 C1-set: Immunoglobulin C1-set domain; InterPro: IPR003597 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [, ], and in various T-cell receptors.; PDB: 3BVN_D 3BXN_A 3PWV_E 3L9R_F 2XFX_B 1BMG_A 1K8I_A 3M1B_G 3M17_C 1EXU_A ....
Probab=36.50 E-value=1.3e+02 Score=24.99 Aligned_cols=47 Identities=15% Similarity=0.000 Sum_probs=24.3
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE----EEEEEecCCCcceeEEEEEe
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV----QVYVQLWTNYDPNCLLTITL 493 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL----~~~v~~~d~G~YtC~~~n~~ 493 (694)
+.|........... ...... ...+|+- ...|...+...|+|.|+-..
T Consensus 27 v~W~~~~~~~~~~~-~~~~~~-~~~dgty~~~s~l~v~~~~~~~ysC~V~H~~ 77 (83)
T PF07654_consen 27 VTWLKNGKEVTEGV-ETTPPP-PNSDGTYSVTSSLTVTWNSGDEYSCRVTHES 77 (83)
T ss_dssp EEEEETTEEETTTE-EEEEEE-EETTSEEEEEEEEEEETTTTGGEEEEEEETT
T ss_pred EEEEeccceeeeee-eecccc-cccccceeeeEEEEecCCCCCEEEEEEEECC
Confidence 67766555544221 111111 1355655 44455445666999997543
No 271
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=36.07 E-value=40 Score=31.03 Aligned_cols=10 Identities=20% Similarity=0.511 Sum_probs=4.5
Q ss_pred HHHHHHhhhc
Q psy8879 593 ICVLVRKICR 602 (694)
Q Consensus 593 ~~~~~~~~~~ 602 (694)
|+++.|+.-|
T Consensus 84 i~y~irR~~K 93 (122)
T PF01102_consen 84 ISYCIRRLRK 93 (122)
T ss_dssp HHHHHHHHS-
T ss_pred HHHHHHHHhc
Confidence 4455555533
No 272
>smart00407 IGc1 Immunoglobulin C-Type.
Probab=35.43 E-value=1.1e+02 Score=25.04 Aligned_cols=14 Identities=14% Similarity=-0.004 Sum_probs=10.4
Q ss_pred cCCCcceeEEEEEe
Q psy8879 480 WTNYDPNCLLTITL 493 (694)
Q Consensus 480 ~d~G~YtC~~~n~~ 493 (694)
.+...|+|.|....
T Consensus 58 ~~~~~~tC~V~H~~ 71 (75)
T smart00407 58 ESGDTYTCQVTHEG 71 (75)
T ss_pred CCCCEEEEEEEEcC
Confidence 55677999997644
No 273
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=35.32 E-value=28 Score=31.42 Aligned_cols=20 Identities=5% Similarity=-0.162 Sum_probs=17.4
Q ss_pred EE-EEEEEecCCCcceeEEEE
Q psy8879 472 TV-QVYVQLWTNYDPNCLLTI 491 (694)
Q Consensus 472 tL-~~~v~~~d~G~YtC~~~n 491 (694)
.| |.+++.+|+|+|.|.+..
T Consensus 77 ~L~I~~~~~~Dsa~YyCa~~~ 97 (117)
T cd04981 77 YLQLNSLTPEDTAVYYCARGL 97 (117)
T ss_pred EEEECCCCHHHCEEEEEEEEc
Confidence 45 899999999999998864
No 274
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=35.32 E-value=1.6e+02 Score=25.59 Aligned_cols=47 Identities=11% Similarity=-0.066 Sum_probs=26.3
Q ss_pred EEEeccCccccccceeEeeeeEEecccEE----EEEEEecCCCcceeEEEEEee
Q psy8879 445 ILALVPTLTSQPLSYVTSLRANVTGLGTV----QVYVQLWTNYDPNCLLTITLY 494 (694)
Q Consensus 445 i~~l~~~~~~~~~~~i~~~~~n~~~~gtL----~~~v~~~d~G~YtC~~~n~~~ 494 (694)
+.|+....... ........-.+||+- ...++..+...|+|.|+-...
T Consensus 34 v~W~~dg~~~~---~~~~~~~~p~~d~tyq~~s~l~~~~~~~~~ysC~V~H~~l 84 (93)
T cd05770 34 IRLLKNGVKIP---KVEQSDLSFSKDWTFYLLKSTEFTPTKGDEYACRVRHNSM 84 (93)
T ss_pred EEEEECCEECC---CcEECcEEECCCCCEEEEEEEEECCCCCCeEEEEEEECCC
Confidence 55655444333 223333334456655 334666677889999986543
No 275
>PF06143 Baculo_11_kDa: Baculovirus 11 kDa family; InterPro: IPR009313 This is a family of uncharacterised Baculovirus proteins that are all about 11 kDa in size.
Probab=34.26 E-value=41 Score=28.75 Aligned_cols=17 Identities=18% Similarity=0.200 Sum_probs=11.8
Q ss_pred ccchhhhHHHHHHHHHH
Q psy8879 567 HYTSLINLSNVLSLCLV 583 (694)
Q Consensus 567 ~~~~~~~~~~~~~~~~~ 583 (694)
--+.++.+++|+|++++
T Consensus 29 N~sfirdFvLVic~~lV 45 (84)
T PF06143_consen 29 NRSFIRDFVLVICCFLV 45 (84)
T ss_pred ChHHHHHHHHHHHHHHH
Confidence 45677888887777653
No 276
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=34.23 E-value=32 Score=22.75 Aligned_cols=14 Identities=43% Similarity=0.681 Sum_probs=10.8
Q ss_pred CCCCEEEccCCCCC
Q psy8879 361 KSLQELRLDDNDIS 374 (694)
Q Consensus 361 ~~L~~L~Ls~N~L~ 374 (694)
++|++|+|++|.|.
T Consensus 2 ~~L~~LdL~~N~i~ 15 (28)
T smart00368 2 PSLRELDLSNNKLG 15 (28)
T ss_pred CccCEEECCCCCCC
Confidence 46788888888875
No 277
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=33.77 E-value=74 Score=27.77 Aligned_cols=31 Identities=6% Similarity=0.044 Sum_probs=20.0
Q ss_pred cEEEEEEEecCCC-cceeEEEEEeeeccceeE
Q psy8879 471 GTVQVYVQLWTNY-DPNCLLTITLYIDGDVIV 501 (694)
Q Consensus 471 gtL~~~v~~~d~G-~YtC~~~n~~~~~~~~~~ 501 (694)
++|....+..|.| .|+|.|++..++....+.
T Consensus 59 S~l~~~P~~~d~Gk~ltC~v~h~al~~~~~~~ 90 (95)
T cd07703 59 SEYSLVPTPEANGKEVTCKVEHETLQEPQLLP 90 (95)
T ss_pred EEEEEecCHHHCCCEEEEEEeCcccCCCeEEE
Confidence 3443344444544 599999999887666554
No 278
>PF05961 Chordopox_A13L: Chordopoxvirus A13L protein; InterPro: IPR009236 This family consists of A13L proteins from the Chordopoxviruses. A13L or p8 is one of the three most abundant membrane proteins of the intracellular mature Vaccinia virus [].
Probab=32.33 E-value=56 Score=26.59 Aligned_cols=19 Identities=32% Similarity=0.606 Sum_probs=12.1
Q ss_pred HHHHHHHHHHHHHHHHHHH
Q psy8879 577 VLSLCLVLLCVLIVILICV 595 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~ 595 (694)
|.-++++++|+.+|++++.
T Consensus 2 I~d~iLi~ICVaii~lIlY 20 (68)
T PF05961_consen 2 IGDFILIIICVAIIGLILY 20 (68)
T ss_pred hHHHHHHHHHHHHHHHHHH
Confidence 4555667778888774433
No 279
>PF11120 DUF2636: Protein of unknown function (DUF2636); InterPro: IPR019995 Members of this protein family are found invariably together with genes of bacterial cellulose biosynthesis, and are presumed to be involved in the process []. Members average about 63 amino acids in length and are not uncharacterised. The gene has been designated both YhjT and BcsF (bacterial cellulose synthesis F).
Probab=32.19 E-value=18 Score=29.10 Aligned_cols=24 Identities=21% Similarity=0.159 Sum_probs=13.5
Q ss_pred HHHHHHHHHHHHHHHHHHhhhcCCCCC
Q psy8879 581 CLVLLCVLIVILICVLVRKICRTPRNS 607 (694)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (694)
++.|++++.++ +..|..++++|+.
T Consensus 11 ~l~AlI~~pLG---yl~~~~~~r~~~~ 34 (62)
T PF11120_consen 11 ILCALIFFPLG---YLARRWLPRIRRT 34 (62)
T ss_pred HHHHHHHHhHH---HHHHHHhHHHHHH
Confidence 33344444444 7777777775543
No 280
>PHA03289 envelope glycoprotein I; Provisional
Probab=31.06 E-value=4e+02 Score=28.65 Aligned_cols=60 Identities=22% Similarity=0.434 Sum_probs=35.1
Q ss_pred CCCCCCCCCCCCCCCCCCCccchhhhHH-------HHHHHHHHHHHHHHHHHHHHHHHhhhcCCCCCcee
Q psy8879 548 FPSPPALPLAGPSTPTHSSHYTSLINLS-------NVLSLCLVLLCVLIVILICVLVRKICRTPRNSTIH 610 (694)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (694)
++|++-+..-.-.-++-++.||+-|+++ +|-|+..+++|+|.++ +..+-..||. +|+||-
T Consensus 234 ~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iy~s~~~~~~~~~l~--i~~~~~~~~s-~~~~iy 300 (352)
T PHA03289 234 AKSSPDIDLNATNLPLPISNYTDYMSVILRRVLPRLIYMSAYLVLCIIALL--IVTVCSACKS-PRRRIY 300 (352)
T ss_pred ecCCcceecccCCCCCcccccchhHHHHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHcCC-CCCcee
Confidence 3444443332223455677888888874 4666777777766544 3555566775 455554
No 281
>PF13260 DUF4051: Protein of unknown function (DUF4051)
Probab=30.56 E-value=39 Score=25.48 Aligned_cols=24 Identities=29% Similarity=0.516 Sum_probs=14.7
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCCc
Q psy8879 585 LCVLIVILICVLVRKICRTPRNST 608 (694)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~~~ 608 (694)
+++++++--+.-..++||..|+.|
T Consensus 10 li~lv~~gy~~hmkrycrafrqdr 33 (54)
T PF13260_consen 10 LIVLVVVGYFCHMKRYCRAFRQDR 33 (54)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhH
Confidence 334443334456688999987654
No 282
>PF15102 TMEM154: TMEM154 protein family
Probab=29.84 E-value=14 Score=34.88 Aligned_cols=11 Identities=27% Similarity=0.223 Sum_probs=5.4
Q ss_pred HHHHHHhhhcC
Q psy8879 593 ICVLVRKICRT 603 (694)
Q Consensus 593 ~~~~~~~~~~~ 603 (694)
+|+++..+.||
T Consensus 75 vV~lv~~~kRk 85 (146)
T PF15102_consen 75 VVCLVIYYKRK 85 (146)
T ss_pred HHHheeEEeec
Confidence 44555555444
No 283
>PF14654 Epiglycanin_C: Mucin, catalytic, TM and cytoplasmic tail region
Probab=29.62 E-value=1.2e+02 Score=26.62 Aligned_cols=34 Identities=18% Similarity=0.143 Sum_probs=24.5
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcCCCCC
Q psy8879 572 INLSNVLSLCLVLLCVLIVILICVLVRKICRTPRNS 607 (694)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 607 (694)
|-+++|.++-++|.+=++++ +.+-+|+ +.-+|+.
T Consensus 18 WeIfLItLasVvvavGl~aG-LfFcvR~-~lslrn~ 51 (106)
T PF14654_consen 18 WEIFLITLASVVVAVGLFAG-LFFCVRN-SLSLRNT 51 (106)
T ss_pred hHHHHHHHHHHHHHHHHHHH-HHHHhhh-ccccccc
Confidence 78888888877777777888 4466688 5556655
No 284
>PF06679 DUF1180: Protein of unknown function (DUF1180); InterPro: IPR009565 This entry consists of several hypothetical eukaryotic proteins thought to be membrane proteins. Their function is unknown.
Probab=28.76 E-value=1.1e+02 Score=29.62 Aligned_cols=64 Identities=13% Similarity=0.086 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCc----cchhhhHHHHHHHHHHHHHHHHHHHHHHHHHhhhcCCCCCceeec
Q psy8879 547 PFPSPPALPLAGPSTPTHSSH----YTSLINLSNVLSLCLVLLCVLIVILICVLVRKICRTPRNSTIHHH 612 (694)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (694)
+.++.++-+|.+++...|... .....|.-++--++.++.++-.++++++++|.+ |.|++..+++
T Consensus 60 ~~~~~~~~~g~~~~~s~~~~l~~~~s~~~~d~~~l~R~~~Vl~g~s~l~i~yfvir~~--R~r~~~rktR 127 (163)
T PF06679_consen 60 ATSSTDAPTGSASSSSSGGPLASRPSPSSPDSPMLKRALYVLVGLSALAILYFVIRTF--RLRRRNRKTR 127 (163)
T ss_pred CCCCCCCCCCCCCCCCCCCCcccccCCCcCCccchhhhHHHHHHHHHHHHHHHHHHHH--hhccccccce
No 285
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=26.03 E-value=1e+02 Score=28.42 Aligned_cols=27 Identities=19% Similarity=0.261 Sum_probs=9.1
Q ss_pred HHHHHHHHHhhhcCCCCCceeeccccCCC
Q psy8879 590 VILICVLVRKICRTPRNSTIHHHACFIPV 618 (694)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (694)
|+.++++++.+.|+.+|+....|- +|.
T Consensus 78 Ig~Illi~y~irR~~Kk~~~~~~p--~P~ 104 (122)
T PF01102_consen 78 IGIILLISYCIRRLRKKSSSDVQP--LPE 104 (122)
T ss_dssp HHHHHHHHHHHHHHS--------------
T ss_pred HHHHHHHHHHHHHHhccCCCCCCC--CCC
Confidence 343666666666666666566533 555
No 286
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=25.76 E-value=1.3e+02 Score=25.61 Aligned_cols=24 Identities=13% Similarity=0.023 Sum_probs=17.6
Q ss_pred cEEEEEEEecCCCc-ceeEEEEEee
Q psy8879 471 GTVQVYVQLWTNYD-PNCLLTITLY 494 (694)
Q Consensus 471 gtL~~~v~~~d~G~-YtC~~~n~~~ 494 (694)
++|...++..|.|. |+|.|.|..-
T Consensus 44 S~L~~~p~~eDdG~~~~C~a~~~~l 68 (82)
T cd05883 44 SQLMLKVTKEDDGVPVICLVDHPAV 68 (82)
T ss_pred EEEEEECchhhCCCEEEEEEcCccc
Confidence 56656666666665 9999999764
No 287
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=25.64 E-value=42 Score=45.58 Aligned_cols=32 Identities=34% Similarity=0.425 Sum_probs=26.3
Q ss_pred EccCCCCCCCCccccccCCCCccEEEccCCCCC
Q psy8879 149 GLPNNLLSVVPTSALAPLAPNLDRLDLSHNQLY 181 (694)
Q Consensus 149 ~Ls~N~L~~lp~~~~~~l~~~L~~L~Ls~N~L~ 181 (694)
||++|+|+.++...|..+ ++|++|+|++|.+.
T Consensus 1 DLSnN~LstLp~g~F~~L-~sL~~LdLsgNPw~ 32 (2740)
T TIGR00864 1 DISNNKISTIEEGICANL-CNLSEIDLSGNPFE 32 (2740)
T ss_pred CCCCCcCCccChHHhccC-CCceEEEeeCCccc
Confidence 578888888888888888 88888888888764
No 288
>COG2871 NqrF Na+-transporting NADH:ubiquinone oxidoreductase, subunit NqrF [Energy production and conversion]
Probab=25.62 E-value=77 Score=33.41 Aligned_cols=55 Identities=11% Similarity=0.217 Sum_probs=35.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhcCCCCCceeeccccCCCCccccccccCCCCCceeeeehhHHHhhccc
Q psy8879 577 VLSLCLVLLCVLIVILICVLVRKICRTPRNSTIHHHACFIPVAQQEDDINRNNSDSRYVKLQATTILLSSLK 648 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (694)
+..+.|+++++++++ ++++.|+. -|..|-|-+-. ++.+ .+-+-..|--+||.+|-
T Consensus 8 l~~~~Ft~i~l~Lv~-vIL~ak~k-------lv~~gd~ti~I-N~d~--------e~~~t~~aG~kLL~~L~ 62 (410)
T COG2871 8 LGIVMFTVIVLILVA-VILFAKSK-------LVKVGDITIKI-NGDP--------EKTKTVPAGGKLLGALA 62 (410)
T ss_pred HHHHHHHHHHHHHHH-HHHHHHhh-------eeecCceEEEe-CCCh--------hhceecCCchhHHHHHH
Confidence 356667777777766 66777765 35677887766 3333 33345677778887764
No 289
>PF05568 ASFV_J13L: African swine fever virus J13L protein; InterPro: IPR008385 This family consists of several African swine fever virus (ASFV) j13L proteins [, , ].
Probab=25.42 E-value=81 Score=29.59 Aligned_cols=42 Identities=24% Similarity=0.407 Sum_probs=19.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhhcC---CCCCceeeccccCCCCcc
Q psy8879 575 SNVLSLCLVLLCVLIVILICVLVRKICRT---PRNSTIHHHACFIPVAQQ 621 (694)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 621 (694)
++|+.++++.+ +++|+|++|+-|+--|+ +-+..|| |+|+.||
T Consensus 32 ~tILiaIvVli-iiiivli~lcssRKkKaaAAi~eediQ----finpyqD 76 (189)
T PF05568_consen 32 YTILIAIVVLI-IIIIVLIYLCSSRKKKAAAAIEEEDIQ----FINPYQD 76 (189)
T ss_pred HHHHHHHHHHH-HHHHHHHHHHhhhhHHHHhhhhhhccc----ccCcccc
Confidence 44445544333 33334466666554333 3333344 5666454
No 290
>PF04277 OAD_gamma: Oxaloacetate decarboxylase, gamma chain ; InterPro: IPR005899 This family comprises distantly related, low complexity, hydrophobic small subunits of several related sodium ion-pumping decarboxylases. These include oxaloacetate decarboxylase gamma subunit and methylmalonyl-CoA decarboxylase delta subunit [].; GO: 0008948 oxaloacetate decarboxylase activity, 0015081 sodium ion transmembrane transporter activity, 0071436 sodium ion export, 0016020 membrane
Probab=24.73 E-value=1.3e+02 Score=24.89 Aligned_cols=31 Identities=16% Similarity=0.275 Sum_probs=15.0
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHhhhcCC
Q psy8879 573 NLSNVLSLCLVLLCVLIVILICVLVRKICRTP 604 (694)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 604 (694)
.+..++|+++++..+++++ ++.+..++.++.
T Consensus 6 ~i~i~Gm~iVF~~L~lL~~-~i~l~~~~~~~~ 36 (79)
T PF04277_consen 6 QIMIIGMGIVFLVLILLIL-VISLMSKLIRKF 36 (79)
T ss_pred HHHHHHHHHHHHHHHHHHH-HHHHHHHHHHhh
Confidence 3434455544444444434 445666665553
No 291
>PF15048 OSTbeta: Organic solute transporter subunit beta protein
Probab=23.56 E-value=88 Score=28.73 Aligned_cols=34 Identities=26% Similarity=0.358 Sum_probs=16.3
Q ss_pred hhhhHH-HHHHHHHHHHHHHHHHHHHHHHHhhhcCCCCCcee
Q psy8879 570 SLINLS-NVLSLCLVLLCVLIVILICVLVRKICRTPRNSTIH 610 (694)
Q Consensus 570 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 610 (694)
+=||.. ++++++++ +|. ++++.|++-. =|+.++|
T Consensus 33 tpWNysiL~Ls~vvl-----vi~-~~LLgrsi~A-NRnrK~~ 67 (125)
T PF15048_consen 33 TPWNYSILALSFVVL-----VIS-FFLLGRSIQA-NRNRKMQ 67 (125)
T ss_pred CCcchHHHHHHHHHH-----HHH-HHHHHHHhHh-ccccccc
Confidence 338884 33333332 223 3456677733 3455555
No 292
>smart00013 LRRNT Leucine rich repeat N-terminal domain.
Probab=23.47 E-value=54 Score=22.52 Aligned_cols=26 Identities=27% Similarity=0.801 Sum_probs=16.3
Q ss_pred CCCCCCCCCCCCCCCcEEEccCCCchhhhhhhc
Q psy8879 56 CPSIKNDLCACDLPHTLRCTANKSDLYAISESL 88 (694)
Q Consensus 56 Cp~~~~~~C~C~~~~~v~C~~~~~~l~~i~~~L 88 (694)
||. .|.|. ...+.|.+. .|..+|.++
T Consensus 2 CP~----~C~C~-~~~V~C~~~--~L~~vP~~i 27 (33)
T smart00013 2 CPA----PCNCS-GTAVDCSGR--GLTEVPLDL 27 (33)
T ss_pred cCC----CCEEC-CCEeEeCCC--CcCccCCCC
Confidence 776 78887 667877653 344455444
No 293
>PF05393 Hum_adeno_E3A: Human adenovirus early E3A glycoprotein; InterPro: IPR008652 This family consists of several early glycoproteins (E3A), from human adenovirus type 2.; GO: 0016021 integral to membrane
Probab=23.28 E-value=72 Score=27.38 Aligned_cols=8 Identities=38% Similarity=0.426 Sum_probs=4.6
Q ss_pred cccccccc
Q psy8879 620 QQEDDINR 627 (694)
Q Consensus 620 ~~~~~~~~ 627 (694)
++-+.+||
T Consensus 74 P~~~~~~~ 81 (94)
T PF05393_consen 74 PQNLQIHR 81 (94)
T ss_pred CCcccccc
Confidence 34456677
No 294
>COG3190 FliO Flagellar biogenesis protein [Cell motility and secretion]
Probab=23.12 E-value=1.8e+02 Score=27.36 Aligned_cols=28 Identities=18% Similarity=0.542 Sum_probs=17.4
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHhhhc
Q psy8879 573 NLSNVLSLCLVLLCVLIVILICVLVRKICR 602 (694)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (694)
++..++.+.+.+|.+|++ ++|++|++.|
T Consensus 23 ~~~~~~gsL~~iL~lil~--~~wl~kr~~~ 50 (137)
T COG3190 23 ELAQMFGSLILILALILF--LAWLVKRLGR 50 (137)
T ss_pred HHHHHHHHHHHHHHHHHH--HHHHHHHHhh
Confidence 665555555555544432 5699999975
No 295
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=22.99 E-value=39 Score=28.56 Aligned_cols=30 Identities=3% Similarity=-0.243 Sum_probs=19.1
Q ss_pred EEEEEecCCCcceeEEEEEeeeccceeEEeec
Q psy8879 474 QVYVQLWTNYDPNCLLTITLYIDGDVIVQKNT 505 (694)
Q Consensus 474 ~~~v~~~d~G~YtC~~~n~~~~~~~~~~~~~~ 505 (694)
....+.+|+|.++|.|+ -++.........+
T Consensus 47 ~~~~~~~d~G~w~C~a~--~~~~k~~~s~~~i 76 (80)
T PF05790_consen 47 TFTPTTEDSGTWVCTAS--DNEPKERESKIEI 76 (80)
T ss_dssp EESBTCGGSEEEEEEEE--ECTTEEEEEEEEE
T ss_pred EecCCCCCCEEEEEEEc--CCceEEEEEEEEE
Confidence 34456799999999997 3444444444333
No 296
>PF13120 DUF3974: Domain of unknown function (DUF3974)
Probab=22.24 E-value=61 Score=28.11 Aligned_cols=40 Identities=23% Similarity=0.236 Sum_probs=27.1
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHhhhcCCCCCceeec
Q psy8879 573 NLSNVLSLCLVLLCVLIVILICVLVRKICRTPRNSTIHHH 612 (694)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 612 (694)
-+++++..+++.++|-+++|++.|.|+..-..-+|--.+|
T Consensus 5 ~~vl~l~g~llligftivvl~vyfgrk~ylswakpykrah 44 (126)
T PF13120_consen 5 KMVLLLIGTLLLIGFTIVVLLVYFGRKFYLSWAKPYKRAH 44 (126)
T ss_pred HHHHHHHHHHHHHHHHHHhhhheecceeeeeecChhhHHH
Confidence 3466677778888888888888888876544444444444
No 297
>PRK13415 flagella biosynthesis protein FliZ; Provisional
Probab=22.14 E-value=1.5e+02 Score=30.02 Aligned_cols=14 Identities=29% Similarity=0.520 Sum_probs=10.0
Q ss_pred HHHHHHHHHhhhcC
Q psy8879 590 VILICVLVRKICRT 603 (694)
Q Consensus 590 ~~~~~~~~~~~~~~ 603 (694)
|+|++++.||+.||
T Consensus 79 I~Liy~l~rwL~rR 92 (219)
T PRK13415 79 IFLIYALVKWLNKR 92 (219)
T ss_pred HHHHHHHHHHHHHh
Confidence 44466777899887
No 298
>PHA03281 envelope glycoprotein E; Provisional
Probab=22.13 E-value=2.8e+02 Score=31.85 Aligned_cols=19 Identities=5% Similarity=-0.354 Sum_probs=16.9
Q ss_pred EEEEEEEecCCCcceeEEE
Q psy8879 472 TVQVYVQLWTNYDPNCLLT 490 (694)
Q Consensus 472 tL~~~v~~~d~G~YtC~~~ 490 (694)
.+|.++..+++|-|.|++.
T Consensus 477 L~F~nApasaSGLYVfVl~ 495 (642)
T PHA03281 477 LKFVDAAESLSGLYVFIIH 495 (642)
T ss_pred eEeccCCcccCceEEEEEE
Confidence 4599999999999999985
No 299
>PHA03049 IMV membrane protein; Provisional
Probab=21.98 E-value=1.1e+02 Score=24.82 Aligned_cols=20 Identities=35% Similarity=0.595 Sum_probs=11.9
Q ss_pred HHHHHHHHHHHHHHHHHHHH
Q psy8879 577 VLSLCLVLLCVLIVILICVL 596 (694)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~ 596 (694)
|.=++++++|+.+|+|++..
T Consensus 2 I~d~~l~iICVaIi~lIvYg 21 (68)
T PHA03049 2 IGDIILVIICVVIIGLIVYG 21 (68)
T ss_pred hHHHHHHHHHHHHHHHHHHH
Confidence 34455667788777754433
No 300
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=21.64 E-value=1.5e+02 Score=25.65 Aligned_cols=30 Identities=7% Similarity=0.055 Sum_probs=19.3
Q ss_pred cEEEEEEEecCCCc-ceeEEEEEeeecccee
Q psy8879 471 GTVQVYVQLWTNYD-PNCLLTITLYIDGDVI 500 (694)
Q Consensus 471 gtL~~~v~~~d~G~-YtC~~~n~~~~~~~~~ 500 (694)
++|....+..|.|. |+|.+++..+..+...
T Consensus 59 S~l~~~p~~~d~G~~~tC~v~h~~l~~~~~~ 89 (95)
T cd05719 59 SEYRLVPSREANGKELTCVVSHPTLQEPQRF 89 (95)
T ss_pred EEEEEecCHHHCCCEEEEEEeCcccCCCeEE
Confidence 34444445555555 9999999888765433
No 301
>PF01462 LRRNT: Leucine rich repeat N-terminal domain; InterPro: IPR000372 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain and a C-terminal LRR domain (IPR000483 from INTERPRO). This entry represents the N-terminal LRR domain. ; PDB: 3E6J_A 1W8A_A 2V9S_C 2V9T_B 3TWI_D 3ZYN_A 3ZYO_A 1OOK_G 1QYY_G 1SQ0_B ....
Probab=20.83 E-value=42 Score=22.27 Aligned_cols=17 Identities=35% Similarity=1.077 Sum_probs=11.8
Q ss_pred CCCCCCCCCCCCCCCcEEEccC
Q psy8879 56 CPSIKNDLCACDLPHTLRCTAN 77 (694)
Q Consensus 56 Cp~~~~~~C~C~~~~~v~C~~~ 77 (694)
||. .|.|. ...|.|.+.
T Consensus 2 CP~----~C~C~-~~~V~C~~~ 18 (28)
T PF01462_consen 2 CPR----PCTCS-GLTVDCSGR 18 (28)
T ss_dssp SET----TSEEE-TTEEEETTS
T ss_pred cCC----CCEec-CCEeECCCC
Confidence 665 78887 667777653
No 302
>KOG1480|consensus
Probab=20.61 E-value=55 Score=38.88 Aligned_cols=29 Identities=10% Similarity=-0.063 Sum_probs=22.5
Q ss_pred ccEE-EEEEEecCCCcceeEEEEEeeeccc
Q psy8879 470 LGTV-QVYVQLWTNYDPNCLLTITLYIDGD 498 (694)
Q Consensus 470 ~gtL-~~~v~~~d~G~YtC~~~n~~~~~~~ 498 (694)
++.+ +..+.++|.|.|||++.|++-.-..
T Consensus 182 d~~li~~~arlsd~~nytc~a~ni~~~r~~ 211 (909)
T KOG1480|consen 182 DHNLIISQARLSDSGNYTCEATNIVAKRKS 211 (909)
T ss_pred cCCccccchhhhhcccceeeeehhhccccc
Confidence 3444 8899999999999999996654433
No 303
>PF03597 CcoS: Cytochrome oxidase maturation protein cbb3-type; InterPro: IPR004714 Cytochrome cbb3 oxidases are found almost exclusively in Proteobacteria, and represent a distinctive class of proton-pumping respiratory haem-copper oxidases (HCO) that lack many of the key structural features that contribute to the reaction cycle of the intensely studied mitochondrial cytochrome c oxidase (CcO). Expression of cytochrome cbb3 oxidase allows human pathogens to colonise anoxic tissues and agronomically important diazotrophs to sustain nitrogen fixation []. Genes encoding a cytochrome cbb3 oxidase were initially designated fixNOQP (ccoNOQP), the ccoNOQP operon is always found close to a second gene cluster, known as fixGHIS (ccoGHIS) whose expression is necessary for the assembly of a functional cbb3 oxidase. On the basis of their derived amino acid sequences each of the four proteins encoded by the ccoGHIS operon are thought to be membrane-bound. It has been suggested that they may function in concert as a multi-subunit complex, possibly playing a role in the uptake and metabolism of copper required for the assembly of the binuclear centre of cytochrome cbb3 oxidase.
Probab=20.52 E-value=1.4e+02 Score=22.43 Aligned_cols=7 Identities=0% Similarity=-0.102 Sum_probs=3.2
Q ss_pred HHhhhcC
Q psy8879 597 VRKICRT 603 (694)
Q Consensus 597 ~~~~~~~ 603 (694)
..|..|+
T Consensus 21 f~Wavk~ 27 (45)
T PF03597_consen 21 FLWAVKS 27 (45)
T ss_pred HHHHHcc
Confidence 3455444
No 304
>cd07697 IgC_TCR_gamma T cell receptor (TCR) gamma chain constant immunoglobulin domain. IgC_TCR_gamma; immunoglobulin (Ig) constant (C) domain of the gamma chain of gamma-delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha-beta TCRs but a small subset contain gamma-delta TCRs. Alpha-beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma-delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma-delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds.
Probab=20.03 E-value=2.5e+02 Score=24.49 Aligned_cols=16 Identities=13% Similarity=-0.041 Sum_probs=9.9
Q ss_pred EEEecCCCc-ceeEEEE
Q psy8879 476 YVQLWTNYD-PNCLLTI 491 (694)
Q Consensus 476 ~v~~~d~G~-YtC~~~n 491 (694)
.++.++.|. |+|.|.-
T Consensus 67 ~vt~~~~~~~ysC~V~H 83 (96)
T cd07697 67 TVTKDSLGKKFRCIYKH 83 (96)
T ss_pred EECchhCCCeEEEEEEE
Confidence 344433354 9999965
Done!